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Abstract 
 
The temporal regulation of restriction-modification (RM) systems is essential for 
the continued survival of the host cell. In many RM systems, this regulation is 
carried out by a controller (C) protein that is a key component of an intricate 
genetic switch. In the Esp136I RM system, the C-protein is a 79 amino acid protein 
that binds as a dimer to each of its three recognition sites (OM, OL and OR). A new 
purification strategy was devised to increase the yield of C.Esp1396I and two 
mutant proteins were expressed to either increase the solubility (Y29S) or 
increase the extinction coefficient (Y29W). 
 
The monomer-dimer equilibrium constant (Kdim) was determined to be ca. 1.6 µM  
by sedimentation equilibrium analytical ultracentrifugation. DNA binding studies 
were carried out using surface plasmon resonance and the affinities of C.Esp1396I 
for OM, OL and OR were determined to be 0.61 nM, 5.6 nM and 121 nM respectively. 
Binding of a dimer of C.Esp1396I to OL increases the affinity of a second dimer 
binding to OR ~130-fold, and is thus highly cooperative.  
 
The free protein structure of C.Esp1396I and an R53A mutant were determined by 
X-ray crystallography to 2.8 Å and 3.0 Å respectively. In both structures a flexible 
loop was identified between helices 3 and 4 that was able to adopt two distinct 
conformations. Structures of C.Esp1396I bound to either OL or OM were solved by 
X-ray crystallography (to 2.1 Å and 2.8 Å respectively). These nucleoprotein 
complex structures demonstrate that the flexible loop is involved in recognition of 
the C-boxes (inverted tetranucleotide repeats with the consensus: GACT), which 
are spaced differently in the two binding sites. R35, T36 and R46 were identified as 
key residues involved in sequence recognition. In the OL complex the flexible loop 
plays a key role in C.Esp1396I recognising two conserved elements that obey 
different symmetries. 
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 Chapter 1: Introduction 
1.1 Transcription in Prokaryotes 
The central dogma of molecular biology was outlined by Francis Crick (1970) in 
which he described the relationships between DNA, RNA and protein. The central 
dogma states that DNA directs its own replication and its transcription to mRNA 
and that the mRNA (in conjunction with other types of RNA) directs the translation 
of the genetic information to form proteins. The first stage of gene expression is 
the transcription of DNA to form mRNA. 
 
Transcription is carried out by the enzyme RNA polymerase (RNAP). RNAP 
catalyses the addition of nucleotide triphosphates (NTPs) into a polynucleotide 
through the release of pyrophosphate. The order in which the NTPs are added 
depends upon the sequence of the bases in the DNA template strand. Transcription 
can be divided into four phases: template binding, chain initiation, chain 
elongation and chain termination. The following sections describe transcription as 
it occurs in eubacteria (e.g. E. coli). 
1.1.1   Template binding 
The RNAP binds non-specifically to DNA and is recruited to specific sites by a 
sigma (ς) factor. There are a variety of different sigma factors in bacteria that are 
activated in response to different environmental conditions (e.g. when exposed to 
heat ς-32 is utilised in transcription). The regular ς-factor is ς-70, which is able to 
recognise a specific sequence (the -35 site) within the promoter region ca. 35 bp 
upstream of the transcription start site. Transcription can occur but with a lower 
efficiency if the -35 sequence is absent. The -35 site exhibits a large degree of 
sequence variability (e.g. GTAAGA upstream of the chloramphenicol 
acetyltransferase gene and CTGACG upstream of the araBAD operon; Hawley & 
McClure, 1983) and has the consensus sequence: TTGACA (Harley and Reynolds, 
1987). As the sequence is asymmetric, the ς-subunit must bind in a particular 
orientation, which determines the direction of transcription and defines the 1
 template strand. Once the RNAP-promoter complex is formed the polymerase 
unwinds ~20 base pairs (bp) of the DNA to form the open-complex which is 
required for initiation to occur. 
1.1.2   Chain initiation 
In the initial reaction the RNAP catalyses the reaction between two NTPs to form a 
dinucleotide with the release of pyrophosphate which is further hydrolysed and 
provides sufficient energy to drive the reaction. Nearly all prokaryotic mRNA 
transcripts have a purine (A > G) at the 5' end. During the transcription of the first 
15 bp the ς-subunit is released and the remainder of the transcription process is 
carried out by the core polymerase. It is common for the initial stages of 
transcription to result in abortive release of the nascent transcript (usually 2-3 
nucleotides in length) due to the relatively low efficiency of the initial 
polymerisation reactions.  
1.1.3   Chain elongation 
The transition from initiation to elongation is thought to occur when the nascent 
mRNA strand exceeds the volume of the active site pocket of the RNAP (Cheetham 
& Steitz, 1999). During the elongation phase the mRNA chain is extended in the 
5'-3' direction as the RNAP translocates along the DNA template. The incoming 
nucleotides base pair with the template strand and are incorporated into the 
growing mRNA strand. Movement of the RNAP along the DNA results in the DNA 
becoming supercoiled, with positive supercoiling occurring ahead of the 
transcription bubble (the unwound section of DNA) and negative supercoiling 
occurring behind the transcription bubble. The transcription of the DNA into 
mRNA occurs very rapidly (~ 20 - 50 nucleotides per second in E. coli) and with 
high fidelity. 
1.1.4   Chain termination 
Termination of transcription can occur through the action of additional factors or 
through the formation of secondary structures within the mRNA strand. The 
factor-independent termination of transcription occurs when the RNAP reaches a 
GC-rich palindromic sequence (termination sequence). When the RNAP reaches 2
 this sequence it pauses whilst the sequence is unwound. The unwinding of this 
sequence requires more energy due to the fact that C-G base pairs are able to form 
three hydrogen bonds as opposed to A-T base pairs which can only form two 
hydrogen bonds. The pause permits the mRNA transcript to form stable stem-loop 
structures that can cause spontaneous displacement of the mRNA from the 
template (if the following sequence contains a polyadenine tract) due to the weak 
A-U basepairs formed between the transcript and the template. The size of the 
poly-A tract is linked to the efficiency with which termination occurs (Tomizawa & 
Masukata, 1987). 
 
The factor-dependent termination of transcription occurs when the 
homohexameric Rho (ρ) factor binds to its recognition site on the mRNA and 
translocates along it (whilst unwinding the RNA-DNA duplex) in the 5'-3' direction 
until it encounters the RNAP at which point the mRNA strand is released. This can 
only occur if the RNAP is paused at the termination site. Other factors are known to 
play a role in the factor-dependent termination of transcription (e.g. NusA; Liu et 
al., 1996) but these are not yet fully understood, although it is proposed that NusA 
might act as a chaperone to promote the formation of the stem-loop mRNA 
structure, which is the irreversible step of chain termination (Epshtein et al., 
2007). 
1.2 Transcriptional regulation within prokaryotes 
The control of gene expression in all organisms involves complex interactions 
between proteins and DNA. It is important to have such control mechanisms in 
place so that specific genes will only be transcribed when required (e.g. in the 
presence of specific chemicals). This control achieves two major things: energy 
efficiency and continued survival of the host cell. In eukaryotes, controlling the 
transcriptional state of the gene permits cellular specialisation (e.g. neuronal cells) 
as every diploid cell contains the full complement of genes. In unicellular 
prokaryotes the regulation of gene expression is much simpler and can be divided 
into three types: positive, negative and attenuation. 
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 1.2.1   Positive regulation 
The lac operon is an example of gene regulation that exhibits both positive and 
negative regulation. The lac operon consists of three genes Z, Y  and  A that encode 
β-galactosidase, β-galactoside permease and β-galacoside transacetylase 
respectively. These genes are transcribed into a single mRNA from which the three 
proteins are translated. The expression of this operon is under the control of the 
promoter element directly upstream of the lacZ gene. The lac operon is expressed 
in response to the presence of lactose or low cellular concentration of glucose. 
 
When the cellular concentration of glucose decreases, the cellular concentration of 
cyclic adenosine monophosphate (cAMP) increases. cAMP then interacts with the 
catabolite gene activator protein (CAP) and the complex binds to the DNA 
upstream of the promoter element. Provided the CAP-cAMP complex binds on the 
same face of the DNA as the RNAP, it can stimulate the transcription of the lac 
operon through the recruitment of RNAP (figure 1.1 - top panel). This type of 
regulation is termed positive regulation. 
1.2.2   Negative regulation 
The lac operon also exhibits negative regulation. The operon is usually maintained 
in an "off" state by the action of the lac repressor protein which is encoded by the I 
gene. The repressor protein binds to the DNA directly upstream of the lacZ gene at 
region called the lac operator and prevents the RNAP from forming a viable 
initiation complex. This is an example of negative regulation as the constitutively 
active lacI gene encodes a protein that prevents the expression of the lac operon. 
In the case of the lac operon, this negative regulation is reversed when lactose is 
present. The lactose binds to a site on the repressor protein, which prevents it 
from binding to DNA thus permitting the formation of an RNAP open complex and 
the transcription of the lac operon (figure 1.1 - bottom pannel).  
1.2.3   Attenuation 
A well studied example of attenuation is found in the control of the trp operon that 
contains genes that mediate the synthesis of tryptophan (Yanofsky, 1988). In many 
cases in bacteria the translation of the mRNA is coupled with its transcription 4
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Figure 1.1: Positive and negative regulation of the expression of the lac operon. The 
promoter region lies upstream of the lacZ gene and lacZ, lacY and lacA are co-transcribed to 
produce a single mRNA transcript. (top panel) In conditions of low cellular glucose 
concentration, cyclic AMP (cAMP; black circle) binds to the catabolite gene activator protein 
(CAP; light green). This complex binds to the binding site in the promoter region and recruits 
RNA polymerase (RNAP) which upregulates transcription. (bottom panel) The repressor 
protein is transcribed from the lacI gene and binds to the operator sequence in the promoter 
region. This prevents binding of RNAP to the promoter and transcription is repressed (a). 
When an inducer (e.g. lactose) binds to the repressor it causes a conformational change, 
which reduces the affinity of the repressor for its operator sequence. This permits the RNAP 
to bind and facilitates the transcription of the lac operon in order to utilise lactose (b). 5
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Figure 1.2: Control of the trp operon by attenuation in E. coli. As the leader sequence is 
transcribed (blue line) it is translated into a polypeptide by the ribosome. The sequence 
indicated by box 1 contains two consecutive codons for tryptophan and boxes 2-4 are 
capable of interacting with each other to form stem-loop structures. (a) When cellular 
concentrations of tryptophanyl-tRNA are high, the ribosome does not stall at the trp-trp 
codons and this facilitates the formation of the 3.4 stem-loop, which stalls translation and 
acts as a transcription terminator. This prevents the trp operon from being transcribed. (b) 
When cellular concentrations of tryptophanyl-tRNA are low, the ribosome stalls at the two 
trp codons which permits the formation of the 2.3 stem-loop. This structure acts as an 
"anti-terminator" and permits the transcription of the trp operon in order to synthesise 
tryptophan. Figure adapted from Voet & Voet (2004). 6
 (i.e. the ribosome begins translation whilst the mRNA is being transcribed). In the 
trp operon the transcribed mRNA can form two alternative stem-loop structures. 
When a high concentration of tryptophan (and hence a high concentration of the 
tryptophanyl-tRNA) is present, the ribosome does not pause at the tryptophan 
codons in the leader peptide mRNA, permitting the formation of the 3.4 hairpin 
which acts as a transcriptional terminator (figure 1.2a). At low concentrations of 
tryptophan the ribosome translating the leader peptide mRNA pauses at the 
consecutive tryptophan codons. This permits the formation of the favoured 2.3 
hairpin which acts as an "anti-terminator" and permits transcription of the trp 
operon (figure 1.2b). In all cases, attenuation is regulated by the concentration of a 
particular charged tRNA and the formation of stem-loop structures, which can 
cause dissociation of the RNAP and hence transcriptional termination. 
1.3 DNA binding motifs 
In order for proteins to perform transcriptional control, they must recognise and 
bind to specific DNA sequences. The tertiary structure of the regulatory proteins 
provide this sequence "readout" capability. In prokaryotes the typical binding 
motifs are: helix-turn-helix (HTH), helix-loop-helix (HLH), leucine zipper and zinc 
finger. 
1.3.1   Helix-turn-helix (HTH) 
This is the most common DNA binding motif found in prokaryotes. The motif 
consists of two α-helices almost perpendicular to one another that are joined by a 
short region of amino acids that constitutes the turn. The more C-terminal helix 
(recognition helix) is inserted into the major groove of the DNA (figure 1.3) and the 
amino acid side chains form hydrogen bonds with specific bases (Mondragon & 
Harrison, 1991; Pabo & Sauer, 1992; Wintjens & Rooman, 1996). The more 
N-terminal helix is usually involved in forming non-specific interactions with the 
phosphodiester backbone, which stabilises the protein-DNA interaction.  
 
HTH proteins bind as homodimers to DNA (Pabo & Sauer, 1992), and the 
recognition sequence is composed of two symmetric sequences or "half-sites". This 
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 permits the protein to make two sets of identical interactions, which greatly 
increases the binding affinity. 
1.3.2   Leucine zipper 
The leucine zipper motif plays a role in the dimerisation of the protein and thus 
promotes DNA binding. Two α-helices from different monomers form a region of 
coiled-coil due to the periodic nature of hydrophobic residues (usually leucine) 
which occur every seventh residue. The formation of this leucine zipper can occur 
in the formation of homodimers (figure 1.4a) or heterodimers (figure 1.4b). The 
ability to form heterodimers permits the recognition of a wide variety of DNA 
sequences and is an example of combinatorial control in eukaryotes. 
 
When two proteins dimerise through a leucine zipper, a "Y-shape" structure is 
formed in which the two "arms" are inserted into the major groove of the DNA in 
opposite directions (figure 1.4b). The region of the α-helix that is inserted into the 
major groove of the DNA often contains basic residues (e.g. arginine and lysine) 
that can provide sequence recognition capability. These basic side-chains can also 
bind to the phosphate backbone of the DNA in a sequence independent manner. 
1.3.3   Helix-loop-helix (HLH) 
The helix-loop-helix motif shares common features with the leucine zipper, in that 
two α-helices are packed together through hydrophobic interactions and that the 
motif is responsible for both dimerisation (either heterodimers or homodimers) 
and DNA binding. The α-helices are part of the same polypeptide and are joined by 
a flexible loop region that permits one helix to fold back and pack against the other 
helix (figure 1.5a). 
 
DNA binding is accomplished by regions of positive charge that are in close 
proximity due to the dimerisation of the helix-loop-helix proteins (Sun et al., 
2000). The DNA recognition by the helix-loop-helix motif is carried out in a similar 
way to that seen in the leucine zipper (figure 1.5b). 
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Figure 1.3: The helix-turn-helix (HTH) DNA binding motif. The structure of cro bound to its 
DNA recognition sequence was solved by Mondragon & Harrison (1991; PDB accession code: 
3CRO). The HTH motif is highlighted,  where helix 2 is blue and the recognition helix (helix 3) 
is orange. cro binds as a dimer to the DNA and the recognition helix from each monomer is 
inserted into successive major grooves (a). The side chains of the recognition helix are shown 
as sticks to demonstrate the potential for sequence recognition (b). 9
90o 
a 
Figure 1.4: The leucine zipper DNA binding motif. (a) The structure of the c-Jun homodimer 
was solved by Junius et al. (1996; PDB accession code: 1JUN). The alpha helices from 
different subunits form a coiled-coil structure that is held together through the hydrophobic 
interaction of leucine residues. (b) The structure of the c-Jun/ATF-2 heterodimer bound to 
DNA was solved by Panne et al. (2004; PDB accession code: 1T2K). The ATF-2 is coloured 
blue and the c-Jun is coloured green. The helices are inserted into the major groove of the 
DNA and some of the N-terminal residues that are involved in binding to DNA are 
represented as sticks.* Residues make non-specific contacts with phosphate backbone.           
†  Residues are involved in both specific and non-specific interactions. 
b 
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Figure 1.5: The Helix-loop-helix (HLH) DNA binding motif. (a) The structure of the coat 
protein-binding domain of bacteriophage P22 scaffolding protein was solved by Sun et al. 
(1995; PDB accession code: 2GP8). The two helices (blue) are joined by a 4 amino acid turn 
(red). The motif is stabilised by the interactions between hydrophobic side chains. (b) The 
structure of the transcription factor Max (myc-associated factor X) bound to its cognate 
recognition sequence as a homodimer was solved by Ferré-D'Amaré et al. (1993; PDB 
accession code: 1AN2). The helices are joined by the red loop regions and a HLH motif is 
present between the helices of the same monomer. The helices are inserted into the major 
groove and recognition can be carried out in a similar way to the leucine zipper motif. 11
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Figure 1.6: The zinc finger DNA binding motif. The coordinated zinc ions are represented as 
pink spheres. (a) The structure of the glucocorticoid receptor bound to DNA was solved by 
Luisi et al. (1991; PDB accession code: 1R4O). The protein binds as a dimer and contains two 
cys4 zinc finger motifs, i and ii, which stabilise the dimer interface and the recognition helix 
respectively. The recognition helix is inserted into the major groove and can provide 
sequence recognition capability in the same way as HTH motifs. (b) The structure of the 
zif268-DNA complex was solved by Paveltich & Pavo (1991; PDB accession code: 1ZAA). The 
protein contains three consecutive cys2his2 zinc finger motifs (blue, green and orange), which 
permits the recognition of a larger DNA sequence by residues contained within the helices. 12
 1.3.4   Zinc finger 
The zinc finger motif comprises regions of secondary structure that are held in 
place by the coordination of a zinc ion by four highly conserved residues (cysteine 
and/or histidine). Although this motif was first identified and is predominantly 
found in eukaryotes, it can also be found in prokaryotes. The coordination of zinc 
can position two α-helices in a similar manner to the HTH motif, which permits 
dimerisation and DNA recognition through the insertion of one of the helices into 
the major groove (Luisi et al., 1991; figure 1.6a). 
 
An α-helix and a β-sheet can also be held together through the coordination of a 
zinc cation. This particular structure is often found in repeating units within a 
DNA-binding protein where the α-helix from each repeated element is inserted 
into the major groove (Pavletich & Pabo, 1991; figure 1.7b). This provides a strong 
and specific interaction between protein and DNA. This type of zinc finger motif 
allows the strength and specificity of the interaction to be modulated during 
evolution by adjusting the number of repeated zinc fingers in the protein. 
1.4 Restriction-modification (RM) systems 
Restriction-modification (RM) systems are present in most bacteria and protect 
the host from invasion (e.g. by bacteriophage; Wilson & Murray, 1991). The system 
consists of enzymes that perform two different functions that are encoded by 
genes often found on a plasmid, although some (e.g. ecoKI) are chromosomal. The 
methyltransferase (MTase) recognises a specific DNA sequence and transfers a 
methyl group from a donor (e.g. S-adenosyl methionine) to either a cytosine or an 
adenine. In the majority of cases, methylation of the recognition sequences is 
sufficient to protect the DNA from the action of the restriction endonuclease 
(ENase). However, in some cases (e.g. type IV RM systems and type IIM systems) 
methylation of the recognition sequence is required for ENase activity. The ENase 
recognises the same DNA sequence as the MTase and causes cleavage (or 
restriction) of the DNA either within the recognition sequence or at a distance. 
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 The RM system is named after the genus and species in which it was first 
discovered, the strain in which it was discovered and the order in which the RM 
system was identified (e.g. the EcoRI RM system was the first system to be 
discovered in the R strain of E. coli and EcoRV was the fifth to be discovered in the 
same strain). 
 
RM systems are divided into four major Types (Types I, II, III and IV) based on 
their subunit composition, their cofactor requirements and the position at which 
the ENase cleaves (Roberts et al., 2003a; Tock & Dryden, 2005; table 1.1). These 
Types can also contain subtypes (e.g. Type IIA and Type IIM). The details of the 
four major types are briefly considered below. 
1.4.1   Type I RM systems 
Type I RM systems (e.g. EcoR124I) are composed of three different protein 
subunits: the specificity subunit (HsdS), the modification subunit (HsdM) and the 
restriction subunit (HsdR) where Hsd is an acronym for host specificity for DNA 
and is often omitted from the protein name. In order to methylate the host DNA, a 
complex between one S and two M subunits is formed and the MTase subunits 
utilise S-adenosyl methionine (SAM) to methylate adenine residues in the bipartite 
and generally asymmetric recognition sequences, with a non-specific “spacer” (Kan 
et al., 1979). The restriction complex is formed from one S subunit, two M subunits 
and two R subunits. The R subunits utilise ATP to translocate the DNA before 
restriction occurs at a distant site (Seidel et al., 2004). Restriction occurs once 
translocation is stalled, which can occur through a blockage on the DNA such as 
another translocating enzyme, and requires Mg2+ (Janscak et al., 1999). Each R 
subunit cleaves a single DNA strand. 
1.4.2   Type II RM systems 
The majority of Type II RM systems contain a separate ENase and MTase that act 
independently of each other. Both the ENase and MTase recognise the same DNA 
sequence, which is usually palindromic and can range from 4-8 base pairs (bp) in 
size. The methyltransferase usually acts as a monomer, requires SAM as a cofactor 
and can methylate double-stranded DNA at positions 4 or 5 of cytosine or position 14
Type I Type II Type III Type IV 
Example RM system EcoKI EcoRI EcoP1I EcoMcrBC 
Genes hsdR, hsdM. hsdS ecoIR, ecoIM mod, res mcrB, mcrC 
Subunits Three different 
subunits (R, M & 
S) combine to 
form R2M2S1 and 
M2S1 
Two different 
subunits (R & M) 
conbine to form 
R2 or M1 
Two different 
subunits (mod & 
res) combine to 
form mod2res2 
Two different 
subunits are 
present, McrB & 
McrC 
Enzyme activities ENase, MTase, 
ATPase 
ENase or MTase ENase, MTase, 
ATPase 
ENase, GTPase 
Cofactors required 
for DNA cleavage 
ATP, SAM, Mg2+ Mg2+ ATP, Mg2+, (SAM) GTP, Mg2+ 
Cofactors required 
for methylation 
SAM SAM SAM No methylation 
Recognition 
sequence 
Asymmetric & 
bipartite 
Mostly symmetric Asymmetric Bipartite & 
methylated 
Cleavage site Variable locations 
1000 bp from 
recognition site 
Fixed location at 
or near the 
recognition site 
Fixed location 
25-27 bp from 
recognition site 
Between 
methylated bases 
at multiple sites 
DNA translocation Yes No Yes Yes 
Table 1.1: Characteristics of different classes of restriction-modification (RM) systems. 
Reproduced from Tock & Dryden (2005). 15
 6 of adenine. The ENase recognises the unmethylated DNA sequence (except in 
certain subtypes, e.g. Type IIM) and cleaves the DNA. The ENase usually acts as a 
homodimer (except Type IIT which are heterodimers, e.g. Bpu10I) with each 
monomer cleaving a single strand of the DNA. The double strand break in the DNA 
caused by the action of the ENase can have 5' overhangs (e.g. BamHI), 3' overhangs 
(e.g. KpnI) or bunt ends (e.g. SmaI). This property has made Type II restriction 
endonucleases useful in molecular biology and cloning and is the primary reason 
why there are more known Type II systems than any other Type of RM system. 
1.4.3   Type III RM systems 
Type III RM systems (e.g. EcoP1I) are composed of two different subunits: a 
modification subunit (mod) and a restriction subunit (res). The restriction of DNA 
requires a res2mod2 complex to be formed, as the restriction subunit is only active 
when associated in this complex (Janscak et al., 2001). Protection against 
restriction can be achieved through the action of a mod subunit, which is capable 
of hemi-methylating the recognition site through the transfer of the methyl group 
from SAM to the N6 of adenine. Two res2mod2 complexes must bind to asymmetric 
recognition sites that are orientated inversely. As for Type I RM systems, the Type 
III system first translocates the DNA and only cleaves upon stalled translocation 
(Dryden et al., 2001). The DNA is cleaved ~25 bases from the res subunit and each 
res2mod2 complex cuts a single strand. 
1.4.4   Type IV RM systems 
Type IV systems are homologous to motor proteins (e.g. DnaA) and only cleave 
modified DNA. Type IV RM systems consist of two different subunits (mcrB and 
mcrC), which are both involved in DNA restriction. For example, McrBC from E. coli 
K12 (Stewart et al., 2000) recognises two DNA sequences that are separated by 
between 40 and 3000 bases. The recognition sequence contains a purine followed 
by a cytosine, either of which must be methylated. The bound McrBC translocates 
DNA through utilisation of GTP (Pieper et al., 1997) and the stalling of 
translocation initiates restriction. 
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 1.4.5   Function and evolution of RM systems 
Although the RM system acts as a primitive "immune" system and protects its host 
from incoming foreign DNA, it also prevents incorporation of potentially 
advantageous plasmids into the host. In this "selfish" behaviour they act like 
viruses or transposons (Kobayashi, 2001). Additionally, if the RM system is 
displaced from the host (e.g. due to competition with other plasmids), the growth 
of the bacterial colony will be inhibited (Naito et al., 1998). Association of the RM 
genes with mobility-associated genes (Kita et al., 1999) further supports the 
theory that the RM system acts as a selfish, mobile genetic element. Another 
hypothesis suggests that Type I RM systems are involved in homologous 
recombination events and that this leads to an increase in genetic diversity (Price 
& Bickle, 1986). 
 
The mobility of RM systems is supported by evidence of horizontal gene transfer. 
The codon usage within the RM system and the bacterial chromosome can vary 
significantly which is indicative of horizontal gene transfer (Jeltsch & Pingoud, 
1996). Indeed, some bacteria contain many potential RM systems but only one is 
functional at any given time (Alm et al., 1999; Handa et al., 2001). This allows the 
bacteria to rapidly adapt to changes in their environment and increases the 
likelihood of survival. 
1.5 Controller proteins 
The order in which the RM enzymes are expressed within the bacterial host must 
be under strict temporal control. If the ENase is active before the host DNA has 
been fully methylated, the consequences may lead to auto-restriction and host cell 
death. It has been shown by Mruk and Blumenthal (2008) that upon establishment 
of the PvuII RM system within a naive host, the ENase activity is delayed by ~10 
minutes with respect to MTase activity. This transcriptional regulation is carried 
out by a small HTH protein called a controller (C) protein. The delay in ENase 
activity may also be due in part to the fact that the mRNA transcript containing the 
R gene is often leaderless (Sorokin et al., 2009) which reduces the efficiency of 
translation. 17
  
As of June 2011 there are 18 identified C-proteins and 242 putative C-proteins 
present in the REBASE database (Roberts et al., 2010; rebase.neb.com). The best 
studied of these are C.PvuII, C.AhdI and C.Esp1396I. The remainder of this section 
will provide a chronological account regarding the discovery of the C-proteins, 
determination of their function and binding sites and the elucidation of the first 
X-ray crystal structures. 
1.5.1   Activity and gene organisation 
In 1988, Nathan and Brooks (1988) noticed that interrupting a short open reading 
frame (ORF) in the type II RM system BamHI, was sufficient to alter the levels of 
expression of the RM genes. Similarly, Tao et al. (1991) repeated the experiment 
on a short ORF in the PvuII system and proposed that the ORF coded for a protein 
that acted in trans, which they designated the controller (C) protein. Having 
sequenced the plasmid containing the entire PvuII RM genome, it was discovered 
that the ORF lay between the ENase and MTase genes. Frameshift mutations were 
induced in the ORF, altering the DNA sequence and thus the protein sequence. Tao 
and colleagues discovered that the level of expression of the MTase was unaffected 
by the mutation. In contrast, the expression of the ENase gene was greatly reduced. 
This suggested that the C-protein acted as a promoter of ENase expression as the 
MTase was unaffected. Using sequence comparisons, it was demonstrated that the 
C-protein shared common features with known DNA binding proteins (Tao et al., 
1991; Wintjens and Rooman, 1996) and that sequences homologous to the C gene 
in PvuII could be found in other Type II RM systems. In addition, the derived amino 
acid sequence was recognised to be similar to small ORFs in SmaI (Bougueleret et 
al., 1984) and EcoRV (Heidmann et al., 1989). 
 
Subsequently, other ORFs coding for C-proteins were discovered in Eco72I 
(Rimšelienė et al., 1995), Kpn2I (Lubys et al., 1999), Esp1396I (Česnavičienė et al., 
2003) and AhdI (Streeter et al., 2004). The genes for these proteins were fairly well 
conserved, but the organisation differed. In the bacterial systems Eco72I, BamHI 
and PvuII, and indeed in most other RM systems to date, the ENase and MTase 
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 genes are divergent and the C gene is found immediately upstream of the ENase 
gene (Roberts et al., 2003). In Kpn2I, the ENase and MTase genes converge. The  C 
gene is found upstream of the MTase gene and is orientated divergently from the 
MTase gene. The AhdI RM system is found in the pathogen Aeromonas hydrophila, 
and shares features with Type I RM systems in that the methylase consists of M 
(modification) and S (specificity) subunits (Marks et al., 2003).  
 
In the aforementioned RM systems, the action of the C-proteins differs. The 
majority of C-proteins will bind upstream of the C and ENase genes to increase the 
level of transcription of the ENase gene. In some cases the C-protein also acts as a 
repressor of MTase expression. However, in the Kpn2I RM system, the binding site 
for the C-protein was found to be upstream of the MTase gene only (Lubys et al., 
1999). In this system, the C-protein was found to repress the expression of the 
MTase gene whilst having no effect on the expression of the ENase. Another 
exception to the role of the C-protein was found in the LlaI RM system (O'Sullivan 
and Klaenhammer, 1998), in which the C gene was found upstream of the MTase 
gene, but which regulated at the level of post-transcription.  
1.5.2   Controller protein binding sites 
In order for the C-protein to act as an activator for the ENase gene, it would have to 
have a binding site upstream of the ENase gene. In order to characterize this site, 
DNA sequences upstream of the C gene were studied. Rimšelienė et al. (1995) 
hypothesized that as all C-proteins were predicted to contain a HTH motif, they 
would bind to similar DNA sequences. Hence, they compared the DNA sequences 
upstream of the C gene in a number of different RM systems. A 12 bp sequence was 
identified and proposed as a potential target site for the C-protein. This sequence 
was named a C-box. However, Anton et al. (1997) also identified a possible C-box 
upstream of the BglII C gene. They proposed that an 18 bp sequence upstream of 
the C gene was responsible for the control of C expression. It was argued (Bart et 
al., 1999) that both of these putative C-boxes were too large for a C-protein binding 
site. Comparison of the target sites for known HTH motif containing proteins, they 
suggested, would result in the C-box containing 7 bp. An 11 bp C-box was 
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 experimentally determined by Vijesurier et al. (2000) that was of a symmetrical 
nature. The two inverted repeats were separated by three bases, suggesting that 
the C-protein bound DNA as a homodimer. This idea of C-protein dimerisation was 
initially proposed by Lunnen et al. (1997) and was thought to be mediated by 
leucine zippers. 
 
Kita et al. (2002) used deletion analysis to determine the size of the C-box in the 
EcoO109I RM system. Initially, the C-protein was assayed for activity in vivo. In 
agreement with other findings, the C-protein was found to act in trans and 
stimulated the expression of the ENase gene, whilst having no effect on the MTase 
gene expression. By using synthetic oligonucleotides of varying lengths, it was 
shown by gel shift analysis that the C-protein bound to two 5bp sequences 
separated by five nucleotides. Whilst distinctly different from the PvuII system, it 
highlighted the fact that the C-protein bound DNA as a homodimer. 
 
Sequence comparisons of putative C-protein binding sites identified a consensus 
sequence for the C-box: GACT-(N3)-AGTC-(N4)-GACT-(N3)-AGTC (Vijesurier et al., 
2000; Knowle et al., 2005; figure 1.7). This sequence would permit the binding of 
two dimers upstream of the C/R operon, one dimer to each GACT-(N3)-AGTC 
operator site (OL: distal (left) operator site; OR proximal (right) operator site) as 
first suggested by Streeter et al., (2004) and subsequently demonstrated by gel 
shift analysis and analytical ultracentrifugation (McGeehan et al., 2006). The 
consequence of having two dimer binding sites will be discussed in relation to its 
mechanism of regulation in section 1.5.4. It was noted that other elements outside 
the C-boxes were also highly conserved. In fact, a central GT pair is more highly 
conserved than the C-boxes themselves. Mruk and colleagues (2007) noted that a 
flanking TG (and its symmetry related pair: CA) along with TAT and the central GT 
were highly conserved (figure 1.7). It was noted by McGeehan et al. (2008) that 
this alternative conserved element exhibited a different dyad symmetry axis and 
that both the conserved elements might play a role in sequence recognition. These 
alternative symmetries will be discussed in detail in section 1.6.  
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TGnGACTTATAGTCnGTnGACTTATAGTCnnCA 
OL OR 
Figure 1.7: The consensus sequence of the C-protein binding site upstream of the C and R 
genes. (top) Reproduced from Knowle et al. (2005). The C/R promoter region of different 
RM systems are aligned. "?"  indicates a putative C-protein. The tetranucleotide inverted 
repeats are highlighted in the grey boxes (1A, 1B, 2A, 2B). The logo analysis of this alignment 
shows the degree of conservation of a particular base, where a value of 1 indicated that the 
base is conserved across all species. The grey boxes indicate the position of the C-boxes. 
(bottom) The idealised consensus sequence suggest that in addition to the conservation of 
the C-boxes (underlined) other bases are conserved (red) which have a pseudo-dyad axis 
that is shifted by half a base. The pseudeo-dyad axis for the C-box symmetry is shown as a 
black arrow and the axis for the other conserved elements is shown as a red arrow. The 
promoter can be split into two operators (OL and OR) each of which is capable of binding a 
C-protein dimer. 21
 1.5.3   The structure of controller proteins 
The amino acid sequence of the C-protein suggested that it would contain a 
helix-turn-helix (HTH) motif (Tao et al., 1991). HTH motifs are common in DNA 
binding proteins and have been shown to bind DNA with a helix inserted across 
the major groove (section 1.3.1). Tao et al. (1991) compared the amino acid 
sequence of the PvuII controller protein with other known DNA binding proteins. It 
was found that a 16 amino acid sequence of the C-protein was highly conserved 
with the HTH region of the cI protein of the lambda (λ) bacteriophage. As the 
sequences of the C gene are also highly conserved across RM systems, it was 
hypothesized that all C-proteins would contain a HTH motif that would bind to 
similar sites in the DNA (Ives et al., 1995). 
 
In 2005, the first structure of a C-protein was elucidated (McGeehan et al., 2005; 
figure 1.8) by X-ray crystallography. As predicted, the protein C.AhdI consisted of 
five helices joined by unstructured regions and forms homodimers, as expected 
from analytical ultracentrifugation (AUC) studies in solution (Streeter et al., 2004). 
Dimerisation is mediated by interactions between the N-terminal region of helix 1, 
helix 5 and the loop regions between helices 3 and 4 of each of the monomers. 
Comparing the elucidated crystal structure with that of the cI protein of the 
bacteriophage lambda added weight to the hypothesis (Streeter et al., 2004) that a 
C.AhdI dimer could interact with the ς-70 subunit of RNAP (McGeehan et al., 
2005). This proposed mechanism would allow the C-protein to act as an activator 
of the ENase gene, provided that there was a -35 site in close proximity to the 
C-protein target site. The evidence for the hypothesis that the C-protein could act 
as a transcriptional regulator is discussed in section 1.5.4. 
 
Subsequently, the structure of C.BclI was also solved by X-ray crystallography 
(Sawaya et al., 2005; figure 1.9). This structure is very similar to that of C.AhdI, 
containing an HTH motif but has an extended helix 5 which increases the buried 
surface area at the dimer interface. The structure of C.Esp1396I bound to its DNA 
recognition sequence was subsequently solved by McGeehan et al. (2008). This 
structure will be discussed in more detail in section 1.6. 22
Figure 1.8: The X-ray crystal structure of a monomer of C.AhdI. The protein consists of 5 
α-helices joined by loop regions (yellow). Helices 2 and 3 form the HTH motif with helix 3 
acting as the recognition helix. The structure was solved as a dimer and the dimer interface 
is formed between the N-terminal region of helix 1, helix 5 and the loop region between 
helices 3 and 4. Reproduced from McGeehan et al. (2005). 23
Helix 3 
Helix 2 
Helix 1 
Helix 5 
Helix 4 
Figure 1.9: The X-ray crystal structure of a monomer of C.BclI. The dimeric structure was 
solved by Sawaya et al. (2005; PDB accession code 2B5A). The protein consists of 5 α-helices 
joined by loop regions. Helices 2 and 3 form the HTH motif with helix 3 acting as the 
recognition helix. The dimer interface is formed between the N-terminal region of helix 1, 
helix 5 and the loop region between helices 3 and 4. 24
 1.5.4   C-proteins as genetic switches 
In 2004, Streeter et al. proposed that C-proteins acted as genetic switches. They 
suggested that at low concentrations the predominant species of C.AhdI would be 
the monomer as the KD for the dimer was 2.5 µM. As the concentration of C.AhdI 
increased (via transcription from a weak upstream promoter) it would dimerise 
and be capable of binding to its operator sites. It was proposed that the C-protein 
would first bind to the distal operator site (OL) and this would permit recruitment 
of the RNAP to the -35 site through interactions between C.AhdI and the ς-70 
subunit. Consequently, this would upregulate the expression of both the C and R 
genes. As the C.AhdI concentration increased further, C.AhdI would bind to the 
proximal operator site (OR) and occlude the -35 site. The binding of a tetramer was 
thus proposed to down-regulate the expression of the C and ENase genes in AhdI. 
This mechanism (outlined in figure 1.10) was subsequently verified by AUC and 
EMSA studies of the relevant protein-DNA interactions (McGeehan et al., 2006). It 
was demonstrated that C.AhdI could bind to a 35 base sequence as a tetramer. 
There was clear evidence of cooperativity, with the binding of a C-protein dimer to 
OR greatly increased if there was a dimer already bound to the stronger binding 
site, OL. 
 
Further evidence to support the hypothesis that C-proteins act as genetic switches 
has been obtained (Mruk et al., 2007; Bogdanova et al., 2008; Mruk & Blumenthal, 
2008). In the PvuII system, the C-protein regulates the expression of its own gene 
and the ENase gene, and upon introduction of the PvuII RM system into a naїve 
host, the ENase expression was delayed by ~10 minutes with respect to the MTase 
expression. This, alongside other in vivo and in vitro experiments suggested that 
C.PvuII may act as a genetic switch. Bogdanova et al., (2008) performed 
transcription assays which demonstrated that the expression from the C.AhdI C/R 
promoter varied with the concentration of C.AhdI. At very low C.AhdI 
concentrations, transcription was negligible. The transcriptional activity reached 
maximal levels at ~10 nM C.AhdI and that further increases in C.AhdI 
concentration resulted in reduced transcriptional activity. 
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Figure 1.10: The C-protein as a genetic switch in the AhdI RM system. (a) The structure of 
the operator sequence upstream of the C gene (blue). The -10 site is indicated in pink. At 
critical concentration monomers of C.AhdI dimerise (b). The dimer then binds to the distal 
operator sequence (OL) and interacts with the σ-70 subunit of RNAP (c) thereby increasing 
the level of expression of the C gene. At increased concentrations of C.AhdI (d) the proximal 
operator (OR) is occupied by a second dimer of C.AhdI This acts to repress transcription of 
the C gene by occluding the -35 site. Reproduced from McGeehan et al. (2006).  
a 
b 
c 
d 
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 1.6 The Esp1396I RM system 
The Esp1396I RM system was first isolated from Enterobacter species strain 
RFL1396. It is a Type IIP RM system and contains the genes esp1396IM, esp1396IR 
and esp1396IC. The C gene is located upstream of the R gene and both the C and R 
genes are transcribed as a single operon to produce one mRNA transcript. The C/R 
genes are arranged in a convergent manner with the M gene (figure 1.11 - top) and 
it is thought that both ORFs could share the same transcriptional terminator 
(Česnavičienė et al., 2003). The MTase (332 amino acids) and ENase (307 amino 
acids) recognise the sequence 5'-CCANNNN/NTGG-3' (where "/" signifies the 
ENase cleavage site). The MTase was found to methylate the 6 position of the 
adenine and unregulated expression of the MTase was toxic to the cell. 
(Česnavičienė et al., 2003) 
 
The esp1396IC gene was identified from the sequence of the plasmid containing the 
RM system (Česnavičienė et al., 2003). It was noted that there was an ORF 
upstream of the R gene which coded for a 79 amino acid protein which shared 
~50% sequence identity with other known C-proteins. They noted that similar to 
other C-proteins the predicted protein contained a possible HTH motif. C.Esp1396I 
was found to act as a transcriptional repressor of esp1396IM and acted as a 
transcriptional activator of the esp1396IC/R genes. 
1.6.1   Recognition sequences 
Česnavičienė et al. (2003) located four putative C-boxes upstream of the C/R genes 
(figure 1.11 - bottom). These boxes were arranged in a similar manner to those 
found in other RM systems containing C-proteins. Subsequently, McGeehan 
et al. (2008) demonstrated that the WT DNA sequence was capable of binding a 
tetramer (or two dimers) of C.Esp1396I in a cooperative manner. Deletion of the 
two C-boxes proximal to the transcriptional start site (boxes 3 and 4 in figure 1.11) 
only permitted binding of a dimer of C.Esp1396I. Deletion of the two boxes distal 
to the transcriptional start site (boxes 1 and 2 in figure 1.11) abolished binding of 
C.Esp1396I. These results suggested that the regulation of the esp1396IC/R genes 
was similar to that observed in the AhdI system and that the promoter could be 27
C R M 
1kb 
Box 1 Box 2 Box 3 Box 4 
Figure 1.11: Proposed gene organisation and C-protein recognition sequence of the 
Esp1396I RM system. (top) The C and R genes form an operon that is convergent with the M 
gene. Both the C/R operon and the M gene may share a transcriptional terminator located 
between R and M. (bottom) Sequence alignment of the regions upstream of the C and R 
genes and M gene. The C-boxes are boxed (1-4) and the conserved residues are shaded in 
grey. The C-box consensus sequence and the ideal inverted repeats are shown. The 
sequences prefixed with M indicate that they lie upstream of the M gene in the indicated 
systems and the sequences prefixed with C indicate that they lie upstream of the C/R operon 
in the indicated systems. gaps in the alignment are indicated with an asterisk (*). 
Reproduced from Česnavičienė et al. (2003). 28
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 split into two distinct operators: OL and OR (distal and proximal to the 
transcriptional start site respectively). 
 
Česnavičienė et al. (2003) also postulated a similar arrangement of C-boxes 
upstream of the esp1396IM gene (figure 1.11). During the course of this PhD 
investigation, Bogdanova et al. (2009) published a paper in which they mapped the 
transcriptional start sites of all of the genes in the Esp1396I RM system and 
performed DNA footprinting of the promoter regions. In collaboration with the 
Portsmouth lab they confirmed the ability of a tetramer to bind to the C/R 
promoter but found that only a dimer bound to upstream of the esp1396IM gene. 
Moreover, this binding site (designated OM) overlapped the transcriptional start 
site of the M gene (figure 1.12).   
1.6.2   Protein-DNA complex 
The C.Esp1396I C/R promoter contains four C-boxes that are highly conserved 
across many different C-proteins (Vijesurier et al., 2000; Knowle et al., 2005; Mruk 
et al., 2008; Sorokin et al., 2008). Additionally, it contains other highly conserved 
bases. These two conserved elements have a different pseudo-dyad axis relating 
the two operator sites (McGeehan et al., 2008; figure 1.13). Mutational analysis of 
the promoter region demonstrated that both conserved elements were important 
in the formation of nucleoprotein complexes (Bogdanova et al., 2009). If the dimers 
are centred about the C-boxes, the pseudo-dyad axis falls between the centrally 
conserved GT (figure 1.13a). However, if the dimers are centred about the 
conserved TATA sequence, the pseudo-dyad axis falls on the centrally conserved T 
(figure 1.13b). It was hoped that determination of the structure of the C.Esp1396I 
protein bound to its promoter would shed light on this enigma. 
 
Although published in 2008 (McGeehan et al., 2008), the structure of a tetramer 
bound to the WT C/R promoter was elucidated prior to the start of this 
investigation by the Biomolecular Structure Group at the University of Portsmouth 
and the details will be briefly discussed here. The structure of a tetramer bound to 
the WT C/R promoter was solved to 2.8 Å. The structure highlighted the role of 
30
 some key residues in C.Esp1396I and identified some of the protein-DNA 
interactions (figure 1.14). In particular, R35 was identified as a key residue that 
played a role in sequence recognition (figure 1.14d) and in the interaction between 
the two dimers (figure 1.14b). It was postulated that the interaction at the 
dimer-dimer interface between R35 from one dimer and E25 from a second dimer 
may play a role in the cooperative nature of the binding. Indeed, gel-shift analysis 
demonstrated that an E25A mutant of C.Esp1396I resulted in a much lower 
cooperativity and that mutation of R35 abolished specific binding. The R35 was 
found to recognise guanine in the conserved elements flanking the C-boxes and 
formed two hydrogen bonds between the guanidinium head group and the N7 and 
O6 of the guanine. Additionally, the planar head group of the R35 was found to be 
involved in π-stacking with the conserved T. 
 
The interface between the two monomers was found to be mediated by mostly 
backbone interactions (figure 1.14a). Other key residues that were identified 
included Y37 and S52, although the extent of their interactions were unclear. 
These residues were found to be interacting with the phosphate backbone of the 
DNA on either side of the conserved TATA sequence and were thought to be 
responsible for stabilising the bend in the DNA. 
 
The information that could be extracted from this structure was limited due to 
symmetry averaging. This occurred due to the structure existing in two evenly 
distributed orientations within the crystal that were related by the pseudo-dyad 
axis. This symmetry averaging made the identification of interactions between the 
recognition helix (helix 3) and the C-boxes difficult. Also, due to the fact that the 
resolution of the structure was 2.8 Å, solvent molecules (which could potentially 
be involved in mediating protein-DNA interactions) could not be identified. 
1.7 Project aims 
At the outset of this project, relatively little had been published about C.Esp1396I. 
Česnavičienė et al. (2003) had identified the RM system and demonstrated that 
C.Esp1396I acted as a repressor of esp1396IM and as an activator of esp1396IC/R. 31
Figure 1.13: The two conserved elements in the esp1396IC/R promoter have a different 
centre of symmetry. (a) The C-box symmetry with the pseudo-dyad axis centred on GT. (b) 
An alternative symmetry with the pseudo-dyad axis centred on T relates the other conserved 
elements. The pseudo-dyad axis within the operators is shown as a blue dashed line and the 
pseudo-dyad axis between the two operators is shown as a red dashed line. Reproduced 
from McGeehan et al. (2008). 
a 
b 
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Figure 1.14: The X-ray crystal structure of the tetrameric repression complex formed 
between C.Esp1396I and the C/R promoter. The two dimers bind to almost opposite faces 
of the DNA and helix three from each monomer is inserted into the major groove. (a) The 
interactions involved at the dimer interface in the loop region between helices 3 and 4. (b) 
The R35 from one dimer interacts with the E25 of the other dimer across the expanded 
major groove of the DNA and the remaining R35 interacts with the centrally conserved 
guanine. (c) Y37 and S52 are involved in the compression of the minor groove at the TATA 
sites through interacting with the phosphodiester backbone. (d) The R35 residues from the 
outer monomers make a bidentate interaction with the conserved guanine. This figure is also 
published in McGeehan et al. (2008). 33
 The Biomolecular Structure Group at the University of Portsmouth, in 
collaboration with Dr. Konstantin Severinov's group at Rutgers University (New 
Jersey, USA), had evidence to suggest that C.Esp1396I acted as a genetic switch in 
the manner of C.AhdI (McGeehan et al., 2006). Subsequently, the structure of the 
tetrameric repression complex was solved and key residues (e.g. R35 and E25) 
were identified. 
 
Due to the relatively low resolution and the symmetry averaged nature of the 
structure, no information could be obtained to identify interactions between the 
recognition helix and the DNA. There were two possible symmetries that the 
nucleoprotein complex could adopt and this could not be resolved from the 
tetrameric structure. Therefore, it was the aim of this project to obtain structural 
information regarding the OL and OM nucleoprotein complexes using X-ray 
crystallography. The buried surface area at the monomer-monomer interface 
(~1900 Å2) was greater than that observed in the C.AhdI structure (~1400 Å2; 
McGeehan et al., 2005) due to an extended helix 5 and it was postulated that the 
C.Esp1396I dimer would be more stable than the C.AhdI dimer. To obtain the 
affinity constant for the monomer-dimer equilibrium sedimentation equilibrium 
analytical ultracentrifugation (AUC) would be performed. In order to obtain a 
reliable estimate for the affinity constant, protein concentrations above and below 
the KD were required. As the KD was expected to be < 2.5 µM it would be necessary 
to produce a mutant protein (using site-direced mutagenesis) with a higher 
extinction coefficient to enable the collection of AUC data at low C.Esp1396I 
concentrations. 
 
Also, the relative binding affinities of C.Esp1396I for OM, OL, OR and the native C/R 
promoter (OL+R) were unpublished, although it was known that the affinity for OL 
was greater than the affinity for OR as had been seen in C.AhdI (McGeehan et al., 
2006) and gel-shift assays of C.Esp1396I and the C/R promoter demonstrated that 
the binding of two dimers was highly cooperative (Streeter, S. D., personal 
communication). Therefore, it was planned to perform surface plasmon resonance 
34
 (SPR) experiments to provide both kinetic and affinity data for the binding of 
C.Esp1396I to its operators. 
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 Chapter 2: Materials and Methods 
 
2.1 Materials 
All buffers were made using deionised water and either filtered through sterile 
0.2 µm filters or autoclaved. 
2.1.1   Stock solutions 
10% w/v APS    stored as 250 µL aliquots at -20°C 
10 mg/mL EtBr   light sensitive, stored in the dark 
1 M IPTG    made fresh when required 
50 mg/mL Kanamycin  stored as 250 µL aliquots at -20°C 
100 mM PMSF    
3 M Tris-HCl pH 8.45 
3 M sodium acetate 
5 M NaOH 
2.1.2 Electrophoresis 
ProtoGel     30% w/v acrylamide 
(National Diagnostics)   0.8% w/v Bis-acrylamide 
 
19:1 AccuGel     38% w/v acrylamide 
(National Diagnostics)   2% w/v Bis-acrylamide 
 
Tris-tricine SDS PAGE anode buffer 200 mM Tris-HCl pH 8.9 
 
Tris-tricine SDS PAGE cathode buffer 100 mM Tris 
      100 mM Tricine 
      0.1% w/v SDS 
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 4% Tris-tricine SDS PAGE   13.3% v/v ProtoGel 
stacking gel solution    1 M Tris-HCl pH 8.45 
      0.1% w/v APS    
      0.2% v/v TEMED 
 
12% Tris-tricine SDS PAGE   40% v/v ProtoGel  
resolving gel solution   1 M Tris-HCl pH 8.45 
      10% v/v glycerol 
      0.1% w/v APS 
      0.2% w/v TEMED 
 
16% native PAGE gel   1 x TBE 
      40% AccuGel 
      0.1% w/v APS 
      0.2% v/v TEMED 
 
Native Page running buffer   1 x TBE 
 
10 x TBE     0.89 M Tris-Borate pH 8.3 
(National Diagnostics)   20 mM EDTA 
 
Agarose gel solution    agarose at the desired % w/v 
      1 x TBE 
      3% v/v ethidium bromide 
 
Agarose gel running buffer   1 x TBE 
 
3 x Tris-tricine SDS loading dye  360 mM Tris-HCl pH 6.8 
      9% w/v SDS 
      15% v/v glycerol 
      15% v/v β-mercaptoethanol 
      0.2% w/v Bromophenol Blue 37
 5 x Orange G     100 mM Na2-EDTA pH 8 
      25% w/v Ficoll 
      5% w/v Orange G 
2.1.3   Cloning and expression 
2 x YT medium (1 L)    16 g tryptone 
      10 g yeast extract 
      5 g NaCl 
      pH to 7.2 with NaOH and autoclave 
 
LB agar     10 g tryptone 
      5 g yeast extract 
      5 g NaCl 
      pH to 7.2 with NaOH  
      12.5 g agar 
      autoclave same day. Kanamycin can be 
      added (to a final concentration of  
      50 µg/mL when the agar has cooled to 
      ~50°C. Plates consisting of 30 mL LB 
      agar can be poured and stored at 4°C. 
 
Lysozyme lysis buffer   40 mM Tris-HCl pH 8 
      25 mM NaCl 
      2 mM Na2-EDTA 
2.1.4   Protein purification 
Lysis buffer     40 mM Tris-HCl pH 8 
      500 mM NaCl 
      2 mM Imidazole 
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 HisTrap loading buffer   40 mM Tris-HCl pH 7.5 
      500 mM NaCl 
      5% w/v glycerol 
      20 mM Imidazole 
 
HisTrap elution buffer   40 mM Tris-HCl pH 7.5 
      500 mM NaCl 
      5% w/v glycerol 
      500 mM Imidazole 
 
Cleavage buffer    40 mM Tris-HCl pH 7.5 
      150 mM NaCl 
      5% w/v glycerol 
      2.5 mM CaCl2 
 
Heparin elution buffer   40 mM Tris-HCl pH 7.5 
      1 M NaCl 
      5% w/v glycerol 
 
Final dialysis/storage buffer  40 mM Tris-HCl pH 7.5 
      150 mM NaCl 
      5% w/v glycerol 
2.1.5   DNA duplex formation and purification 
Annealing buffer    10 mM Tris-HCl pH 8.2 
      10 mM MgCl2 
      150 mM NaCl 
 
DNA elution buffer    500 mM sodium acetate pH 8 
      1 mM EDTA 
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2.1.6   Site-directed mutagenesis 
10 x Vent reaction buffer   200 mM Tris-HCl pH 8.8 
      100 mM ammonium sulphate 
      100 mM KCl 
      20 mM magnesium sulphate 
      1% Triton X-100 
 
NZY+ medium (1 L)    10 g NZ amine (casein hydrolysate) 
      5 g Yeast extract 
      5 g NaCl 
      pH to 7.5 with NaOH 
      Autoclaved the same day and then add: 
      12.5 mM magnesium sulphate 
      12.5 mM magnesium chloride 
      0.4% w/v glucose 
2.1.7   Surface plasmon resonance 
HBS-P+     10 mM HEPES pH 7.4 
      100 mM NaCl 
      5 mM magnesium chloride 
      5 mM calcium chloride 
      0.05% v/v Tween-20 
2.1.8   Analytical ultracentrifugation 
AUC buffer     20 mM Tris-HCl pH 7.5 
      150 mM NaCl 
      5% w/v glycerol 
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2.1.9   Nuclear magnetic resonance spectroscopy 
M9 minimal media    6 g di-sodium hydrogen phosphate 
      3 g potassium di-hydrogen phosphate 
      0.5 g NaCl 
      dH2O to 975 mL and autoclave then add: 
      5 mL 20% w/v (15NH4)2SO4 
      10 mL 20% w/v D-glucose 
      1 mL 1 M magnesium sulphate 
      1 mL 0.1 M calcium chloride 
      1 ml 1 M Thiamine 
      10 mL E.coli trace elements 
 
E.coli trace elements    5 g Na2-EDTA 
      dH2O to 800 mL 
      adjust to pH 7 with HCl then add the 
      following (adjusting to pH 7 after each 
      addition): 
      0.5 g FeCl3 
      0.05 g ZnCl2 
      0.01 g CuCl2.2H2O 
      0.01 g H3BO3 
      adjust to 1 L with dH2O 
 
NMR measurement buffer   10 mM MES pH 6 
      100 mM NaCl 
      made with 10% D20 and 90% dH2O 
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2.2 UV-visible spectroscopy 
Protein and DNA concentrations were measured by obtaining a UV spectrum 
(across a wavelength range of 350 - 220 nm) on 450 µL sample in 500 µL quartz 
cuvettes (path length = 1 cm) using a lambda-25 (Perkin-Elmer). Samples were 
serially diluted, such that their absorbance was in the range 0.3 - 0.45. Plasmid 
concentrations were similarly calculated, except that the UV spectrum was 
performed using a Nanodrop ND-1000 (Nanodrop). 
 
To calculate the concentration of both protein and DNA, the Beer-Lambert law is 
used: 
 
         
 
where A is the absorbance at a given wavelength (native protein: 276 nm; Y29W 
mutant protein: 280 nm; DNA: 260 nm), EM is the molar extinction coefficient and 
has the units M-1.cm-1, c is the molar concentration of the measured sample and l is 
the distance (in cm) through the sample that light must travel (typically 1 cm). 
2.2.1 DNA concentration 
A rough estimation of DNA concentration can be obtained using the knowledge 
that a sample of duplex DNA that has an absorbance of 1 at 260 nm has a 
concentration of 50 µg/mL. This estimation was only employed for calculating 
plasmid DNA concentrations, as it does not account for sequence-dependent 
variations in hyperchromicity. Where a more accurate measurement of DNA 
concentration was required the percentage hyperchromicity of the duplex DNA 
was calculated and used to correct EM. 
 
The theoretical EM of a synthetic, double-stranded DNA oligonucleotide can be 
calculated by summing the EM of the individual bases that comprise the duplex. 
The following EM values were used in this calculation: A - 15,200 M-1.cm-1, 
C - 7,050 M-1.cm-1, G - 12,010 M-1.cm-1, T - 8,400 M-1.cm-1 (Wallace & Miyada, 1987).  42
  
A 420 µL sample of duplex DNA with an A260 between 0.3 and 0.45 was placed in a 
500 µL quartz cuvette and a UV spectrum was obtained (as previously) and the 
A260 was recorded. To this was added 5 µL snake venom phophodiesterase from 
Crotalus durissus terrificus (Sigma-Aldrich) at a concentration of 0.01 Units/µL. The 
sample was stoppered and incubated overnight at 37°C to allow the reaction to 
reach completion. A UV spectrum of the digested sample was performed against a 
420 µL buffer blank containing 5 µL snake venom and the A260 was recorded. Using 
the recorded A260 values for the digested and undigested duplex, the percentage 
hyperchromicity was calculated and used to modify the theoretical EM: 
 
                
               
             
 
 
where Ecorr is the molar extinction coefficient corrected for hyperchromicity, Etheor 
is the theoretical molar extinction coefficient. 
 
Hereafter, where synthetic, duplex DNA oligonucleotide concentration is shown, it 
has been calculated using Ecorr. 
2.2.2 Protein concentration 
A UV spectrum from 200 to 350 nm was obtained. The concentration of the native 
protein was determined using a molar extinction coefficient of  2900 M-1.cm-1 and 
an absorbance measured at 276 nm. The Y29W mutant protein has an extinction 
coefficient of 6990 M-1.cm-1 and the absorbance was measured at 280 nm. For both 
proteins, the absorbance at 320 nm was subtracted from the absorbance at either 
276 or 280 nm to effectively set the baseline to zero. If the region of the spectrum 
between 320 and 350 nm appeared to be sloped, the slope was extrapolated back 
and the value at either 276 or 280 nm was subtracted from the absorbance 
measured at these wavelengths in order to correct for the sloping background 
(which is assumed to be linear). 
 
43
  For the C.Esp1396I-GSH Y29S mutant protein, a UV spectrum was inaccurate due 
to the protein containing a single chromophore (Y37). In order to obtain accurate 
concentrations of this protein a modified Bradford assay was performed (Zor & 
Selinger, 1996). Namely, a wavelength scan from 800 - 400 nm was performed and 
the ratio between the absorbance at 595 nm and 465 nm was calculated. 
 
A calibration curve was constructed using protein of known concentration (either 
native C.Esp1396I-GSH or the Y29W mutant). 40 µL protein at various 
concentrations (0 - 0.5 mg/mL) was incubated with 960 µL fresh Bradford reagent 
for 15 minutes at room temperature to allow the colour to fully develop. The ratio 
of the A595 to A465 was calculated and the values plotted as a linear graph of ratio 
versus concentration (see section 3.4 - figure 3.15). 
 
To determine the concentration of the Y29S mutant, a 40 µL sample was incubated 
with 960 µL Bradford reagent and incubated at room temperature for 15 minutes 
before a wavelength scan (800 - 400 nm) was performed. The ratio of the A595 to 
A465 was calculated and the concentration determined using the above equation. If 
the A595:A465 of the unknown sample fell outside the range of the calibration curve 
(0.5 - 3), the sample was diluted until the ratio fell within this range. 
 
For all stated protein concentrations this refers to the total concentration of 
protein measured using the extinction coefficients for a monomer (as given above). 
 
2.3 Electrophoresis 
All gel plates, combs and gaskets were washed with dH2O, degreased using 70% 
ethanol and dried thoroughly before use. 
2.3.1 Agarose gel electrophoresis 
DNA was separated on the basis of size using submarine agarose gel 
electrophoresis. The gel pore size was controlled by varying the percentage of 
agarose, depending on the length of fragments to be resolved. The agarose was 
added to 1 x TBE, heated in a microwave and allowed to cool to approximately 44
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 65°C, whereupon 5 µg EtBr was added for every 100 mL gel solution. The solution 
was poured into a sealed gel sled, a well-forming comb was added at the top of the 
gel and the gel was allowed to set. Gels were run in 1 x TBE running buffer at 60 V 
(50 mL gels) or 100 V (150 mL gels) for 90 minutes. 
 
Samples were mixed with 5 x Orange G loading dye (to a final concentration of 
1 x Orange G) and loaded into the wells whilst the gel was submerged in running 
buffer. The gels were visualized by UV transillumination and, if required, the size of 
samples was determined by measurement against either a 100 bp ladder or a 1 kb 
ladder (figure 2.1) depending upon the size of the fragments to be resolved. 
 
Typically a 0.8% agarose gel was used for separation of PCR products formed 
during site-directed mutagenesis. 
2.3.2 Native PAGE 
DNA fragments smaller than 100 bp were separated on the basis of size using 
native polyacrylamide gel electrophoresis. 16% native gels were routinely used to 
determine the extent of duplex formation of synthetic oligonucleotides and for 
DNA purification. For checking the extent of duplex formation, mini gels 
(12 x 10 cm plates) requiring 10 mL gel solution were used and for DNA 
purification, midi gels (16 x 16 cm plates) requiring 40 mL gel solution were used 
to achieve better separation. Gel solutions of the required volume were prepared 
using 1 x TBE, 0.1% w/v APS,  0.2% v/v TEMED and the requisite volume of 
polyacrylamide from a 40% stock (Accugel 19:1). Gels were pre-run at 4°C for 1 
hour in 1 x TBE at 100 V for 10 mL gels and 200 V for 40 mL gels. Samples were 
mixed with 5 x Orange G loading dye (to a final concentration of 1 x Orange G), 
loaded into the pre-formed wells alongside an aliquot of low molecular weight 
DNA ladder (NEB; figure 2.1), run at the requisite voltage for 90 minutes (10 mL 
gels) or 3 hours (40 mL gels) and visualised using EtBr and UV transillumination. 
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 2.3.3   Tris-tricine SDS PAGE 
Tris-tricine polyacrylamide gels (Schägger & von Jagow, 1987) are able to resolve 
proteins of low molecular weight (≤ 10 kDa) based on their molecular weight. 12% 
mini gels were made using 6.6 mL Tris-tricine resolving gel solution and the 
remaining volume of Tris-tricine stacking gel solution. Once the resolving gel was 
poured, a small volume of water-saturated butanol was carefully applied to the top 
in order to achieve a smooth interface between the resolving and stacking gels. The 
resolving gel was allowed to set, the butanol was removed and the gel rinsed with 
dH2O. The stacking gel was then poured and the well-forming comb was carefully 
placed to avoid the formation of bubbles. Once set, the sealing gasket and plate 
clamps were removed and the gel was placed in the gel tank. Anode buffer was 
added to the lower reservoir and cathode buffer to the upper reservoir. The comb 
was removed and the wells were cleaned using cathode buffer.  
 
Samples were mixed with 3 x Tris-tricine PAGE loading dye to a final concentration 
of 1 x loading dye. The samples were then heated to 95°C for 2 minutes, 
centrifuged at 12,000 g for 1 minute and loaded into the wells alongside 5 µL 
Benchmark protein ladder (Invitrogen; figure 2.1). The gels were run at 60 V 
(35 min) followed by 150 V until the dye front had reached the bottom of the gel 
(typically ~90 min).  
 
The gel was removed from the plate and washed by placing it in dH2O, heating it in 
a microwave for ~ 1 minute and agitating at room temperature for 5 minutes. The 
washing process was repeated a further two times after which ~ 30 mL 
SimplyBlue safe stain (Invitrogen) was added. The solution was heated and left 
agitating at room temperature for at least 1 hour. The gels were then washed as 
before until sufficiently destained, visualised and photographed. 
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 2.4 Protein expression 
2.4.1 Plasmid preparation 
Small amounts of plasmid were prepared using a High Pure plasmid isolation kit 
(Roche) according to the manufacturer's instructions. 
2.4.2 Transformation of competent cells 
A 200 µL aliquot of competent BL21(DE3) cells (Agilent) was thawed on ice and 
100 µL was transferred to a cold microcentrifuge tube. To the competent cells was 
added 1 µL plasmid and the mixture was incubated on ice for 10 min. The cells 
were heat shocked at 42°C for 45 s and returned to ice for a further 2 min. 900 µL 
cold 2x YT media was added to the transformed cells and the cells were placed in a 
shaking incubator at 37°C for 1 hr. The cell suspension was pelleted by 
centrifugation for 10 s and 800 µL supernatant was aspirated. The pelleted cells 
were resuspended in the remaining 200 µL supernatant and 100 µL was spread 
onto an LB agar plate containing 50 µg/mL kanamycin. The plate was incubated 
overnight at 37°C. 
2.4.3 Overnight starter cultures 
An individual colony from the transformation plate (section 2.4.2) was picked and 
added to 15 mL 2x YT broth containing 50 µg/mL kanamycin. The cultures were 
incubated overnight at 37°C in a shaking incubator. 
2.4.4 Optimisation of expression and large-scale protein expression 
A 10 mL overnight starter culture was used to inoculate 1 L pre-warmed 2x YT 
broth containing 50 µg/mL kanamycin. Cultures were grown until the optical 
density at 600 nm (OD600) measured 0.6 at which point a 15 mL aliquot was taken. 
The remaining culture was induced by adding IPTG to final concentration of 1 mM. 
After a further 3.5 hours another 15 mL aliquot was taken. The remaining culture 
was pelleted by centrifugation (7000 g, 30 min, 4°C) and the pellets were stored at 
-20°C.  
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 The two 15 mL aliquots (induced and uninduced cells) were lysed by sonication 
(section 2.5.1) and then each was split into three 5 mL aliquots (total, soluble and 
insoluble fractions). Two of the 5 mL aliquots were cleared by centrifugation 
(20000 g, 30 min, 4°C). From one aliquot (soluble) the supernatant was retained 
and from the other (insoluble) the pellet was retained and resuspended in 5 mL 
lysis buffer. Samples from each aliquot were run on a 12% Tris-tricine SDS 
polyacrylamide gel as described in section 2.3.3. 
 
For optimisation of the length of the induction period, 5 mL of overnight starter 
culture was used to inoculate 500 mL pre-warmed 2x YT broth containing 
50 µg/mL kanamycin. Cultures were grown until OD600 = 0.6 whereupon the 
culture was split into  two 250 mL cultures. One of these cultures was induced with 
IPTG to final concentration of 1 mM while the other was left uninduced. 1.5 mL 
aliquots from the two cultures were taken at specific time points and the aliquots 
were pelleted by centrifugation (16000 g, 10 min, 4°C) and the supernatant was 
discarded. Pellets were resuspended in 100 µL lysozyme lysis buffer and PMSF was 
added to a final concentration of 1 mM. Lysozyme was added to a final 
concentration of 1 mg/mL and the aliquots were placed in a shaking incubator at 
37°C for 30 min. The incubated cells were frozen at -20°C and thawed, whereupon 
MgSO4 and CaCl2 were added to a final concentration of 100 mM. 0.1 mg/mL 
DNase I was added and the samples were placed at 37°C for 30 min. The mixture 
was clarified by centrifugation (16000 g, 10 min, 4°C) and the supernatant was 
aspirated and kept. The samples were run on a 12% Tris-tricine SDS 
polyacrylamide gel as described in section 2.3.3. 
 
2.5 Protein purification 
2.5.1 Bacterial cell lysis 
Bacterial cell pellets were resuspended in 20 mL lysis buffer per liter of culture. 
The resuspended cells were placed in a glass beaker that was set in an ice bath and 
were lysed using a Vibracell VCX 500 high intensity ultrasonic processor (Jencons-
PLS) with a CV 33 probe. The sonication was performed at an amplitude of 30% at 49
 ≤ 9°C using eighteen 5 s pulses interspersed with 9.9 s rest periods. Lysis of 
bacterial cells usually required 2-3 cycles of sonication. The lysate was cleared of 
cell debris by centrifugation at 40000 g for 30 min at 4°C. 
2.5.2 Nickel affinity chromatography 
The cleared bacterial lysate was degassed and typically 18 mL was loaded onto a 
1 mL HisTrap HP Nickel affinity column (GE Healthcare) using an ÄKTA purifier 
system (GE Healthcare). The column was pre-equilibrated with 5 column volumes 
(CV) HisTrap loading buffer, the sample was injected onto the column and the 
column was washed with 15 mL HisTrap loading buffer until the absorbance 
returned to baseline levels. The immobilised C.Esp1396I-6His was eluted from the 
column using a 48 CV linear gradient of 0-100% HisTrap elution buffer. During 
elution the flow-through was fractionated into 1 mL fractions. All other fractions 
were 2 mL. The appropriate fractions (as determined by Tris-tricine SDS PAGE) 
were pooled and dialysed overnight against cleavage buffer. 
2.5.3 Hexahistidine tag removal 
The dialysed C.Esp1396I-6His was passed through a 0.1 µm Anotop (Whatman) 
filter and the concentration was determined by UV spectrometry using a Nanodrop 
ND-1000 (Thermo Scientific, Wilmington, DE, USA). Thrombin (Sigma-Aldrich) was 
added at 10 units per 1 mg C.Esp1396I-6His and the mixture was agitated at room 
temperature for 3 hours. The cleavage reaction was stopped by the addition of 
PMSF to a final concentration of 1 mM. 
2.5.4 Size exclusion chromatography 
A 26/60 Sephacryl S-200 HR size exclusion column (GE Healthcare) was 
equilibrated in cleavage buffer and typically 12 mL C.Esp1396I-GSH was injected. 
An isocratic run was performed across 1.2 CV and 2 mL fractions were collected. 
The appropriate fractions (as determined by Tris-tricine SDS PAGE) were pooled. 
2.5.5 Heparin afffinity chromatography 
A 1 mL HiTrap Heparin HP chromatography column (GE Healthcare) was 
equilibrated with 5 CV cleavage buffer and C.Esp1396I-GSH (typically ~40 mL) 50
 was injected. The column was washed with a further 15 CV cleavage buffer and the 
bound protein was eluted as 0.2 mL fractions using a 0-100% step gradient of 
heparin elution buffer. The appropriate fractions (as determined by Tris-tricine 
SDS PAGE) were pooled and dialysed overnight against storage buffer. 
2.5.6   Protein concentration 
The concentration of C.Esp1396I was determined as described in section 2.2.2. 
2.5.7 Protein storage 
The dialysed C.Esp1396I-GSH was centrifuged (16000 g) to remove any precipitate 
and the supernatant was passed through a 1 µm filter prior to storage at 4°C. The 
protein was stored for up to six months. 
2.5.8 Purification of insoluble protein 
The pellets formed during the centrifugation step (section 2.5.1) were 
resuspended in 20 mL wash buffer I and repelleted by centrifugation (20000 g, 15 
min, 4°C) and the supernatant was discarded. This process was repeated once 
using wash buffer I and twice using wash buffer II. The final pellet was 
resuspended in 5 mL denaturing HisTrap loading buffer and gently stirred for 1 hr 
at room temperature. The suspension was cleared by centrifugation (20000 g, 15 
min, 4°C) and the lysate was injected onto a pre-equilibrated 1 mL HisTrap HP 
nickel affinity column (GE Healthcare). On-column refolding was performed using 
a 45 CV linear gradient (0-100% HisTrap loading buffer) at a flow rate of ≤ 0.5 
mL/min. The refolded protein was eluted from the column as described in section 
2.5.2. Subsequently, the refolded protein was purified following the native 
protocol. 
 
2.6 DNA duplex formation and purification 
2.6.1   Duplex formation 
The synthetic oligonucleotide was re-dissolved in annealing buffer to the desired 
concentration. The two single strands were mixed together in approximately 
equimolar amounts and heated to 90°C for 10 minutes. The solution was allowed 51
 to gradually cool to room temperature overnight. 5 x Orange G loading dye was 
added to a final concentration of 1 x Orange G and the sample was loaded onto a 
40 mL 16% native gel (section 2.3.2) and subjected to electrophoresis. 
2.6.2   Gel extraction 
The appropriate bands (determined following electrophoresis and visualisation) 
were carefully excised. These gel slices were then crushed by pushing them 
through a syringe. The crushed bands were then placed in a 10 mL polycarbonate 
centrifuge tube to which DNA elution buffer was added such that the fragments 
were entirely immersed. The solution was left at room temperature overnight 
whilst agitating at 1800 rpm using a Vibrax VXR type  VX 2E shaker (Janke & 
Kunkel).  
 
Following overnight agitation, the samples were centrifuged at 48,000 g for 
30 minutes at 4°C and the eluent was aspirated and stored at 4°C. The fragments 
were covered in fresh elution buffer and shaken as before for 4 hours. The 
centrifugation/aspiration step was repeated and the fragments were then placed 
in a small volume of absolute ethanol and shaken for 1 hour (or until the fragments 
became opaque). The sample was then placed in a 0.45 µm spin-x micro-centrifuge 
tube (Costar) and the eluent was recovered by centrifugation at 13,000 g at 4°C for 
10 minutes. 
2.6.3   Ethanol precipitation 
To the combined eluent from the gel extraction procedure was added 0.1 volumes 
of 3 M sodium acetate (pH 5.2) and 3 volumes of ice-cold absolute ethanol. The 
samples were then incubated at -70°C for 1 hour. Following incubation the solution 
was centrifuged at 27,000 g (30 minutes, 4°C) after which the supernatant was 
aspirated and discarded. The pelleted material was washed with 70% ethanol and 
centrifuged at 16,000 g (30 minutes, 4°C). The supernatant was aspirated and 
discarded and the samples were dried by inversion at room temperature. The DNA 
was then resuspended in a small volume of annealing buffer and its concentration 
(corrected for hyperchromicity) was determined as described in section 2.2.1. The 
DNA was stored in small aliquots at -20°C. 52
  
2.7 Site directed mutagenesis 
2.7.1 Primer design 
Primers were designed to be completely overlapping with ~45 bases, ~40% GC 
content and a melting temperature, Tm, of ~70°C. The primer ends consisted of one 
or more G or C bases. The properties of the primers were calculated using the 
Agilent QuikChange online tool. The primers used for mutagenesis are shown in 
figure 2.2. 
2.7.2 Polymerase chain reaction 
125 ng of the forward and reverse primers were incubated with 10 ng plasmid 
containing the esp1396IC gene in 1x vent reaction buffer and 4 mM MgSO4. 500 µM 
dNTP mix (NEB) was added with 2 units of Vent(exo-) (NEB). The polymerase 
chain reaction (PCR) was set up with an initial 5 minute melting period (95°C) and 
proceeded as follows: 
1) 1 min at 95°C (melting) 
2) 30 s at 55°C (annealing) 
3) 5 min 36 s at 72°C (extension at 1 min/kb) 
 
Steps 1-3 were repeated 24 times followed by a final extension period (72°C) of 
5 minutes. 
2.7.3 Digestion of template DNA and DNA sequencing 
The template DNA was digested using 10 units DpnI (Agilent) and incubating the 
PCR products at 37°C for 1 hr. DpnI recognises and digests the methylated 
template DNA strands and the mutant strands are left undigested. The samples 
were then run on a 10 mL native polyacrylamide gel alongside an aliquot of 1 kb 
DNA ladder (NEB; figure 2.1) as described in section 2.3.2. Following 
electrophoresis, 2 µL of the digestion product was transformed into XL-10 gold 
ultracompetent cells (Agilent) as directed by the manufacturers. These cells were 
grown in NZY+ broth and 250 µL cell suspension was spread onto LB agar plates 
containing 50 µg/mL kanamycin. The plates were incubated overnight at 37°C and 53
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 the plasmid was extracted for sequencing (section 2.4.1). Sequencing was 
performed by GATC Biotech using the universal T7 terminator and T7 promoter 
primers. Once verified as containing the desired mutation, the plasmid was used to 
express mutant protein as described in section 2.4. 
 
2.8 Surface Plasmon Resonance (SPR) 
The Biacore T-100 (GE Healthcare) was regularly cleaned using the built in 
protocols and proprietary wash buffers. 
2.8.1   Immobilisation of ligand 
Synthetic 35 bp oligonucleotides were purchased (Eurofins MWG) containing 
either the OM, OL, OR or the entire C/R promoter (OL+R) sequence (figure 2.3). The 
oligonucleotides were then resuspended and annealed to form a duplex as 
described in section 2.6.1. One of the strands in the duplex contained biotin 
covalently linked to the 5' phosphate. The surface of the SPR sensor chips  
consisted of a dextran matrix with covalently attached streptavadin. The chips 
were inserted into the Biacore T-100 (GE Healthcare) and the running buffer (HBS-
P+) was used to prime and equilibrate the required flow cells. The duplex was 
diluted with HBS-P+ to ~20 nM and passed across either flow cell two or flow cell 
four at 30 µL/min using short duration injections (typically ~10 -20 s) until ~200 
RU had been immobilised. No duplex was immobilised in the reference channels 
(flow cells 1 and 3). 
2.8.2   Sample preparation and titration 
Purified C.Esp1396I was dialysed against 5 L HBS-P+ overnight at 4°C. The dialysis 
buffer was then filter sterilised and used to dilute an aliquot of the protein to a 
stock concentration of 20 µM. Further serial dilutions were made prior to each SPR 
titration to minimise errors. At each concentration there needed to be a specific 
volume of sample to prevent the injection of air into the system. This volume was 
determined by the injection time, flow speed and dead volume in the chosen 
sample vials and was determined by the BiaControl software that came with the 
instrument (version 2.0.2). The samples were placed in the sample rack and this 
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Figure 2.3: The 35 bp oligonucleotides used for SPR analysis of C.Esp1396I and its operator 
sequences. The four oligonucleotides containing either OM, OL, OR or the entire C/R 
promoter region (OL+R) are shown. 
OM:  5’-Biotin-ATGTAGACTATAGTCGACGAAGCCTAGCCTAGCCT 
 
 
OL:  5’-Biotin-ATGTGACTTATAGTCCGTCTAGCCTAGCCTAGCCT 
 
 
OR:  5’-Biotin-CTAGCCTAGCCTAGCCGTGTGATTATAGTCAACAT 
 
 
OL+R: 5’-Biotin–ATGTGACTTATAGTCCGTGTGATTATAGTCAACAT 
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 was inserted and kept at 20°C for the duration of the experiment. To determine if 
the interaction was mass-transport controlled, a titration series of constant 
concentration at different flow rates was performed using the built in wizard in the 
BiaControl software.  
 
In order to determine the binding affinity between C.Esp1396I and its operators, 
an equilibrium titration was performed (after it was determined that kinetic 
analyses were unsuccessful). The titration was set up with a flow rate of 30 
µL/min, an injection duration of 45 s and a dissociation phase of 180 s. After each 
injection the flow cells were regenerated with 2 M NaCl (5 s injection at 
50 µL/min). All experiments were performed at 20°C. 
2.8.3   Data analysis 
For the activity assay (chapter 4) the data were analysed using the steady-state 
equilibrium affinity model in the BiaEval software (version 2.0.2) that came with 
the instrument without converting the sample concentrations to actual dimer 
concentrations (section 5.2) as these assays were for comparative purposes. 
 
For the determination of the affinity constant the data were fitted to the following 
equations using GraFit version 5.0.11 (Erithacus Software Ltd.): 
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where R is the generated response, Rmax is the maximum response possible which 
is determined by the binding capacity of the immobilised ligand, [D] is the dimer 
concentration and KD is the dissociation constant of the interaction. The dimer 57
 concentration was determined using the monomer-dimer equilibrium constant 
determined by AUC and the equation shown in section 2.9. 
 
2.9 Analytical Ultracentrifugation 
A sample of the Y29W mutant of C.Esp1396I was dialysed against 5 L AUC buffer. 
Sedimentation equilibrium experiments were performed at 20°C using a Beckman 
Optima XL-A analytical centrifuge (Beckman-Coulter, Palo Alto, CA, USA) with 
absorbance optics. Six-channel cells with an optical path length of 12 mm were 
used. Three pairs of channels were set up containing 90 µL C.Esp1396I-GSH Y29W 
in one channel and 100 µL buffer in the other. The following range of protein 
concentrations was used: 1, 5, 10, 15, 20, 30 µM. 
 
The rotor was accelerated to 3000, 15000, 21000, 28000 and 40000 rpm and 
absorbance scans versus radial displacement were measured at three 
wavelengths: 225, 250 and 280 nm. These measurements were taken with a radial 
step size of 0.01 mm after equilibration for 15, 18 and 21 hours at each rotor 
speed. 
 
The resulting data were fitted to either a single ideal species model or a 
self-association model using SEDPHAT (Vistica et al., 2004). The partial specific 
volume of the protein and the  solution density were calculated using SEDNTERP 
(http://www.rasmb.bbri.org/). For the single ideal species model only the 280 nm 
data was used. The extinction coefficient was fixed at 6990 M-1.cm-1 and the 
molecular mass was allowed to vary. For the self-association model, the extinction 
coefficient at 280 nm was fixed as was the molecular mass (9529 Da) and the 
association constant was allowed to vary. A global fit was performed across a 
range of concentrations and wavelengths. For both models the errors were 
estimated using F-statistics. 
 
The self-association constant could be used to calculate the concentration of dimer 
in a sample of known total concentration. This is necessary when determining the 
affinity between C.Esp1396I and its DNA recognition sequences (section 2.8) as the 58
 dimer is the active binding species in the sample. The following equation is used to 
determine the actual dimer concentration:  
 
    
                      
 
 
 
where [D] is the dimer concentration, T is the total concentration as determined by 
UV spectroscopy using the extinction coefficient of a monomer and KD is the 
dissociation constant determined by AUC. The equation is derived from first 
principles in section 5.2. 
 
2.10 Crystallography 
2.10.1   Sparse matrix screening 
96 well MRC plates (Molecular Dimensions Ltd., Newmarket, Suffolk, UK) were set 
up using a Cartesian HoneyBee X8 nano dispensor (Digilab Inc., Holliston, MA, 
USA). Commercially prepared sparse matrix screens (such as PACT Premier, 
Structure Screen (I and II) and the Nucleix Suite) were purchased from Molecular 
Dimensions Ltd. 60 µL of the mother liquor was placed in the wells using an 
8-channel pipette.  
 
Free protein samples were prepared at room temperature and inserted into the 
robot via aspiration using dispensing tip 7. A 100 nL sample was mixed with 
100 nL motherliquor in a relative humidity of 70% to prevent evaporation. The 
trays were sealed and placed in an incubator at either 4°C or 16°C. Nucleoprotein 
complex samples were made by mixing C.Esp1396I and its operator sequence at a 
ratio of 2:1 protein:DNA (although other ratios were tried ranging from 4:1 to 1:2 
protein:DNA) and leaving overnight at 4°C. If additives were to be used (i.e. 
spermine or spermidine) they were added to the complex before incubation to a 
final concentration of 20 mM. The trays were set up as before with the complex in 
the "A" position and the complex with additive in the "B" position. The trays were 
sealed and placed in an incubator at either 4°C or 16°C. A few different duplexes 59
Figure 2.4: The oligonucleotides used in crystallisation of the OL and OM complexes. The 
oligonucleotides consist of a 18 bp duplex with 5' overhanging bases which were designed to 
promote pseudo-continuous DNA. 
OL duplex: ATGTGACTTATAGTCCGTG 
     ACACTGAATATCAGGCACT-5’ 
 
 
 
OM duplex: ATGTAGACTATAGTCGACA 
     ACATCTGATATCAGCTGTT-5’ 
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 for each operator sequence were tried (including blunt ends or overhanging ends 
with different overhanging bases) but only two (one for each operator) produced 
usable crystals and these are shown in figure 2.4. 
 
The trays were checked for evidence of crystallisation by polarising light 
microscopy using a Leica MZ12-5 with mounted camera. Any small crystals that 
formed were mounted in an appropriate size loop and examined by X-ray 
diffraction on an Xcalibur Nova (Oxford Diffraction). Conditions that produced 
crystals that were not salt and that diffracted better than ~4 Å were optimised in 
an attempt to improve the diffraction quality. 
2.10.2   Optimisation of screens 
24 well hanging drop trays (Molecular Dimensions) were set up with 500 µL 
mother liquor in the reservoir. The drop volume was 4 µL and was formed from 
2 µL mother liquor and 2 µL sample (although other ratios were tried). The 
samples were prepared in the same manner as for the sparse matrix screening. 
 
The optimisation conditions were made from stocks that were 10-fold the required 
concentration. The individual components were added at the required 
concentration and the trays were set up to screen a range of precipitant 
concentration and pH. 
 
The wells were sealed and placed in an incubator at either 4°C or 16°C and were 
checked for evidence of crystallisation by polarising light microscopy using a Leica 
MZ12-5 with mounted camera. Crystals were removed from the drop and washed 
through a cryoprotectant (typically the buffer conditions with 35% v/v glycerol 
added) before being mounted in an appropriate sized loop and cryocooled in liquid 
nitrogen. The crystals were then placed in storage dewars filled with liquid 
nitrogen prior to transport to a synchrotron. 
2.10.3   Data collection and refinement 
The data were collected at the European Synchrotron Radiation Facility (ESRF) in 
Grenoble, France under the supervision of Dr. John McGeehan. The beamlines 61
 where the data were collected and the details of the detection hardware are 
detailed in the appropriate sections. The number of images required for a complete 
dataset and the start angle were calculated using X-PLAN. 
 
The data were integrated and scaled with either XDS and XSCALE (Kabsch, 1993) 
or MOSFLM (Leslie, 1992) and SCALA (Collaborative Computational Project, 
Number 4, 1994) as detailed in the appropriate sections. XDS/SCALA tended to 
produce better quality electron density maps and MOSFLM/SCALA tended to 
produce higher overall completeness. In both cases the data were indexed and the 
space group and unit cell were determined. Using these values, integration was 
performed across the desired range of images. Once integrated, the data were 
scaled and all resolution shells with an Rmeas ≤ 40% were included in the final 
output.  
 
The number of complexes in the unit cell was determined using the cell content 
analysis program in CCP4i (Collaborative Computational Project, Number 4, 1994) 
and specifying the molecular mass of the individual components. The model to be 
used for molecular replacement was prepared and was typically a C.Esp1396I 
dimer (without the 5 C- and N-terminal residues) and a B-form duplex of ~ 8 to 
10 bp. The actual molecular replacement models used are detailed in the 
appropriate sections. Molecular replacement was then performed using the 
program PHASER (McCoy et al., 2005).  
 
The model was refined using REFMAC5 (Murshudov et al., 1997) typically 
employing TLS-based restrained refinement. NCS restraints were applied based on 
the complex and data quality and are detailed in the appropriate sections. 
Real-space refinement was carried out using the program COOT (Emsley & 
Cowtan, 2004). Iterative cycles of REFMAC followed by COOT were used to refine 
the structure. Where necessary to prevent over interpretation of the electron 
density, the weighting of the refinement was changed in favour of good 
stereochemistry. In some cases simulated annealing was carried out by Dr. John 
McGeehan using the program PHENIX (Adams et al., 2010). In the OL complex 62
 structure, the waters were located using the "find waters" tool in COOT, but for the 
other structures (at lower resolution) the waters were located manually. 
 
The default values were used in all programs unless otherwise specified in the 
appropriate sections. 
2.10.4   Validation and deposition of the structure 
The final structure was analysed using SFCHECK and PROCHECK (Collaborative 
Computational Project, Number 4, 1994). The structure was then validated and 
deposited using the ADIT server of the Protein Data Bank (PDB; www.pdb.org).  
 
Nucplots were made by uploading the data to the PDBsum website 
(http://www.ebi.ac.uk/pdbsum; Luscombe et al., 1997). Electrostatic surface 
potentials were calculated using the program DELPHI (Rocchia et al., 2002). All 
structural images were created using the program PyMOL (DeLano, 2002). 
 
2.11 Nuclear Magnetic Resonance (NMR) spectroscopy 
To prepare labelled samples, an overnight culture (obtained after transformation 
and colony selection as described in section 2.4) of C.Esp1396I was diluted 
100-fold into 1 L M9 minimal media containing a source of 15N (ammonium 
chloride) and 50 µg/ml Kanamycin. The culture was placed in a shaking incubator 
at 37°C and induced by the addition of IPTG (to a final concentration of 1 mM) once 
the culture had reached an optical density of 0.6 (measured at 600 nm). 
 
The bacterial cells were harvested by centrifugation (7000 g, 30 min, 4°C) and 
stored at -20°C until required. The protein was purified as described in section 2.5. 
The pure protein was buffer exchanged into NMR reaction buffer using a 2 mL 
Amicon Centricon centrifugal filter device (Millipore, Billerica, MA, USA) with a 
3 kDa cutoff as directed by the manufacturer's instructions. The solution was 
reduced in volume to ~300 µL and the concentration was determined by UV 
spectroscopy as described in section 2.2.2. An 84 µM sample was used to obtain 
preliminary data. The 15N-labelled HSQC data was collected and processed by 
Dr. Chris Read using a 600 MHz spectrometer. 63
 2.12 Miscellaneous 
2.12.1 Dynamic Light Scattering 
Dynamic light scattering (DLS) was performed upon C.Esp1396I-GSH of known 
concentration which had been passed through a 0.1 µm Anotop filter (Whatman). 
Measurements were performed at 10°C using a Protein Solutions DynaPro 
MSTC800 light scattering instrument. The protein solution was allowed to 
equilibrate prior to measurements being taken and at least 20 measurements were 
taken to obtain the hydrodynamic radius (Rh). From the Rh an estimate of the 
molecular weight (Mr) of the protein could be calculated using the following 
empirical formula for globular proteins: 
 
     (1.6       
2.34 
 
The measurements and calculations were performed using the program Dynamics 
(version 5.26.60; Protein Solutions) provided with the instrument. 
 
2.12.2   Fluorescence emission spectrometry 
Fluorescence emission spectrometry was carried out using an LS50-B 
Luminescence Spectrometer (Perkin Elmer). 2 µM samples of native and Y29W 
mutant C.Esp1396I were placed in a quartz cuvette (path length = 10 mm). 
Measurements were taken at 20°C using an excitation wavelength of 280 nm. An 
emission scan was recorded between 280 nm and 400 nm at a rate of 100 nm/min. 
The excitation/emmission slit widths (nm) were set at 2.5/3  and 5/7 for the 
Y29W mutant and native protein respectively. The scans were run in triplicate and 
the spectra were corrected for buffer contributions. 
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 Chapter 3: Expression, purification 
and characterisation of C.Esp1396I 
 
3.1  Introduction 
The plasmid expressing the C gene (esp1396IC; figure 3.1) was kindly supplied by 
the group of Dr. Konstantin Severinov (Rutgers University, New Jersey, USA). In 
order to obtain the highest possible yield of C.Esp1396I, expression tests were 
performed to determine the optimum post-induction incubation time. This 
optimised procedure was used to express two C.Esp1396I mutants, Y29W and 
Y29S. However, in the case of the mutant expression, further optimisation was 
required to achieve yields similar to that of the native protein. 
 
The published method (McGeehan et al., 2008) for the purification of C.Esp1396I 
produced a protein of sufficient purity for structural and biophysical 
characterisation. However, the overall yield of C.Esp1396I was relatively low and 
required optimisation. Initially the extent to which C.Esp1396I was expressed as a 
soluble or insoluble protein was determined and a strategy for purification of 
insolubly expressed C.Esp1396I was developed. Optimisation of the yield and of 
the solubility was also performed. The new protocol permitted the purification of 
C.Esp1396I to > 95% purity with yields 2-3 fold higher (~4 mg/L culture) than for 
the published method. 
 
This optimised strategy was also used to purify the two mutant proteins and the 
15N-labelled C.Esp1396I. In all cases the purity of the protein was > 95%. The yield 
of the two mutant proteins was equivalent to that of the native C.Esp1396I, but the 
15N-labelled protein appeared less soluble and the yield was ~2-fold lower than 
the native protein. 
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Figure 3.1: DNA and amino acid sequence of the transcribed region of the 
pET28b(+) plasmid containing the esp1396IC gene. The esp1396I gene (codons 1 – 
80) was inserted into the multiple cloning site (MCS) of the pET28b(+) vector. The open 
reading frame (middle row) is transcribed and translated into a polypeptide (bottom 
row). The protein contains an N-terminal hexahistidine tag (blue) which can be cleaved 
by thrombin between the R-G residues (arrow) . The cleaved protein contains 3 N-
terminal, non-native amino acids (red). The native C.Esp1396I begins at residue 1. 66
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Figure 3.2: Organisation of the pET-28b/esp1396IC plasmid construct. esp1396IC is 
inserted into the multiple cloning site (MCS) of the pET-28b(+) plasmid and is expressed 
as a hexahistidine tagged fusion protein under the control of the T7lac promoter. The 
plasmid encodes a kanamycin resistance gene (KanR) that permits recombinant 
screening on selective media.  67
 3.2  Protein expression 
The plasmid expressing the C.Esp1396I as an N-terminal hexahistidine tag 
(His-tag) fusion protein was kindly provided by Dr. Konstantin Severinov (Rutgers 
University, New Jersy, USA). This fusion tag permits purification of the target 
protein by immobilised metal affinity chromatography (IMAC). The His-tag can be 
removed by the serine protease thrombin, which selectively cleaves Arg-Gly bonds. 
Gene expression is under the control of the T7lac promoter and recombinant 
screening can be performed as the vector also contains a kanamycin resistance 
gene (figure 3.2). 
 
BL21(DE3) cells were transformed as described in section 2.4.2. Overnight starter 
cultures and larger-scale expression cultures were prepared as described in 
sections 2.4.3 and 2.4.4 respectively. Previous studies (S.D. Streeter, personal 
communication) had determined  that the optimal stage at which to induce the 
cells with 1 mM IPTG was at an optical density of 0.6 measured at 600 nm 
(OD600 = 0.6).  The length of the post-induction incubation required optimisation. 
 
1 mL aliquots of bacterial cells were lysed by the addition of lysozyme, the DNA 
digested by the addition of DNAseI and the cell debris removed by centrifugation. 
Tris-tricine SDS PAGE was performed on the cleared cell lysates and densitometry 
of the gel was performed using the program Scion Image. Figure 3.3 demonstrates 
that after 3 hours of induction, the level of expression of the esp1396IC gene had 
reached a maximum and that a longer induction was unnecessary.  
 
Expression analysis also suggested that C.Esp1396I-6His was expressed in both 
the soluble and insoluble fractions in approximately equal amounts (figure 3.4a). 
To ascertain whether the C.Esp1396I-6His expressed in the insoluble fraction 
could be recovered, the pelleted post-sonication cell debris was treated as 
described in section 2.5.1. Figure 3.5 shows an overall schematic of the purification 
strategy and the steps unique to the recovery of C.Esp1396I-6His from the 
insoluble fraction are marked as the “insoluble pathway”. 
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Figure 3.3: Analysis of soluble expression of C.Esp1396I-6His from the pET-28b(+) 
plasmid. 1.5 mL aliquots of induced (I) or uninduced (U) cells were removed from a 500 
mL large-scale culture at the the specified time points after induction. The cells were 
lysed by  addition of lysozyme and the lysate was cleared by centrifugation.  The 
supernatant was mixed with loading dye and heated to 95oC for 5 minutes. The sample 
loadings were normalised to 0.1 OD600 cell culture per lane by adjusting the loading 
volumes and were run alongside the benchmarkTM protein ladder (M; figure 2.1). The 
C.Esp1396I-6His bands were analysed by densitometry using the program Scion Image 
and it can be seen that maximum expression is achieved after ~3 hours at 37oC. 
1 2 3 4 Time (hours) 
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Figure 3.4: Recovery of C.Esp1396I-GSH from either the soluble or insoluble 
fraction. (a) A 12% Tris-tricine SDS polyacrylamide expression gel showing the 
proportion of C.Esp1396I expressed in the total (T), soluble (S) or insoluble (I) fraction 
before and after induction with 1 mM IPTG for 3.5 hours. 15 mL cultures were lysed by 
sonication and split into 3 x 5 mL aliquots. Two of these aliquots were centrifuged and 
the supernatant was kept from one (soluble fraction) and the cell debris was 
resuspended in 5 mL lysis buffer (insoluble fraction). The uncentrifuged aliquot was 
used as the total expression. Samples were mixed with 3x SDS loading dye and 5 µL 
were loaded onto the gel. (b) Two 12% Tris-tricine SDS polyacrylamide gels showing a 
crude purification of C.Esp1396I-GSH from either the soluble or insoluble fraction of a 1 
L cell culture. The protein was separated from the lysate by nickel affinity, the His-tag 
was removed and the protein concentrated using heparin affinity chromatography. 
Selected fractions eluted from the Heparin column were loaded onto the gel alongside 
the load (L), flow-through (FT) and BenchmarkTM protein ladder (M; figure 2.1). 
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Figure 3.5: Schematic representation of the purification strategy for C.Esp1396I.  
The cell pellet was resuspended and lysed by sonication. Solubly expressed protein was 
purified following the soluble pathway (blue) and any protein expressed in the insoluble 
fraction was purified following the insoluble pathway (red). Only the soluble pathway 
was routinely used for purification of C.Esp1396I. Steps which were optimised are 
highlighted with an asterisk (*). 
i. Sonication * 
ii. Centrifugation 
Resuspended cell pellet 
Supernatant Cell debris 
Immobilised C.Esp1396I-6His 
Refolded C.Esp1396I-6His 
Immobilised C.Esp1396I-6His 
Eluted C.Esp1396I-6His 
C.Esp1396I-GSH 
Concentrated C.Esp1396I-GSH 
i. Triton X-100 
ii. Guanidinium 
iii. Nickel affinity 
i. Imidazole 
i. Imidazole * 
i. Nickel affinity 
i. Dialysis * 
ii. Thrombin * 
iii. Size exclusion 
i. Heparin affinity 
ii. Dialysis 
i. Removal of 
guanidinium 
Insoluble 
pathway 
Soluble 
pathway 
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 During the pellet washing and denaturing steps the pellet became white and 
slightly translucent and the consistency went from viscous to “fluffy”. The 
supernatant from each wash step was retained and was immobilised on a 1 mL 
HisTrap HP column along with the denatured C.Esp1396I-6His recovered from the 
insoluble fraction. Renaturation was performed on-column by removal of 
guanidinium using a 45 CV linear gradient as described in section 2.5.2. The 
renatured protein was eluted from the column using 48 CV gradient of 20 – 500 
mM imidazole. In order to determine the extent of the recovery of C.Esp1396I-6His 
from the insoluble fraction, fractions containing the protein were pooled, the His-
tag was removed by thrombin cleavage and the sample was concentrated by 
heparin affinity chromatography, as described in sections 3.3.3 and 3.3.5 
respectively. 
 
Figure 3.4b shows tris-tricine SDS PAGE analysis of the fractions obtained from the 
heparin affinity chromatography. The cleared lysate from the 1 L expression pellet 
was treated as described in section 2.5.8 (figure 3.5; soluble pathway) and after 
elution from the nickel affinity column was treated the same as the renatured 
C.Esp1396I-6His. Both the protein expressed in the soluble and insoluble fractions 
is still relatively impure. However, the C.Esp1396I-GSH recovered from the 
insoluble fraction was approximately 20-fold less concentrated than the solubly 
expressed protein as determined by UV spectrometry. 
 
As the yield from the “insoluble pathway” was significantly lower than that of the 
soluble protein, only the purification of C.Esp1396I-6His from the soluble fraction 
was optimised (section 3.3). 
3.3  Optimisation of protein purification 
Following the published method for expression and purification of C.Esp1396I 
(McGeehan et al., 2008), it was noted that during routine dialysis to remove 
imadizole prior to the N-terminal His-tag removal, a crystalline precipitate of 
C.Esp1396I was formed (see chapter 4). This resultant loss of protein reduced the 
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 yield significantly. In order to retain the protein in solution the purification 
strategy was optimised. 
 
Figure 3.5 shows an overall schematic for the purification strategy and the steps 
highlighted by an asterisk (*) were targeted for optimisation. Many different 
strategies were attempted, including a denaturing step, on-column refolding and 
on-column cleavage. Denaturation of soluble C.Esp1396I-6His post sonication did 
not yield a purer or more soluble protein at the end of the purification. It also 
requires that the protein renatures to form the native secondary and tertiary 
structures which may not have the same activity as the non-denatured protein. For 
these reasons, a protocol that does not involve a denaturation step was adopted. 
On-column cleavage was much less efficient than cleavage of the His-tag in solution 
and even after 24 hours, there was a significant proportion of the uncleaved 
C.Esp1396I-6His remaining in the mixture. 
3.3.1   Bacterial cell lysis 
Cell lysis was performed by sonication of resuspended cell pellets as described in 
section 2.5.1. The lysate was cleared of cell debris by centrifugation.  
 
The effect of adding a denaturing step was assayed by lysing the cells under 
denaturing conditions (6 M guanidinium). However, this did not lead to a purer or 
more soluble protein after complete purification. As there was no obvious 
advantage to denaturing and refolding the protein, the denaturation step was 
abandoned as the final refolded protein may not have had the same activity as the 
protein that had not undergone the denaturing and refolding process. 
3.3.2   Nickel affinity chromatography 
Nickel affinity chromatography is often used to purify His-tagged proteins from 
crude cell extract and can achieve a relatively high purity in a single step. The 
nitrogen of the amino acid histidine acts as ligand to the immobilised nickel, 
displacing coordinated water molecules (figure 3.6). His-tagged proteins generally 
bind  to nickel affinity columns more tightly than untagged proteins, allowing 
separation of  tagged and non-tagged proteins. 73
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Figure 3.6: The principle of purification using a His-tagged protein. The structures 
were created using ChemDraw Ultra version 12.0 (CambridgeSoft) (a) Divalent Nickel 
ions are immobilised by the matrix attached ligand. The adjacent histidine residues in 
the His-tag coordinate a single divalent nickel ion with relatively high affinity. (b) 
Elution of the protein can be acheived by lowering the pH or by using increasing 
concentrations of  imidazole. 74
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Figure 3.7: Nickel affinity chromatography elution profile and 12% Tris-tricine 
SDS PAGE of selected fractions. The elution profile of C.Esp1396I-6His is shown with 
the absorbance at 276 nm in black, the absorbance at 254 nm in blue and the 
conductivity in red. The C.Esp1396I-6His sample was eluted from the column using a 
linear 20 – 500 nM imidazole gradient over 48 column volumes (48 mL) and collected as 
1 mL fractions. Selected fractions at the volumes indicated were run on a 12% Tris-
tricine SDS polyacrylamide gel alongside the load (L), the column flow-through (FT) and 
the BenchmarkTM protein ladder (M; figure 2.1). Fractions from the second peak 
(marked with an asterisk [*]; 34-45 mL) were pooled and dialysed overnight against 5 L 
cleavage buffer. 
* 
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Cleared bacterial lysate was loaded onto a 1 mL HisTrap HP column and the 
elution of N-terminally His-tagged C.Esp1396I (C.Esp1396I-6His) was performed 
as described in section 2.5.2. A typical elution profile is shown in figure 3.7. 
Tris-tricine SDS PAGE identified that C.Esp1396I-6His elutes between 150 – 275 
mM imidazole and that there are relatively few higher molecular mass 
contaminants. C.Esp1396I-6His typically eluted in a volume of 12 mL. 
 
The fractions containing C.Esp1396I-6His were then pooled and dialysed into 
cleavage buffer. It was noted that during the removal of imidazole some of the 
protein precipitated. In order to overcome this, other methods of elution from the 
nickel affinity column were assayed, including lowering the pH to 4, on-column 
cleavage and using EDTA to strip the nickel from the column. However, none of 
these methods was as efficient as imidazole in eluting the C.Esp1396I-6His.  
 
The composition of the purification buffers was also varied. This mainly involved 
the alteration of the pH and the buffering components in order to move either 
toward or away from the theoretical pI of the protein (~9). Neither alteration of 
the pH, nor the addition of solubilising agents (e.g. Tween) prevented the 
precipitation of some of the C.Esp1396I-6His during dialysis. However, it was 
noted that retaining imidazole in the dialysis buffer was sufficient to prevent the 
majority of the precipitate from forming. Serial dialysis of the C.Esp1396I-6His into 
decreasing concentrations of imidazole determined that the majority of the protein 
was retained in solution at imidazole concentrations above 50 mM. Therefore, 
imidazole was retained in buffers throughout purification at this level of 50 mM to 
minimise precipitation. 
3.3.3   Hexahistidine-tag removal 
The N-terminal His-tag has an internal thrombin cleavage site to permit the 
removal of the tag. Thrombin preferentially cleaves between Arg-Gly amino acids 
and leaves three non-native N-terminal amino acids: Gly-Ser-His (C.Esp1396I-
GSH). The His-tag was removed by incubation with thrombin as described in 
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 section 2.5.3. The reaction was stopped by addition of PMSF to a final 
concentration of 1 mM. On-column cleavage was also attempted by the manual 
addition of thrombin to the C.Esp1396I-6His immobilised on the nickel affinity 
column and incubation at room temperature. However, even after a 24 hour 
incubation period, there was still a significant amount of uncleaved protein, 
reducing the overall yield. Due to reduced efficiency of on-column cleavage, the 
His-tag was routinely removed on protein that was free in solution. 
3.3.4   Size-exclusion chromatography 
Size exclusion chromatography is often used as a final “polishing” step in a 
purification procedure and allows proteins to be separated according to size, with 
the smallest being retarded to the greatest degree. The His-tag removal reaction 
introduced thrombin (Mr = 36.7 kDa) to the sample and some C.Esp1396I-6His 
(Mr = 11.4 kDa) remained uncleaved. In order to separate these contaminants 
from C.Esp1396I-GSH (Mr = 9.5 kDa) the cleavage reaction mixture was applied to 
a 26/60 Sephacryl S-200 HR size exclusion column as this column has an effective 
separation range of 5-250 kDa and a loading capacity of up to 13 mL. 
 
The elution was performed as described in section 2.5.4 and a typical elution 
profile is shown in figure 3.8. The C.Esp1396I-6His that is undigested by thrombin 
elutes first as a much smaller peak than the digested C.Esp1396I-GSH. The 
C.Esp1396I-GSH is the major peak (peak 2 at ~210 mL) on the profile and occurs 
across a volume of approximately 40 mL as determined by tris-tricine SDS PAGE. 
Although the protein is very pure at this stage, the concentration is relatively low 
(typically ~10 µM) and requires concentrating. Concentration of the C.Esp1396I 
was performed using heparin affinity chromatography.  
3.3.5   Heparin affinity chromatography 
Heparin is a polysaccharide formed of repeating disaccharide units, each unit 
containing three sulphate groups. This makes heparin one of the most highly 
charged biological molecules and permits separation of molecules by charge. 
Heparin is not only an effective cation exchange medium, it is also a structural 
mimic for DNA and is routinely used to purify DNA-binding proteins (figure 3.9). 77
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Figure 3.8: Size exclusion chromatography elution profile and 12% Tris-tricine 
SDS PAGE of selected fractions. The elution profile of C.Esp1396I-6His is shown with 
the absorbance at 276 nm in black, the absorbance at 254 nm in blue and the 
conductivity in red. The C.Esp1396I-GSH sample was eluted from the column 
isocratically over 1.1 column volumes (approximately 360 mL) and collected as 2 mL 
fractions. Selected fractions from across the peaks (1, 2 and 3) were run on a 12% Tris-
tricine polyacrylamide gel alongside the load (L) and the BenchmarkTM protein ladder 
(M; figure 2.1). Fractions from the second contained pure C.Esp1396I-GSH and were 
pooled. 78
  
The dilute C.Esp1396I-GSH from the size exclusion step was loaded onto a 1 mL 
HiTrap Heparin column in 150 mM NaCl. The elution was performed using a step 
gradient of 150 mM – 1 M NaCl (as described in section 2.5.5) and a typical elution 
profile is shown in figure 3.10. There were no contaminants in the flow-through 
and the C.Esp1396I eluted as a single peak upon the increase of NaCl. C.Esp1396I-
GSH was identified by tris-tricine SDS PAGE and typically eluted in a volume of 1.6 
mL.  
 
Following dialysis and 0.1 µm filtration the concentration of the pure protein was  
measured using UV spectroscopy (figure 3.11) as described in section 2.2.2. The 
spectrum is reasonably flat between 350 and 320 nm, with a maximum at 276 nm, 
a clear minimum at 260 nm and an off-scale region below ~240 nm. Typically, if 
the region between 350 and 300 nm did not measure 0 AU, then the A276 value 
could be corrected for by extrapolating the gradient to estimate the value at 276 
nm. The concentration of purified C.Esp1396I-GSH was typically ~2.5 mg/mL 
(approximately 260 µM). Approximately 4 mg pure C.Esp1396I-GSH is produced 
from 1 L cell culture.  
3.4  Expression and purification of Y29 mutants 
Based on the crystal structure of C.Esp1396I (Ball et al., 2009; chapter 4) two 
mutants were designed and made as described in section 4.6. Cells transformed 
with either the Y29W or Y29S mutant plasmid returned a significantly lower yield 
(2-3 fold) of target protein after purification. Expression tests were carried out as 
for the native C.Esp1396I (section 3.1) and analysis by tris-tricine SDS PAGE 
showed that there was a relatively high level of background (“leaky”) expression of 
the mutant proteins (data not shown). 
 
The regulation of expression from the T7lac promoter can be enhanced by the 
addition of glucose (Grossman et al., 1998). Expression tests were carried out in 
the presence of 1% glucose and analysed by tris-tricine SDS PAGE (figure 3.12). 
Densitometry of the gel using the program Scion Image suggests that the addition 79
12 Å 20 Å 
Figure 3.9: The structural similarity of heparin to DNA. Heparin is a polysaccharide 
that is made up of repeating disaccharide units. These units each contain 3 sulphate 
groups, making heparin highly negatively charged. (Drawn using ChemDraw Ultra 
version 12.0, CambridgeSoft). (b) The tertiary structure of heparin, as determined by 
Mulloy et al., 1993, (left) adopts a helical confirmation with a diameter of approximately 
12 Å. This mimics the structure of DNA (right) and for this reason, heparin affinity 
chromatography is often used in the purification of DNA-binding proteins. 
a 
b 
80
1 
1 
M     FT 
Figure 3.10: Heparin affinity chromatography elution profile and 12% Tris-
tricine PAGE of selected fractions. The elution profile of C.Esp1396I-6His is shown 
with the absorbance at 276 nm in black, the absorbance at 254 nm in blue and the 
conductivity in red. The C.Esp1396I-GSH sample was eluted from the column using a 
0.15 – 1 M NaCl step gradient and collected as 0.2 mL fractions. Selected fractions from 
across the peak (1) were run on a 12% Tris-tricine SDS polyacrylamide gel alongside 
the column flow-through (FT) and the BenchmarkTM protein ladder (M; figure  2.1). 
Fractions containing C.Esp1396I-GSH were pooled and dialysed overnight against 5 L 
storage buffer. 81
Figure 3.11: Overall purification of C.Esp1396I-GSH and typical UV spectrum. A UV 
spectrum from 200 – 350 nm of C.Esp1396I-GSH was obtained using a lambda-25 
(Perkin-Elmer). The absorbance due to the buffer component has been subtracted. 
(Inset) 10 µL C.Esp1396I samples (indicated by the labels above the gel) were mixed 
with 5 µL loading dye and 10 µL was loaded onto a 12% Tris-tricine SDS polyacrylamide 
gel alongside the BenchmarkTM protein ladder (figure #). The C.Esp1396I-6His runs at 
approximately 11.5 kDa (6His) and the C.Esp1396I-GSH runs at approximately 9.5 kDa 
(GSH). The overall purity of C.Esp1396I-GSH is > 95% as determined by densitometry. 
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 of glucose increased the expression of C.Esp1396I-6His approximately 1.5-fold. 
Despite the mutant proteins originally being expressed 2-3 fold lower than the 
native protein, the overall yield after purification was equivalent to that of the 
native protein. This discrepancy cannot be explained by differences in cell density 
as the loadings on the SDS-PAGE gels were normalised for optical density of the 
bacterial culture. 
 
The mutant proteins were purified as for the native protein.  The concentration of 
the mutants was measured by UV spectrometry (using the values shown in table 
3.1) and the overall purity of the proteins was the same as the native C.Esp1396I 
(figures 3.13 and 3.14). The two mutants, Y29S and Y29W, eluted from the size 
exclusion column at the same elution volume as the native protein (~210 mL). As 
the native protein is assumed to be a homodimer when eluted, this suggests that 
both mutants are also homodimeric. 
 
The Y29S mutant has an extinction coefficient of 1450 M-1cm-1 at 276 nm (i.e. half 
that of the native protein; table 3.1). Although the protein is > 95% pure, any 
impurities that absorb near 276 nm will lead to an over-estimation of the protein 
concentration. Also, at low concentrations, the peak at 276 nm on the UV spectrum 
is small and the signal:noise ratio is such that the calculation of protein 
concentration is error prone. To verify the concentration of the Y29S mutant, the 
concentration was also determined using the modified Bradford assay (Zor & 
Selinger, 1996) as described in section 2.2.2. Figure 3.15 shows the construction of 
the calibration curve from standards of native C.Esp1396I-GSH of known 
concentration and the determination of the Y29S concentration. The 
concentrations of Y29S determined by UV spectroscopy and by the Bradford assay 
were very similar and differed by ~2.5%. 
 
DNA sequencing of the Y29W mutant plasmid showed that a tryptophan had been 
introduced into the protein which increased the extinction coefficient from 
2900 M-1cm-1 to 6970 M-1cm-1 and the λmax shifted from 276 nm to ~280 nm. To 
confirm that a tryptophan had indeed been introduced, fluorescence emission 83
Figure 3.12: Analysis of the effect of glucose on the expression of the Y29 mutants 
of C.Esp1396I. The expression of the Y29 mutants was induced with IPTG in the 
presence or absence of 1% glucose and incubated for 3 hours at 37oC. The cells were 
lysed by addition of lysozyme and the lysate was cleared by centrifugation.  The 
supernatant was mixed with loading dye and heated to 95oC for 5 minutes. The sample 
loadings were normalised to 0.1 OD600 cell culture per lane by adjusting the loading 
volumes and were run alongside the BenchmarkTM protein ladder (M; figure 2.1) on a 
12% Tris-tricine SDS polyacrylamide gel. The C.Esp1396I-6His bands were analysed by 
densitometry using the program Scion Image (Scion Corp., Frederick MD.). The 
background for each lane was subtracted from the measurement of the band and the 
integrated density of each band was plotted as a bar chart. In the presence of glucose, 
the integrated density increases for both the Y29W and Y29S mutants.  
M 
lysozyme 
C.Esp1396I-6His 
Y29W Y29S 
1% glucose - + - + 
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Table 3.1: Summary of the properties used in the calculation of protein 
concentration using UV absorbance spectroscopy 
Molar extinction 
coefficient (M-1cm-1 ) 
λmax (nm) 
native 2900 276 
Y29S 1450 276 
Y29W 6970 ~280 
85
Figure 3.13: Overall purification of C.Esp1396I-GSH Y29S and typical UV spectrum. 
A UV spectrum from 200 – 350 nm of C.Esp1396I-GSH Y29S was obtained using a 
lambda-25 (Perkin-Elmer). The absorbance due to the buffer component has been 
subtracted. (Inset) 10 µL C.Esp1396I samples (indicated by the labels above the gel) 
were mixed with 5 µL loading dye and 10 µL was loaded onto a 12% Tris-tricine SDS 
polyacrylamide gel alongside the BenchmarkTM protein ladder (figure 2.1). The 
C.Esp1396I-6His Y29S runs at approximately 11.5 kDa (6His) and the C.Esp1396I-GSH 
Y29S runs at approximately 9.5 kDa (GSH). The overall purity of C.Esp1396I-GSH Y29S 
is >  5% as determined by densitometry. 
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Figure 3.14: Overall purification of C.Esp1396I-GSH Y29W and typical UV 
spectrum. A UV spectrum from 200 – 350 nm of C.Esp1396I-GSH Y29W was obtained 
using a lambda-25 (Perkin-Elmer). The absorbance due to the buffer component has 
been subtracted. (Inset) 10 µL C.Esp1396I samples (indicated by the labels above the 
gel) were mixed with 5 µL loading dye and 10 µL was loaded onto a 12% Tris-tricine SDS 
polyacrylamide gel alongside the BenchmarkTM protein ladder (figure 2.1). The 
C.Esp1396I-6His Y29W runs at approximately 11.5 kDa (6His) and the C.Esp1396I-GSH 
Y29W runs at approximately 9.5 kDa (GSH). The overall purity of C.Esp1396I-GSH Y29W 
is > 95% as determined by densitometry. 87
Figure 3.15: Measuring the concentration of C.Esp1396I-GSH Y29S using a 
Bradford assay. (Top) The ratio of A595/A465 from the spectra (inset) was plotted 
against C.Esp1396I-GSH concentration to form a calibration curve. The inset spectra 
were formed by incubating 40 µL C.Esp1396I-GSH of known concentration with 960  µL 
Bradford dye. A wavelength scan from 400 – 800 nm was performed using a lamda-25 
(Perkin-Elmer). (Bottom) A 40 µL sample of  0.3 mg/mL Y29S (measured by UV 
spectroscopy) was  incubated with 960 µL Bradford dye and a spectrum from 
400 - 800 nm was obtained The ratio of A595/A465 (~1.35) was converted into 
concentration of 0.307 mg/mL using the calibration curve. The error between the two 
methods of concentration determination is 2.3%. 88
Amino 
acid 
Excitation 
maximum (λ, nm) 
Emission 
maximum (λ, nm) 
Quantum 
yield 
Phe 257.4 282 0.08 
Tyr 274.6 303 0.14 
Trp 279.8 330-355* 0.20 
Figure 3.16: Fluorescence emission spectra of native and Y29W C.Esp1396I-GSH. 
The excitation and emission maxima of the three aromatic amino acids along with the 
quantum yield is shown in the table (adapted from Teale & Weber, 1957). The λmax for 
tryptophan varies dependent upon its environment. 2 µM samples of native and Y29W 
were placed in a 1 mL quartz cuvette and the fluorescence  emission spectra were 
obtained at an excitation wavelength of 280 nm using an LS50-B fluorescence 
spectrometer (Perkin-Elmer) and the spectra were corrected for buffer contributions. 
The excitation/emission slit widths (nm) were 2.5/3 and 5/7 for the Y29W and native 
C.Esp1396I-GSH respectively. The native protein spectrum has a maximum at 
approximately 303 nm which is consistent with tyrosine fluorescence in the absence of 
tryptophan. The Y29W spectrum has a maximum at approximately 355 nm which is 
indicative of tryptophan fluorescence in a polar environment. 89
Figure 3.17: Overall purification of 15N-labelled C.Esp1396I-GSH and UV spectrum. 
A wavelength scan from 200 – 350 nm was performed on C.Esp1396I-GSH using a 
lambda-25 (Perkin-Elmer). The absorbance due to the buffer component has been 
subtracted. (Inset) 10 µL C.Esp1396I samples (indicated by the labels above the gel) 
were mixed with 5 µL loading dye and 10 µL was loaded onto a 12% Tris-tricine SDS 
polyacrylamide gel alongside the BenchmarkTM protein ladder (figure 2.1). The 
C.Esp1396I-6His runs at approximately 11.5 kDa (6His) and the C.Esp1396I-GSH runs at 
approximately 9.5 kDa (GSH). The overall purity of C.Esp1396I-GSH is > 95% as 
determined by densitometry. 
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 spectrometry was performed as described in section 2.12.2. Figure 3.17 shows the 
fluorescence emission spectra for the native protein and the Y29W protein at an 
excitation wavelength of 280 nm. It is be expected that tryptophan fluorescence  
dominates the spectrum, but that in the absence of tryptophan, the spectrum will 
be dominated by the tyrosine fluorescence. The native protein has a maximum at 
approximately 303 nm which is indicative of tyrosine fluorescence and the absence 
of tryptophan. In contrast, the Y29W spectrum has a maximum at approximately 
350 nm which confirms that a tryptophan had been introduced into the protein. 
3.5  Expression and purification of 15N-labelled C.Esp1396I 
Expression of 15N-labelled C.Esp1396I was carried out in minimal media as 
described in section 2.11. As the 15N-labelled C.Esp1396I would only be used for 
preliminary nuclear magnetic resonance (NMR) studies, the expression was not 
optimised. 
 
The purification of the 15N-labelled C.Esp1396I followed the strategy developed for 
the native protein and approximately 2 mg of pure protein was obtained 
(figure 3.18).  However, it was noted that the 15N-labelled C.Esp1396I appeared 
less soluble and the yield of pure protein was 2-3 fold lower than for the native 
C.Esp1396I. For further NMR studies the expression and purification of the 
labelled protein requires optimisation which is beyond the scope of this 
investigation. 
3.6  Discussion 
The aim of this work was to optimise the over-expression and purification of 
C.Esp1396I and the Y29 mutants in order to increase the final yield. Preliminary 
studies revealed that bacteria containing the pET-28b(+)/esp1396IC construct 
were optimally induced with 1 mM IPTG at OD600 = 0.6 (S.D. Streeter, personal 
communication). Expression studies identified that an incubation time of between 
3 and 4 hours gave rise to the maximum yield of protein. 
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 In the case of the Y29 mutants, it was necessary to incubate the bacteria in media 
containing 1% glucose to reduce the level of background expression. The native 
protein does not exhibit the same level of background expression and the addition 
of glucose during expression did not improve the overall yield. The mutant 
proteins were produced by PCR amplification of the entire plasmid (see section 
2.7) and it is possible that there were unintended mutations introduced outside of 
the coding region. If these mutations occurred within the transcriptional control 
elements of the plasmid, it could account for the increased background expression 
and hence the need for glucose to tighten the control of expression. The addition of 
glucose improved the overall yield of the mutant proteins to levels roughly 
equivalent to that of the native protein. 
 
Optimisation of the purification strategy for the His-tagged C.Esp1396I 
(C.Esp1396I-6His) was undertaken to obtain a high level of purity, whilst 
attempting to obtain higher yields of pure protein for biophysical studies. Many 
different strategies were explored, including: denaturation and refolding, alternate 
methods of elution from the nickel affinity column, adding solubilising agents (e.g. 
tween) and altering buffer composition and pH. It was decided to retain imidazole 
in the buffers throughout purification as this reduced the tendency of C.Esp1396I 
to precipitate. Prior to use in biophysical studies the imidazole was removed by 
dialysis. 
 
Using affinity and size exclusion chromatography, C.Esp1396I could be purified to 
> 95% purity and the purity at each step is shown in figure 3.11. The overall yield 
of C.Esp1396I was improved 2-3 fold from the previously published method 
(McGeehan et al., 2008), produced approximately 4 mg protein per litre of 
bacterial culture and the overall purity remained > 95%. Although the yield is still 
relatively low (4 mg/L), this provided sufficient C.Esp1396I (typically at 
2.5 mg/mL) for biophysical and structural characterisation. 
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 Chapter 4: The C.Esp1396I protein 
structure and mutagenesis 
4.1   Introduction 
Although the structure of C.Esp1396I bound to DNA is known (McGeehan et al., 
2008), the structure of the free protein was unknown. In order to determine if 
there were conformational changes between the free and bound forms of the 
protein, the structure of the free protein was solved by X-ray crystallography. 
McGeehan and colleagues (2008) reported that mutation of a single residue, R35, 
was sufficient to prevent C.Esp1396I binding to its DNA recognition sequences. In 
order to determine if the loss of the R35 residue resulted in loss of function due to 
misfolding of the protein or whether the R35 was crucial to the DNA binding 
capability of the protein, the structure of the R35A mutant C.Esp1396I was solved 
by X-ray crystallography.  
 
During routine purification of C.Esp1396I the protein had a tendency to 
precipitate. Optimisation of the purification strategy was performed (see chapter 
3) but the solubility of the protein remained low. The free protein structures 
represented an opportunity to identify the crystal packing interactions that are 
involved in the formation of the precipitate and mutants were designed that would 
potentially disrupt these interactions. Tyrosine 29 was identified by examination 
of the free protein structures and was mutated to either serine or tryptophan to 
improve solubility or increase the molar extinction coefficient of the protein 
respectively. These mutant proteins were expressed, purified and compared with 
the native protein for DNA-binding activity. 
4.2  Crystallographic theory 
In order to resolve individual atoms a wavelength of electromagnetic radiation 
that is shorter than the distances between atoms must be used. X-rays with a 
wavelength in the range 0.1 - 1.5 Å are routinely used to determine molecular 93
 structures. X-rays are diffracted by the electrons in the molecule and the electron 
density map can be determined from the diffraction pattern (figure 4.1) by a 
fourier  transformation (assuming the phases are known; see section 4.2.7). X-ray 
diffraction from a single molecule would be weak, so diffraction data is collected 
from a large number of identical molecules that are arranged in an ordered array 
within a crystal. 
4.2.1 Crystallisation and cryoprotection 
The formation of crystals involves three steps: nucleation, growth and cessation of 
growth. The method of crystallisation employed in this thesis was the vapour 
diffusion method. In this method a solution of the macromolecule is mixed with a 
mother liquor containing a buffer system at a particular pH and a precipitant, (e.g. 
polyethylene glycol). A drop of the mixture is then placed in a sealed reservoir and 
equilibrated against buffer at higher concentration than in the drop. Vapour 
diffusion occurs between the drop and the mother liquor and as the equilibration 
proceeds, the protein becomes supersaturated in the drop which leads to 
nucleation and growth (figure 4.2). The drop can either be "sitting" in a concave 
well within the reservoir or "hanging" from the coverslip used to seal the reservoir. 
 
Initially, a large number of crystallisation buffers are screened for the production 
of crystals. This is often done using commercially prepared sparse-matrix screens 
and plating the conditions using a crystallisation robot. The conditions that show 
evidence of crystallisation are then optimised. This usually involves adjusting the 
pH and precipitant concentration along with varying the incubation temperature. 
Crystal size can sometimes be enhanced by providing a nucleation point for 
crystallisation in a process known as seeding. In some cases additives (e.g. 
spermidine) can be used to promote crystal growth.  
 
Data collection is commonly performed at ~100 K as this reduces the effect of free 
radicals caused by exposure to the X-ray beam. The crystal must be placed in a 
solution that prevents the formation of crystalline ice as diffraction from this ice  
would interfere with the diffraction from the protein crystal. This involves placing 
94
Figure 4.1: Diffraction pattern of a nucleoprotein complex. C.Esp1396I bound to 
DNA containing OL was crystallised and exposed to synchrotron radiation on ID14-4 at 
the ESRF in Grenoble. The large white horizontal bar is the beam stop. The crystal 
diffracted to 2.1 Å and was rotated by 1° during  exposure. 95
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Figure 4.2: Phase diagram of precipitate mediated crystallisation. Using the vapour 
diffusion method, the protein concentration is initially too low to form crystals (a). As 
volatile solvents (e.g. water) diffuse from the drop into the mother liquor, both the 
protein and precipitate concentration increase within the drop (b), permitting 
nucleation an growth of crystals. As the protein forms crystals, the protein 
concentration in solution reduces into the metastable growth zone (c). The formation of 
crystals can be optimised by altering the crystallisation buffer to improve the efficacy of 
each step. Figure adapted from figure 3.5 in Rhodes (2006). 96
 the crystals in a cryoprotectant, typically high concentrations of PEG or glycerol. 
The quality of the data that can be obtained from a crystal can be affected by the 
cryoprotectant that is used. The cryoprotectant can be optimised by using a 
different molecular weight PEG or trying other compounds such as glucose and 
varying the concentration of the cryoprotectant.  
4.2.2 Crystals 
Crystals are formed from a three dimensional array of "building blocks." These 
building blocks are called the unit cell and the vertices of the unit cells can form 14 
possible Bravais lattices. The unit cell is representative of the whole crystal and 
can contain more than one asymmetric unit. An asymmetric unit has no symmetry 
elements but can be superimposed upon other asymmetric units through 
symmetry operations. The combination of the symmetry operators in the unit cell 
and the lattice type defines the space group of the crystal. Protein and DNA crystals 
can form in 65 of the 230 possible space groups as both protein and DNA are chiral 
molecules, containing L-amino acids and D-pentoses respectively. 
 
The dimensions of the unit cell is defined by 6 numbers: three cell edges (vectors a, 
b and c) and the angles between them (α, β and γ,  where the angle between b and 
c is α, the angle between a and c is β and the angle between a and b is γ; figure 4.3). 
The vertices of the unit cell can define the points of the crystal lattice. Through 
these lattice points can be drawn an infinite number of equivalent, regularly 
spaced planes. These sets of planes are given a Miller index (hkl) which defines the 
number of times the planes cut through the unit cell edges. So (123) planes with 
pass through a once, b twice and c three times. W.L. Bragg demonstrated that the 
diffraction of X-rays by crystals could be treated as reflections from these planes. 
4.2.3 Bragg's law 
By treating diffraction as if it were reflections from a set of equivalent parallel 
planes, Bragg was able to calculate the angle at which a diffracted X-ray would 
emerge from a crystal. X-rays reflecting from each layer within the sets of planes 
must be in phase with each other in order to produce a diffracted beam. For a set of 
planes with inter-plane spacing dhkl, a diffracted beam is only produced at a specific 97
 angle of incidence, θ, where the difference in path length of the X-rays reflected 
from different layers within the set of planes is equal to an integer number of 
wavelengths, nλ (figure 4.4) such that: 
 
        sin  
 
The intensity of the diffracted ray is proportional to the amount of electron density 
that lies on, or parallel to, this set of planes in the unit cell. A spot (reflection) in the 
diffraction pattern contains contributions from every atom in the unit cell and each 
reflection is designated an index corresponding to the index of the planes that 
produced it.  
4.2.4 Reciprocal space and Ewald's sphere 
The reciprocal lattice points are given the index hkl. The lattice can be constructed 
by drawing lines perpendicular to the (hkl) planes from an arbitrary origin (000) in 
the real lattice. The length of each line is the reciprocal of the inter-plane spacing 
(1/dhkl) of the planes through which the lines are drawn. At the end of the line lies 
the reciprocal lattice point. Thus the planes in a reciprocal lattice are 
perpendicular to the planes in the real lattice and have an inter-plane spacing of 
1/dhkl. The reciprocal lattice has a reciprocal unit cell where the a* edge is 
perpendicular to the (100) plane and has length 1/a, the b* edge is perpendicular 
to the (010) plane and has length 1/b and the c* edge lies perpendicular to the 
(001) plane and has length 1/c. Therefore, a large real unit cell corresponds to a 
small reciprocal unit cell and vice versa. Due to the way in which the reciprocal 
lattice is defined, the real and reciprocal lattices are spatially linked, so as the real 
lattice is rotated (by rotation of the crystal) the reciprocal lattice is also rotated. 
 
A reflection from a set of planes is only produced at certain angles of incidence as 
demonstrated by Bragg's law. By applying Bragg's law in reciprocal space and 
through the construction of the Ewald sphere (figure 4.5), the direction in which a  
diffracted beam occurs can be predicted. As a reciprocal lattice point intersects the 
Ewald sphere, Bragg's law is satisfied and a reflection is produced. The direction in 
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Figure 4.3: The unit cell. The unit cell is described by the constants a, b, c, α, β and γ. a, 
b and c are the lengths of the unit cell edge in the x, y, and z direction respectively. α is 
the angle between the ab face and edge c, β is the angle between the bc face and edge a 
and γ is the angle between the ac face and edge b. Lattice points of the crystal occur at 
the corners of the unit cell. 99
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θ 
dhkl 
x y 
Figure 4.4: Diffraction can be treated as reflections from sets of parallel planes. (a) 
An incident beam strikes the crystal at an angle (θ) to a set of planes. For wave B to 
emerge in phase with wave A, the extra distance travelled by wave B (x + y) must be an 
integral number of wavelengths as described by Bragg’s law (b). For sets of equivalent 
parallel planes with inter-plane spacing dhkl, a diffracted beam (reflection) will only 
occur at a specific angle of incidence. The overall angle of the reflection with respect to 
the incident beam is 2θ. 
a 
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2θ 
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100
Figure 4.5: Construction of the Ewald sphere in two dimensions. An X-ray (blue 
arrow) impinges upon a real lattice at point O (the arbitrary origin). The reciprocal 
lattice (dashed lines) is constructed with its origin at O. The intersections of the dashed 
lines are the reciprocal lattice points. A circle of radius 1/λ is constructed such that the 
circumference touches O and the centre of the circle (C) lies along the path of the X-ray. 
Wherever the circle intersects a reciprocal lattice point (P) a diffracted beam (reflection) 
will occur as Bragg’s law is satisfied. The incident beam is diffracted by 2θ to produce 
the diffracted beam (red arrow). 
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 which this reflection occurs is given by the angle between the incident beam and 
the line between the centre of the sphere and the reciprocal lattice point (red line 
in figure 4.4). Thus the positions of the reflections in a diffraction pattern are 
determined by the unit cell dimensions and not the contents of the unit cell. The 
intensity of the diffracted beam is a sum of the contribution of all of the atoms in 
the unit cell and provides structural information. 
4.2.5 Electron density as a complex wave function 
Simple waves can be described by the equation:                     or 
                   , where A is the amplitude of the wave, h is the 
frequency, x is the position (measured in wavelengths) and α is the phase with 
respect to the origin. Any complex wave can be described by the sum of simple 
waves, which can be written as a Fourier sum:  
 
                     
 
   
 
 
Simple waves can also be described by an equation with an imaginary number 
component (of the form a + ib)       cos                    , where i is 
 (  ). For waves described in this way, the phase is implied by the combination of 
the sine and cosine terms and is defined solely by h and x. Using the identity 
cos              the Fourier sum can be written: 
 
          
        
   
 
 
Electron density, ρ, can be described as a 3D wave and has periodicity due to the 
repeating unit cells. A 3D wave has three frequencies (h, k and l) in the x, y and z 
directions and amplitude Ahkl. The electron density at a specific point,         , can 
be described as the Fourier sum: 
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As it is described as a sum of simple waves, electron density can be calculated from 
X-ray diffraction images using a mathematical operation known as a Fourier 
transform. 
4.2.6 The relationship between electron density and diffraction patterns 
A structure factor, Fhkl, is a description of a single diffracted X-ray that produces 
one reflection on the diffraction pattern and consists of three terms: frequency, 
amplitude and phase. A structure factor can be written as the sum of contributions 
from each volume element (V) of electron density in the unit cell. By making V 
infinitely small, the average electron density in V accurately describes the electron 
density at a specific point,         :  
 
                 
                
 
 
 
The Fourier transform of the electron density describes the diffraction pattern and 
conversely, the diffraction pattern relates to the electron density through the 
reverse Fourier transform (expressed as a Fourier sum as the diffraction pattern is 
a set of discrete reflections): 
 
            
 
 
         
               
   
 
 
 
In order to convert the diffraction pattern into an electron density contour map the 
intensity, frequency and phase of each reflection must be known. 
4.2.7 The phase problem 
The amplitude of a structure factor is proportional to the square root of the 
intensity, I, of the reflection. The phase of a reflection is not recorded by the 103
 detector and the phase component of the structure factor is lost. In order to 
calculate the electron density this "phase problem" must be overcome. Some 
methods of overcoming the phase problem include anomalous dispersion (single 
or multi- wavelength), isomorphous replacement (using electron-rich heavy 
atoms) and molecular replacement. Molecular replacement will be discussed in 
more detail as it was used to provide an initial estimate of the phases for the 
structures solved in this thesis. 
4.2.8 Molecular replacement 
Molecular replacement (MR) uses the phases of a structurally similar molecule 
(search model) as an estimate of the experimental phases for the unknown 
structure (target model). Structural similarity is often judged by primary sequence 
comparisons and usually the sequence identity must be in excess of 30%. Search 
models can often be improved by truncating amino acid side chains (typically to 
alanine) and lowering the B-factors (a measure of the average displacement of an 
atom due to thermal motion) in the hydrophobic core, combined with increasing 
the B-factors of surface residues. If the protein is composed of domains that can 
move relative to one another, the search model can be split into domains and used 
as separate search models. This would permit greater accuracy in positioning the 
domains, but the search for the first domain may fail due to low completeness.  
 
If the model and target protein are isomorphous, then the phases of the search 
model can be used directly. However, if the search and target molecules are 
non-isomorphous, then the search model must be placed in the correct orientation 
and position in the unit cell. This involves a six dimensional search: three angles of 
rotation and three axes of translation. The rotation function and translation 
function are solved separately as this reduces the complexity of the search. Once 
the search model has been placed in the unit cell, the calculated phases can be used 
as an initial estimate for the phases of the target model. There are currently two 
methods for achieving a MR solution. The first uses a comparison of the Patterson 
functions of the search and target models and the second uses a "maximum-
likelihood" approach in reciprocal space. The program Phaser (McCoy et al., 2005) 
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 uses the "maximum-likelihood" approach and was used to obtain MR solutions for 
all the structures presented in this thesis.  
 
The "maximum-likelihood" method of MR involves modelling the differences 
between the observed and calculated reciprocal space structure factors as 
Gaussian distributions using the central limit theorem. The probability that the 
calculated structure factor (Fc) gives rise to the observed structure factor (Fo) is 
used to select the most likely solution to the rotation and translation functions. The 
probabilities of the solutions to these functions for each reflection is combined into 
a total score and the MR solution is selected based on this score. 
 
If the search and target models are identical the phases are identical. When the 
search and target models are not identical, phases from the search model are used 
as an initial estimate of the phases for the target model and these phases are 
improved by cycles of iterative refinement. 
4.2.9 Refinement and model validation 
The initial phases (e.g. from molecular replacement) and the reflection intensities 
provide a starting point for solving the structure factor equation. Solving the 
structure factor equation permits calculation of an electron density map. This map 
can be interpreted in real space and atomic coordinates can be refined using 
computer programs (e.g. Coot; Emsley & Cowtan, 2004). Only by refining the 
position of the atoms within the map can the phases be improved. The structure 
factor equation can be solved by summing the contribution to each reflection of 
every atom within the unit cell: 
 
          
                 
 
   
 
 
where fj is the atomic scattering factor for the jth atom that has coordinates xj, yj, zj 
measured as fractions of the unit cell constants a, b and c. Therefore refining the 
position of the atoms within the unit cell will improve the estimate of the structure 105
 factors. Iterative cycles of refining the atomic coordinates and recalculating the 
electron density map will improve the detail and accuracy of the model. 
 
Repositioning of any atom in the structure will alter the phases for the whole 
model. However, it is important not to over-interpret the electron density and 
introduce bias. As the phases improve, they dominate the Fourier sum. To reduce 
the influence of the model on the calculated electron density a "difference map" 
can be calculated. This uses the differences between the amplitudes of the 
observed and calculated structure factor amplitudes (|Fobs| and |Fcalc| respectively) 
as coefficients in the Fourier transform. One such map is the 2Fo - Fc map: 
 
          
 
 
                  
                    
  
   
 
 
where the calculated phases (α'calc) are provided explicitly. This produces a map 
that contains positive and negative density. Positive density implies that the unit 
cell contains more electron density in a particular region and vice versa for 
negative density.  
 
As the model converges upon the real structure, the measured and calculated 
structure factor amplitudes also converge. This convergence is measured using the 
R-factor: 
 
 
   
                  
       
 
 
An R-factor of zero implies that the model matches the real structure perfectly. The 
R-factor will improve with resolution as the electron density map becomes more 
detailed and the atoms can be positioned more accurately. Another measure 
similar to the R-factor is the free R-factor (Rfree) which measures how well the 
model predicts a subset of data not used in refinement. Measuring both R and Rfree 
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 can be used as guide to identify over interpretation of the data and should result in 
a less biased model. 
 
Once the refinement of the model is completed, the overall validity of the model 
can be assessed. This involves examination of the geometry of the model, in 
particular the inter-atomic bond lengths and the bond angles. The refinement 
process can also be weighted to place greater emphasis on the geometry of the 
model. Also, the model must make chemical sense. For example, interactions 
between charged groups must be between groups with opposite charge. The model 
can be assessed using validation programs (e.g. Procheck; Collaborative 
Computational Project, Number 4, 1994) and if there are no warnings, the model can 
be deposited in an online databank for molecular structures (e.g. the RCSB Protein 
Data Bank; www.pdb.org). 
4.3  Crystallography of C.Esp1396I 
4.3.1   Crystallisation 
During routine purification of C.Esp1396I, following the published method of 
McGeehan et al., (2008), a white precipitate formed during removal of imidazole by 
dialysis. Upon further investigation it was discovered that the precipitate was 
crystalline in nature using polarising light microscopy (Leica MZ12-5; figure 4.6). 
The precipitate consisted of many small irregularly shaped crystals and few large 
crystals (~ 200 x 75 x 75 µm) that were typically either rhombic or cubic in shape.  
 
In-house screening was performed using an Excalibur Nova (Oxford diffraction) on 
precipitate crystals that were cryoprotected in 30% v/v glycerol. The diffraction 
patterns were typical of macromolecular diffraction rather than salt diffraction but 
there was a large variation in the diffraction quality and resolution between 
crystals. In some cases, the resolution extended to approximately 3 Å, but in many  
of these cases the diffraction showed evidence of twinning and was particularly 
poor in certain orientations. 
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Figure 4.6: Crystals formed from precipitation of His-tagged C.Esp1396I. Crystals of 
C.Esp1396I-6His formed by precipitation during removal of NaCl and imidazole by 
dialysis. (a) A typical amount of crystalline precipitate sedimented by centrifugation in a 
15 mL Falcon tube. (b) Typical content of the precipitate visualised by polarising light 
microscopy. (c) Some large crystals (~150 x 75 uM) were present in the precipitate and 
these large crystals were cryocooled in dialysis buffer containing 30% w/v glycerol. 
0 100 
µm 
a 
b 
c 
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 Attempts were made to improve the quality and reproducibility of the crystals by 
using sparse matrix screens (e.g. PACT premier, Molecular Dimensions) combined 
with the use of additives such as spermine and spermidine. 96-well sitting drop 
screens of purified C.Esp1396I-GSH were set up using a Honeybee robot 
(Cartesian) and incubated at either 4 or 16oC. Precipitation occurred across many 
different conditions with very few regular, single crystals formed. Further manual 
focussed screens of a selected subset of these conditions did not yield crystals that 
diffracted beyond ~ 4 Å resolution. As for the precipitate crystals, the spot profile 
was often smeared, anisotropic or twinned. 
 
Crystals of C.Esp1396I-6His and the R35A mutant that were formed from 
precipitation during purification were cryoprotected using 30% v/v glycerol 
mixed with cleavage buffer (40 mM Tris-HCl pH8, 150 mM NaCl, 2.5 mM CaCl2, 5% 
w/v glycerol) and cryocooled using liquid nitrogen. These crystals were then 
stored in liquid nitrogen prior to exposure at a synchrotron. 
4.3.2   Structure solution and refinement 
Cryocooled crystals of the native and R35A mutant protein were exposed to 
synchrotron radiation on ID14-2 at the ESRF (Grenoble). A selection of crystals 
were screened using the automated sample changer and datasets of the most 
promising crystals were collected at 100 K using an ADSC 4Q CCD detector. Both 
native and mutant proteins crystallised in the space group P65 and images were 
collected with a 1o oscillation angle. 180 images were collected for the native 
protein and 90 images were collected for the R35A mutant owing to high 
anisotropy. 
 
Processing and scaling of the native data was performed using XDS/XSCALE as this 
resulted in better integration statistics than processing by MOSFLM. Conversely, 
the R35A structure was processed and scaled using MOSFLM/SCALA, which 
provided higher completeness than using XDS despite poor spot profiles. For both 
structures, the processing was a compromise between data quality and 
completeness. Despite high Rmerge values (native - 14%; R35A – 27%) the native 109
 structure was refined at 2.8 Å and the R35A structure refined at 3.0 Å. The 
processing and refinement procedure is described in sections 2.10.3 and 2.10.4 
and the statistics for both proteins are given in table 4.1. 
4.4   Analysis of the crystal structure of C.Esp1396I 
The native protein crystallised in space group P65 with 14 monomers (i.e. 7 
dimers) in the asymmetric unit. The structure was initially solved by molecular 
replacement using Phaser (McCoy et al., 2005) with residues 5-75 from chain A of 
the DNA-bound C.Esp1396I (McGeehan et al., 2008) as a search model and refined 
to a resolution of 2.8 Å with an R/Rfree = 23.7/26.9%. Initially, TLS-based 
refinement was carried out in Refmac (Murhudov et al., 1997) using NCS restraints 
(residues 5-75; tight backbone, medium sidechain) with chain A as the master 
chain. Using the validate NCS differences tool in Coot (Emsley & Cowtan, 2004) 
residues 43-46 were identified as variable regions between chains (chains L and N 
in particular) and these residues were omitted from the NCS restraints in 
subsequent rounds of refinement. The parameters that were used for the final 
round of refinement are shown in table 4.2. The structure comprises five α-helices 
per monomer and there is a clear helix-turn-helix (HTH) motif in each monomer 
(figure 4.7), which is common in many DNA-binding proteins.  
 
The R35A mutant protein refined to 3.0 Å in space group P65 with two monomers 
(i.e. one dimer) in the asymmetric unit, using TLS-based refinement with NCS 
restraints (residues 5-42, 47-75; tight backbone, medium sidechain) and the 
parameters used for the final round of refinement are shown in table 4.2. The 
structure is shown in figure 4.8 and is almost identical to the native protein 
structure when overlaid. The reduced affinity of the R35A mutant for DNA 
(McGeehan et al., 2008) must be due to the loss of interactions between the 
arginine sidechain and the DNA as the tertiary structure is indistinguishable from 
that of the native protein. As the structures are the same, only the native protein 
structure will be discussed as this affords marginally better resolution and can be 
compared with the native DNA-bound structure. 
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Table 4.1: X-ray crystal data, refinement and model statistics for the native and 
R35A mutant C.Esp1396I-6His. Values in parentheses are for the highest resolution 
shell.  
 
* Rmerge = ∑hkl∑i|Ii(hkl) - «I(hkl)»|/∑hkl∑iIi(hkl),  where «I(hkl)» is the mean intensity of 
reflection I(hkl) and Ii(hkl) is the intensity of an individual measurement of reflection 
I(hkl). ǂ Rcryst = ∑hkl│|Fobs| - |Fcalc|│/∑hkl|Fobs|, where Fobs is the observed structure-factor 
amplitude and Fcalc is the calculated structure-factor amplitude. Rfree is the same as Rcryst 
but for 5% of structure-factor amplitudes which were set aside during refinement. 
      Native   R35A 
Data collection 
Space group    P65    P65 
Unit-cell parameters (Å, o)  a = b = 128.7,  a = b = 48.4, 
         c = 137.5,      c = 135.8, 
        α = β = 90,      α = β = 90, 
         γ = 120      γ = 120 
Resolution limits (Å)   50-2.8 (2.9-2.8)  50-3.0 (3.1-3.0) 
Rmerge* (%)    13.8 (39.0)   27.7 (45.5) 
I/σ(I)     16.8 (7.7)   1.4 (1.9) 
Completeness (%)   96.3 (93.7)   100 (100) 
Redundancy    11.7    7.6 
Refinement model statistics 
No. of reflections   30225   3617 
Rcryst/Rfree
ǂ (%)    23.7/26.9   24.9/26.7 
No. of atoms 
Protein     8696    1197 
Water     4    0 
B factors (Å2) 
Protein     33.1    56.7 
Water     13.6   n/a 
R.m.s deviations from ideal 
Bond lengths (Å)   0.015    0.014 
Angles (o)    1.6    1.7 
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Table 4.2: Final refinement parameters for native and R35A mutant C.Esp1396I.  
Native R35A 
Refinement 
Resolution 
limits 
47 - 2.8 35.7 - 3.0 
B-factors Overall anisotropic Overall anisotropic 
Weighting Auto Auto 
Scaling Simple Simple 
NCS 
No. of groups 2 1 
Chains in group 1: A-K,M. 2: A,L,N A-B 
Residue range 
(restraint level) 
Group 1: 3-34, 36-42, 
48-76 (tight); 35 
(medium); 41-47 
(loose).  
Group 2: 3-34, 36-42, 
48-76 (tight); 35 
(medium). 
3-34, 36-43, 47-75 
(tight) 
TLS 
No. of groups 14 2 
Description individual chains Individual chains 
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Figure 4.7: The free protein structure of C.Esp1396I-6His. (Top) In the asymmetric 
unit of the C.Esp1396I-6His structure there are 14 copies of the monomer which are 
arranged as 7 homodimers. Chains A and B are representative of the overall topology of 
these 7 dimers (blue). (Bottom) Chains A and B are coloured by helix: helix 1 - blue, 
helix 2 - green, helix 3 - yellow, helix 4 - orange, helix 5 - red.  113
Figure 4.8: The free protein structure of the R35A mutant of C.Esp1396I-6His. The 
R35A structure (red) refined to 3 Å in the spacegroup P65 and a single homodimer was 
found in the asymmetric unit of the crystal structure the structure consists of 5 alpha 
helices and shares a very similar tertiary structure with the native free protein (blue). 
The  R35A mutant  has been overlaid with  the  native free protein structure  with an 
RMSD of  0.37 Å (435 backbone atoms).  The absence of R35 in the mutant structure was 
verified (circled). 114
 4.4.1   Alternative conformations 
Comparison of the fourteen monomers found in the asymmetric unit of the native 
C.Esp1396I-6His crystal structure revealed that two monomers (chains L and N) 
exhibited alternative conformations in a loop region between helices 3 and 4 
(figure 4.9). These loop regions were hand-built into clearly interpretable electron 
density (figure 4.10) following the relaxation of NCS restraints. The two alternative 
loop conformations were also present in the R35A mutant structure, (one in each 
subunit), despite there only being a single dimer in the asymmetric unit.  
 
The Cα backbone in this loop region (residues 43-46) follows distinctly different 
paths with some individual Cα atoms displaced by up to ~5 Å. This is accompanied 
by significant side-chain rearrangements (figure 4.10) with the Asn-44 residue 
being rotated about the backbone by approximately 180o and the γ-carbonyl 
oxygen displaced by about 10 Å. In both conformations the residues occupy 
favoured regions of the Ramachandran plot (figure 4.11). 
 
The B-factors for the two alternative loop conformations (averaged across all 
atoms of residues 43-46) in chains M and N (figure 4.12) are 37 Å
2
 (major 
conformation) and 32 Å2 (minor conformation). When the B-factors for the loop 
region are compared with the average B-factor for the rest of the dimer (33Å2), it 
appears that the minor conformation is more rigid than the major conformation. 
This decrease in B-factors in the minor conformation compared with the major 
conformation may be due in part to the inter-chain interaction of R43 with D64, 
which is only present with the loop in the minor conformation (figure 4.12).  
 
These alternate loop regions are proximal to the recognition helix (helix 3) and 
may explain the ability of C.Esp1396I to recognise different DNA sequences with 
different affinities, which is key to its role in the genetic switch. This is discussed in 
more detail in chapter 6. 
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Figure 4.9: Superimposition of the fourteen monomers in the asymmetric unit of 
the native C.Esp1396I-6His structure. Chains A-N have been overlaid across the 
backbone atoms (C,Cα,N) of residues 5-75 excluding residues in the loop between helices 
3 and 4 (43-47).  All chains have had > 185 (mean = 191) atoms superimposed upon 
chain A with an RMSD < 0.1 Å (mean = 0.072 Å). The chains exhibit an almost identical 
structure excepting the termini and loop regions. 12 of the 14 chains have the same loop 
conformation while chains L and N (yellow and red respectively) exhibit an alternate 
loop conformation. 116
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Figure 4.10: Comparison of the two alternative conformations present in the 
crystal structure of native C.Esp1396I-6His. The two conformations (represented by 
chains A and N) could be fitted into clearly interpretable electron density (top). 
(Bottom) Chains A and N are superimposed across 193 backbone atoms (excluding the 
residues 43-47) with an RMSD of 0.098 Å. Light coloured sidechains are from chain A 
while darker coloured sidechains belong to chain N. Residues R43, N44, S45 and R46 are 
shown in green, red, blue and yellow respectively. Residues N44 and S45 are rotated 
about the backbone by approximately 180o and the Cα atoms are displaced by ~5 Å. In 
the case of N44, the sidechain carboxyl group is displaced by ~10 Å.  
R46 S45 
N44 
N44 
R43 
S45 
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Figure 4.11: Kleywegt plot of the two alternative loop conformations. The Kleywegt 
plot was produced using Coot and compares the Ramachandran plots of monomer N 
with monomer A. The pink regions on the plot are preferred regions, yellow areas are 
allowed regions and white areas are disallowed regions. The Phi and Psi angles for the 
loop residues (R43, N44, S45 and R46) are shown, with residues in chain A coloured 
white and residues in chain N coloured blue. All the residues from each conformation lie 
in the preferred region of the Kleywegt plot and the lines show how the phi and psi 
angles vary between the two conformations.  118
Figure 4.12: Temperature-factor analysis of a dimer of native C.Esp1396I-6His 
containing the two alternate loop conformations. (Top) Chains M and N (labelled by 
the arrows) of the native protein are coloured by temperature factor (B-factor) where 
red represents high B-factors and blue represents low B-factors. The scale bar 
represents B-factor ranges from 24-41 Å2. The core of the protein (blue) is relatively 
rigid whilst the C-terminal residues have the highest B-factors. The minor loop 
conformation (chain N) has below average B-factors that may be due in part from the 
packing interaction of R43 with D64 in chain J (botton left). The major loop 
conformation (chain M) has higher than average B-factors as the R43 does not interact 
with D63 from chain E (* this chain is from a symmetry related molecule) (bottom 
right). 
M N 
Chain N 
Chain J 
Chain M 
Chain E* 
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 4.4.2   Electrostatic potential 
The phosphodiester backbone of DNA has a strong negative charge that is coated 
by ordered water molecules and counter ions. In order for a protein to bind to DNA 
this ordered shell must be disrupted and the negative charge of the DNA must be 
counter-charged by the protein. Many, if not all, DNA binding proteins have 
positively charged hydrophilic regions that are capable of forming strong, non-
specific interactions with the phosphate groups of the DNA backbone.  
 
Figure 4.13a shows an electrostatic surface representation of the native 
C.Esp1396I, where positively charged regions are shown in blue and negatively 
charged regions in red. Overall there is a mixture of positively and negatively 
charged and uncharged residues on the surface of the dimer. However, there is a 
pocket of positive charge focussed around residues 43-47 from chain A and lysine 
51 from chain B (figure 4.13b). This pocket of positive charge is localised around 
the flexible loop region and is present in both loop conformations. Residues from 
this pocket have been shown to interact with the backbone phosphates of the DNA 
(McGeehan et al., 2008) and their role in DNA binding will be discussed further in 
chapter 6. 
4.4.3   Dimer interface 
The C.Esp1396I monomers interact primarily through residues in the loop region 
connecting helices 3 and 4 to form a stable dimer (figure 4.14). Reciprocal 
hydrogen bonding interactions in this region are predominantly composed of 
backbone interactions, apart from the γ-carbonyl group of Asn-47 that contacts the 
backbone amide group of Lys-51 and Ile-50. The backbone carbonyl group of 
Leu-48 is able to hydrogen bond with the backbone amide group of Ile-50. These 
interactions are symmetrical which results in a total of 6 hydrogen bonds being 
formed between the two monomers. Four of these hydrogen bonds (grey dashed 
lines) appear to be much weaker or are not well defined in the map as the bond 
distances are greater than 3.2 Å. 
 
120
Figure 4.13: Electrostatic potential on the surface of the C.Esp1396I dimer. (a) 
Chains A and B are represented as an electrostatic surface where red areas are 
negatively charged (acidic) residues and blue areas are positively charged (basic) 
residues. The scale represents electrostatic potential in the range -3 to 3 kT/e as 
calculated by the program DelPhi (Rocchia et al., 2002). (b) Residues R43, N44, S45, R46 
and N47 of one monomer, together with K51 from the other monomer form a pocket of 
positive charge capable of interacting with the phosphate backbone of DNA. The 
sidechains of R43 and N47 are shown to interact with the phosphate backbone in the 
repression complex (McGeehan et al, 2008). 
a 
b 
N47 
R46 
S45 
N44 
R43 
K51 
90o 
121
Figure 4.14: Interactions between residues in a loop between helices 3 and 4 that 
contribute to the stabilisation of the dimer interface. The stability of the C.Esp1396I 
dimer is mediated in part by interactions between residues in a loop region connecting 
helices 3 and 4 (top). (Bottom) Residues 47-51 form hydrogen bonds between 
monomers (dashed lines). Two possible hydrogen bonds per monomer are formed from 
the sidechain carboxyl group of N47 and the backbone amine groups of K51 and I50 
from the other monomer. The third hydrogen bond per monomer is formed between the 
backbone carboxyl of L48 and the backbone amine group of I50.  Three symmetry 
related hydrogen bonds are formed from the other monomer for a total of six hydrogen 
bonds at the dimer interface. Hydrogen bond distances are given in Å.  
3.7 
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Figure 4.15: Hydrophobic interactions between helix 5 contribute to the stability 
of the dimer interface. Hydrophobic sidechains of residues 65-75 of the two 
monomers lie within ~3.8 Å of one another (black dashes) which is sufficient to exclude 
water molecules from the interface.  123
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Figure 4.16: Global tertiary structure rearrangements between free C.Esp1396I-
6His and C.Esp1396I bound to DNA. (a) Chains A and B (protein) and chains E and F 
(DNA) of the DNA bound C.Esp1396I (McGeehan et al., 2008; PDB accession: 3CLC) are 
shown in grey and chains A and B of the free C.Esp1396I-6His (Ball et al., 2009; PDB 
accession: 3G5G) are shown in green. Chain A of both structures (left) have been 
superimposed (RMSD = 0.363 Å across 184 main chain atoms). The global 
rearrangement of the tertiary structure in chain B manifests as a ~1.4 Å movement of 
the peptide backbone in helices 2 (b) and 3 (c). 124
 The extended helix 5 also contributes to the stability of the dimer. This interaction 
is predominantly a hydrophobic one, with aromatic and non-polar sidechains 
within ~3.8 Å of one another, on average (figure 4.15). The total buried surface 
area at the dimer interface is c.a. 2049 Å2 (averaged across all 7 dimers), which is 
~150 Å greater than that seen by McGeehan et al. (2008) in the DNA-bound 
protein (~1900 Å2). This decrease in buried surface area when bound to DNA is 
due to the global repositioning of the two monomers relative to one another 
(section 4.4.4). 
4.4.4   Recognition helix 
The free protein structure closely resembles the DNA-bound protein structure 
(McGeehan et al., 2008) where individual monomers superimpose with an RMSD 
of ~0.5 Å. At a resolution of 2.8 Å it is possible to observe any large structural 
rearrangements that may be present. However, increased resolution is required in 
order to perform an exhaustive analysis of the small scale differences between the 
structures, such as the relative position of amino acid sidechains.  
 
Figure 4.16 shows a superposition of chains A and B of the free C.Esp1396I-6His 
protein and the protein bound to the OR/OL operator (McGeehan et al., 2008). 
Backbone atoms from chain A of both the free and bound protein have been 
overlaid and a global repositioning of chain B relative to chain A can be observed. 
Upon binding DNA, the recognition helix (helix 3) of chain B is displaced by ~1.4 Å 
(approximately half a base pair) as monomer B hinges about helix 5 relative to 
monomer A. The ability of one monomer to move relative to the other in the dimer 
may play a role in the ability of C.Esp1396I to bind to specific sequences that are 
separated by either two or three bases (OM and OL sequences respectively). This is 
discussed further in Chapter 6. 
4.5 Comparison of C.Esp1396I with other bacterial gene 
regulatory proteins 
C.Esp1396I is a small alpha helical protein containing a helix-turn-helix (HTH) 
motif that can bind to its own operator DNA upstream of the gene and regulate 125
 gene expression (Bogdanova et al., 2009; Ball et al., 2009; McGeehan et al., 2008). 
The HTH motif is common to many other bacterial regulatory proteins such as 
C.BclI, C.AhdI and the DNA binding domain of SinR. SinR forms homotetramers that 
repress genes involved in the sporulation process in Bacillus subtilis (Gaur et al., 
1986). The crystal structure of SinR in was solved in 1998 by Lewis et al. in 
complex with its inhibitory protein SinI  (Bai et al., 1993). The structures of two 
other C-proteins, C.AhdI (McGeehan et al., 2004) and C.BclI (Sawaya et al., 2005) 
have also been solved.  
 
C.AhdI, C.BclI,  C.Esp1396I and the DNA binding domain of SinR (residues 1-64) are 
alpha helical proteins that are capable of binding to DNA with a degree of sequence 
specificity. An alignment of the amino acid sequences based on secondary 
structure (figure 4.17) shows that these proteins form five alpha helices, despite 
only limited sequence conservation. Some residues are absolutely conserved 
(shaded red) and the majority of these residues are found in helices 2 and 3 that 
comprise the HTH motif. In the recognition helix (helix 3) the tyrosine, glutamate 
and arginine residues are all conserved. In the case of C.Esp1396I these residues 
are involved in interactions with the phosphate backbone of DNA (McGeehan et al., 
2008). The C-terminal helix (helix 5) varies in length between the four proteins, 
with C.AhdI and SinR having truncated helices and C.Esp1396I and C.BclI having 
more extended helices.  
 
The overall structures of the four proteins are very similar to one another 
(figure 4.18) but as the native C.Esp1396I-GSH is relatively low resolution more 
detailed comparisons of sidechain positions cannot be made. However, the loop 
region between helices 3 and 4 that exhibit two alternate conformations in 
C.Esp1396I-GSH can be compared as the two conformations have different  
backbone positions. The loop region in C.BclI and C.AhdI (residues 47 to 51 and 48 
to 53 respectively) are shown in figure 4.19 and there are no major conformational 
changes between the peptide backbone of the two chains in either structure. In 
both cases, the loop regions from C.AhdI and C.BclI resemble the major loop 
conformation of C.Esp1396I-6His (figure 4.20). The loop region of sinR cannot be 126
Figure 4.17: Alignment of C.Esp1396I-GSH with other bacterial gene regulatory 
proteins. Chain A of C.Esp1396I-GSH, C.AhdI, C.BclI and the DNA-binding domain of 
SinR (residues 1-64) were aligned using the ClustalW 3D algorithm in the STRAP 
program (www.bioinformatics.org/strap). The alignment was visualised using ESPript 
(Gouet et al., 1999) using the MultAlin function with a global score of 0.7. Identical 
amino acids are shaded red and residues present in >70% of the compared proteins are 
shaded yellow.  The helical secondary structure (black spirals) and the residue numbers 
refer to C.Esp1396I.  127
Figure 4.18: Structural comparison of C.Esp1396I-GSH with other bacterial gene 
regulatory proteins. Backbone atoms from chain A of C.AhdI, C.BclI and the 
DNA-binding domain of SinR (residues 1-64) were superimposed upon chain A of 
C.Esp1396I-GSH with an RMSD of < 0.83 Å. C.Esp1396I-GSH is coloured light green, 
C.BclI is blue, C.AhdI is brown and SinR is dark green. 
H5 
H5 
90o 
128
Figure 4.19: No alternative loop conformations have been reported for the 
controller proteins C.AhdI and C.BclI. The loop region between helices 3 and 4 in 
C.AhdI (top) and C.BclI (bottom) do not adopt the minor conformation that is seen in 
C.Esp1396I-GSH. Chains A and B of each C-protein were superimposed across the 
peptide backbone atoms and residues 48-53 (C.AhdI) and 47-51 (C.BclI) are 
represented as sticks. 129
Figure 4.20: The major loop conformation is found in other C-proteins. C.AhdI and 
C.BclI were superimposed upon chains from the C.Esp1396I- structure containing either 
the major (chain A) or the minor (chain N) conformation. Superimposition was 
performed across all backbone atoms excluding the loop regions with an RMSD < 0.5 Å. 
The loop regions from C.AhdI (light green) and C.BclI (dark green) most closely 
resemble the structure of the major conformation of C.Esp1396I (chain A; cyan). 
C.Esp1396I chain N 
C.Esp1396I chain A 
C.AhdI chain A 
C.BclI chain A 
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 compared as there is only one sinR molecule in the asymmetric unit. The lack of 
evidence of an alternate conformation in this loop region does not preclude the 
possibility that this region may be flexible as the B-factors are higher in the loop 
than the overall B-factor average (21.5% higher in C.AhdI and 52.5% higher in 
C.BclI). Additionally, the lack of evidence of alternative loop conformations may be 
due in part to the fact that the structures represent the conformation in crystallo 
rather than the native in vivo conformation. 
 
The native C.Esp1396I-GSH is structurally similar to other C-proteins and other 
bacterial regulatory proteins. Although these proteins are structurally similar they 
all bind to different DNA sequences. The recognition of different binding sites must 
be achieved through interactions between key amino acid residues and the DNA 
bases. In addition to this direct readout, we had also identified indirect readout 
arising from a TG step in the DNA sequence (McGeehan et al., 2008). These 
interactions between C.Esp1396I and its DNA recognition sequences are explored 
in greater detail in chapter 6. 
4.6  Site directed mutagenesis 
4.6.1 Structure-based design 
As described in Chapter 3, native C.Esp1396I precipitates during routine 
purification, which indicates a lack of solubility. In order to attempt to compensate 
for this lack of solubility, site-directed mutagenesis was performed on residue Y29. 
This residue was identified from both the native protein structure and the R35A 
mutant structure as interacting with D26 on another monomer from a different 
dimer (figure 4.21). It was decided to mutate Y29 as, in addition to hydrogen 
bonding with D26, the planar ring of Y29 is also involved in pi-stacking with its 
counterpart from the other monomer. In addition, Y29 is not involved in forming 
the dimer interface, nor is it involved in DNA recognition (McGeehan et al., 2008) 
as it lies at the C-terminal end of helix 2.  
 
131
90o 
Figure 4.21: Y29 and D26 are involved in crystal packing interactions in both the 
native and R35A mutant proteins. (a) Crystal packing arrangement of chains A and B 
(dark) and chains E and F (light) in the native C.Esp1396I-6His structure. (b) Y29 from 
chain B can form hydrogen bonds with the sidechain of D26 in chain E and Y29 in chain 
E makes the reciprocal interaction with D26 in chain A. (c) The planar phenyl rings of 
the two tyrosines are within 4 Å of each other which may permit pi-stacking interactions 
between the dimers. 
a 
c 
b 
Y29 
D26 
Chain B Chain E 
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Figure 4.22: Potential disruption of the crystal packing interactions by 
mutagenesis of Y29. The Y29S (top) and Y29W (bottom) mutants of C.Esp1396I-6His 
were modelled using the mutagenesis tool in PyMol (Delano, 2002) and selecting the 
most common rotamers. The mutated residues are highlighted in grey and the original 
tyrosine is shown in the line representation. The Y29S mutant was designed to increase 
solubility by disrupting both the pi-stacking interactions and the hydrogen bonding 
between dimers. The hyroxyl group is retained but protrudes less far into the solvent by 
~4.3 Å. The Y29W mutant should disrupt the hydrogen bonding between dimers and 
will increase the molar extinction coefficient to improve the sensitivity of detection for 
analytical ultracentrifugation. 133
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 The Y29S mutant was designed for increased solubility as it should disrupt the 
pi-stacking interaction and also the D26 hydrogen bonding interaction as the 
planar ring is removed and the hydroxyl group is approximately 4.3 Å closer to the 
surface of the protein (figure 4.22). The Y29W mutant was designed to increase the 
molar extinction coefficient of the protein for analytical ultracentrifugation and 
other biophysical studies.  
 
Y29S and Y29W mutants were made by site-directed mutagenesis as described in 
section 4.7 and the primers are shown in figure 4.23. Both the Y29W and Y29S 
mutations were achieved (appendix 1) although at a lower than expected 
efficiency. In addition to the desired Y29 mutation there was often an unintended 
K20N mutation (figure 4.24). The codon encoding the K20 residue is directly 
before the 5’ end of the mutagenic primer. Misincorporation of a single base in the 
third position in the codon is sufficient to alter the lysine (AAA) to an asparagine 
(AAT).  
4.6.2 Dynamic light scattering 
Dynamic light scattering (DLS) is commonly used to estimate the hydrodynamic 
radius (Rh) of proteins in solution. The Rh is related to the diffusion coefficient (D) 
by the Stokes-Einstein equation: 
 
    
  
    
 
 
where k is the Boltzmann constant, T is the temperature (Kelvin) and η is the 
solvent viscosity. The diffusion coefficient can be obtained from DLS experiments 
by autocorrelation of the time-dependent fluctuations in scattering intensity (due 
to Brownian motion) when a monochromatic light source (e.g. a laser) is shone 
upon the sample. 
 
An estimate of the molecular weight (Mr) of the protein can be obtained by using 
the calculated Rh. For globular proteins, the Rh is approximately related to the Mr 
by the empirical equation: 136
Figure 4.25: Comparison of hydrodynamic radius and estimated molecular mass 
between native C.Esp1396I-GSH and Y29 mutants determined by dynamic light 
scattering. Dynamic light scattering histograms of (a) native, (b) Y29S and (c) Y29W 
C.Esp1396I-GSH. Protein solutions were 0.1 µm filtered and measured at approximately 
0.5 mg/mL in storage buffer. The peaks corresponding to the buffer have been removed 
but the % mass values still take buffer into account. If corrected for buffer contributions 
the % mass values approach 100%. The table shows the measured Rh of each sample 
and from this value the molecular mass was estimated using the program Dynamics 
(version 5.26.60, Protein Solutions). 
  
Hydrodynamic 
radius Rh (nm) 
% 
polydispersity 
Estimated 
Mr (kDa) 
Native 2.5 14.1 28.7 
Y29S 2.4 13.9 26.1 
Y29W 2.5 12.2 28.7 
b 
c 
a 
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     ( .       )
 .   
(Dynamics, version 5.26.60, Protein Solutions) 
 
However, this equation does not take into account the shape of the molecule, 
which can also affect the Rh. DLS was carried out as described in section 2.12.1 to 
determine whether the mutants retained their globular structure. Figure 4.25 
shows DLS histograms for the native and both mutant proteins. The hydrodynamic 
radius (Rh) of each protein is between 2.4 and 2.5 nm and each has a polydispersity 
of < 15%. The close agreement between the hydrodynamic radii of the native and 
mutant proteins confirms that the mutant proteins are dimeric.   
4.6.3 Surface plasmon resonance 
When an incident beam of monochromatic polarised light strikes a gold film at the 
interface of two transparent materials of different refractive index (glass and 
water) the majority of the incident light is reflected (figure 4.26). However, at a 
specific angle of incidence (the resonance angle), the light is totally internally 
reflected and an evanescent wave is created that extends a short distance into the 
material of lower refractive index (water). At the resonance angle, there is a 
marked decrease in the intensity of the reflected light (figure 4.26b). Any change in 
mass that occurs close to the unlit side of the metal film will influence the 
resonance angle. This change in mass is expressed in resonance units (RU) and can 
be monitored in real-time to produce sensorgrams (figure 4.26c).  
 
In a surface plasmon resonance (SPR) experiment, a molecule is immobilised on a 
chip surface in a single flow channel on the unlit side of the gold film (ligand) and a 
solution containing potential binding partners (analyte) is passed across the ligand 
and a reference channel (usually an empty channel in order to remove any affects 
arising from interactions with the matrix of the chip). If an interaction occurs, the 
mass at the sensor surface changes and a resonance response is observed.  The 
response from the reference channel is subtracted from the response generated 
from the channel containing the ligand to remove any bulk solvent contribution. As 
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Figure 4.26: Using surface plasmon resonance to measure kinetic constants. (a) 
The organisation of the SPR instrument is such that polarised light is passed through a 
prism and is reflected from the gold surface of the sensor chip. At one particular angle 
(the resonance angle) the incident light undergoes total internal reflection and the 
intensity of the reflected light is reduced (b). When analyte (triangles) interacts with the 
immobilised ligands (Y) the resonance angle changes due to a change in mass near the 
surface of the gold film. The rate binding and dissociation can be followed by measuring 
the response against time in a plot called a sensorgram (c). 
b c 
a 
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 the relationship between the mass at the sensor surface and the resonance 
response is relatively linear, SPR can be used to determine binding kinetics and 
equilibrium constants. 
 
In order to determine if the DNA binding capability was retained after 
mutagenesis, an activity assay was carried out using surface plasmon resonance 
(SPR). A 35 bp DNA duplex containing the OL sequence that was biotinylated at one 
end was immobilised onto the surface of a streptavidin chip (GE Healthcare) to a 
level of < 200 RU using a Biacore T-100 (GE Healthcare) as described in section 
2.8.1. The signal from the reference channel (where no DNA had been 
immobilised) was subtracted, to remove contributions from bulk solvent and non-
specific interactions with the dextran matrix and/or streptavadin. Protein at 
varying concentrations was passed across the two channels and the observed 
response once equilibrium had been reached (Req) at each concentration was used 
to calculate the dissociation constant (KD). The 1:1 steady-state affinity model 
provided in the BiaEvalTM software (version 2.0.2) was used to fit the data as the 
fits were comparative and did not require the calculation of the actual dimer 
concentration: 
 
      
        
         
     
 
where Rmax is the maximal response, [A] is the analyte concentration, and R0 is the 
response observed in the absence of analyte. The fitted data and calculated KD are 
shown in figure 4.27. 
 
This experiment was not used to determine accurate KD values but was used to 
compare the KD values of the native and Y29 mutant proteins for OL. As an analyte 
flow rate of 30 µL/min was used, mass transport effects should be negligible and 
remain consistent between experiments. The protein concentrations plotted in 
figure 4.27 represent the total monomer concentration that was injected (despite 
the protein binding as a dimer) as only comparative data were required. Accurate 
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Figure 4.27: Comparison of DNA binding affinity of native and Y29 mutant 
C.Esp1396I-GSH determined by surface plasmon resonance. (a) native, (b) Y29S 
and (c) Y29W were passed across immobilised DNA containing OL at the concentrations 
shown. The total binding response (Rmax) as a function concentration was fitted  to a 1:1 
steady-state affinity model using the BiaEval software version 2.0.2 (section #). The 
concentration of protein represents the total concentration that was injected (expressed 
as a monomer). 
b 
c 
a 
KD = 166 ± 5 nM 
KD = 171 ± 12 nM 
KD = 165 ± 20 nM 
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 determination of DNA binding constants and mass transport considerations are 
discussed in section 2.8.  
 
The apparent dissociation constant (KD) of the native protein and the OL operator 
is ~ 166 nM, with the Y29 mutant proteins also having a KD within experimental 
error of this value. The fact that the apparent KD of the native and both Y29 
mutants are very similar demonstrates that the Y29 mutation does not affect the 
DNA binding affinity of C.Esp1396I-GSH and validates the use of the mutant 
proteins in quantitative biophysical studies. 
4.6.4 Mutant properties 
The Y29W was designed to have a higher molar extinction coefficient to enhance 
the accuracy of AUC measurements at low protein concentration (section 5.3). The 
protein was confirmed to contain the tryptophan residue by fluorescence emission 
spectroscopy as described in section 3.4.  
 
The Y29S residue was designed for increased solubility in aqueous solution to 
enable NMR experiments to be performed. Many NMR experiments require in 
excess of 5 mg/mL protein and the Y29S mutant remained soluble at this 
concentration. The native protein could be concentrated to 5 mg/mL but 
precipitate became visible within a few hours, whereupon the majority of the 
protein would be lost. However, the native protein did remain soluble at 
~ 4 mg/mL. These qualitative measurements suggest that the Y29S mutation 
sufficiently increases the solubility of C.Esp1396I-GSH to be able to perform NMR 
experiments.  
4.7   Discussion 
The structure of free C.Esp1396I-6His and an R35A mutant were solved by 
crystallography from crystals formed by precipitation during routine protein 
purification. The diffracting quality of the crystals was variable with most crystals 
diffracting to >  4 Å or producing twinned or smeared spot profiles and the crystal 
quality could not be improved using sparse matrix screening. The final structure 
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 was refined at 2.8 Å for the native protein and 3.0 Å for the R35A mutant. At this 
resolution the fine detail (such as the precise sidechain conformations) could not 
be clearly interpreted.  
 
Comparison of the mutant and native proteins suggested that the overall tertiary 
structure of the two are extremely similar, suggesting that the inability of the R35A 
mutant to bind to DNA (McGeehan et al., 2008) was not due to the protein 
mis-folding. The protein structures showed a protein of five alpha helices 
containing a typical helix-turn-helix motif and arranged as a homodimer. Both the 
native and mutant proteins exhibited two alternative conformations of a loop 
region (residues 43-47) with some functional groups displaced by up to 10 Å. This 
loop region also forms a strong basic pocket that is capable of binding to the 
phosphate backbone of DNA. Comparison with the DNA-bound protein showed 
that the two monomers in the dimer reposition with respect to one another to 
place their recognition helices in the major grooves of the DNA. The free protein 
structures closely resemble other bacterial gene regulatory proteins, but 
C.Esp1396I is the only one to exhibit the alternate loop structures. 
 
Based on the crystal structure, the site-directed mutation (Y29S) was designed to 
improve the solubility of the protein. Another mutation (Y29W) was designed to 
increase the molar extinction coefficient. Tyrosine-29 was selected as the residue 
to mutate as it interacted with aspartate-26 of a different monomer and it was 
involved in neither the dimer interface nor the DNA-binding region. DLS confirmed 
that the purified mutants were monodisperse and that they formed complexes of 
similar size to that of the native protein. Both Y29 mutants retained the 
DNA-binding capacity of the native protein (as determined by SPR), which 
permitted their use in further biophysical studies. 
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 Chapter 5: DNA-binding studies 
5.1 Introduction 
The expression of the restriction-modification (RM) genes must be tightly 
regulated to prevent auto restriction and host cell death. The order in which the 
components of the Esp1396I RM system are expressed is controlled by the 
C-protein. There is a C-protein recognition sequence that overlaps the 
transcription start site of the methyltransferase gene which down-regulates 
transcription and there are two C-protein binding sites upstream of the C/R 
operon with the proximal site overlapping the -35 site (Bogdanova et al., 2009; 
figure 5.1). Binding to the distal site of the C/R promoter up-regulates 
transcription and binding of a second C.Esp1396I dimer downregulates 
transcription. To achieve temporal control of the expression of the RM system 
C.Esp1396I must bind to its different recognition sequences with differing 
affinities. 
 
Bogdanova and colleagues (2009) used fluorescence anisotropy to measure the 
affinity of C.Esp1396I for its three recognition sites. Their results showed that 
C.Esp1396I binds with highest affinity to the OM site, followed by the OL (distal) 
site and binding with lowest affinity to the OR (proximal) site. As C.Esp1396I only 
binds as a dimer the monomer-dimer equilibrium constant was estimated by 
analytical ultrcentrifugation (AUC) and this value was used in the calculation of the 
protein-DNA binding affinities. The KD (Kdim) for the monomer-dimer equilibrium 
was estimated to be 0.6 µM. However, this value was obtained using protein 
concentrations of ≥ 5 µM. In order to more accurately determine the Kdim a range of 
protein concentrations that span the Kdim should be used (Schuck & Braswell, 
2000). Determination of the affinity constants for C.Esp1396I and the OL and OR 
sites was performed by fitting both parameters along with a cooperativity factor to 
one set of anisotropy measurements. However, fixing Kdim to 600  nM and fitting 
three parameters (in the case of OL+R) to ten C.Esp1396I concentrations that span 3 
orders of magnitude (with each concentration measured in triplicate) should 144
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 provide a reasonable estimate for the parameters. If the value of Kdim is inaccurate, 
the calculation of the affinity constants for the protein-DNA interactions will also 
be inaccurate.  
 
This chapter seeks to improve the accuracy of the Kdim estimated by Bogdanova et 
al. (2009) by performing sedimentation equilibrium AUC on a Y29W mutant of 
C.Esp1396I. The protein-DNA affinity constants were measured using surface 
plasmon resonance (SPR) and the experimentally determined Kdim value. Other 
techniques such as isothermal titration calorimetry (ITC) and fluorescence 
anisotropy were attempted in order to give complementary measurements but 
proved unsuccessful. 
5.2 Determining the dimer concentration 
The concentration of C.Esp1396I is measured by UV spectrometry using the molar 
extinction coefficient (EM) for a single polypeptide chain (2900 M-1.cm-1). The 
measured concentration is therefore a measurement of the total protein 
concentration, which includes both monomeric and dimeric protein. In order to 
ascertain the concentration of protein that is capable of binding to DNA, the 
concentration of protein dimers must be determined. The monomeric and dimeric 
protein populations are in dynamic equilibrium where the decomposition of a 
dimer into two monomers (M) is described by the constant KD:  
 
M + M      <=====>      D 
        KD 
 
The dissociation constant (KD) is expressed as: 
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 where [M] is the concentration of monomer and [D] is the concentration of dimer. 
The total concentration of polypeptide (T) is calculated using the molar extinction 
coefficient for a single polypeptide chain, so: 
 
                                                                      
     
as a dimer contains two polypeptide chains. The concentration of monomer 
present can be described as a molar fraction (θ) of the total protein concentration: 
  
                                                                              
    
where    θ  1. Substituting equation 5.2.3 into equation 5.2.2 and solving for [D] 
gives: 
    
 
 
                                                                
   
KD can be expressed in terms of T by substituting equations 5.2.3 and 5.2.4 into 
equation 5.2.1: 
  
    
      
 
          
                                                       
 
Equation       can be expressed as a quadratic and solved for θ using the quadratic 
formula with       ,        and        : 
  
  
                 
  
                                   
    
Therefore the actual dimer concentration [D] present in a sample of total 
concentration (T) is given by substituting equation 5.2.6 into 5.2.4: 
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 In order to calculate the accurate dimer concentration for use in the analysis of the 
SPR binding studies (in which the KD was fixed), the KD for the monomer-dimer 
equilibrium of C.Esp1396I must be accurately determined. 
5.3 Analytical Ultracentrifugation 
Analytical ultracentrifugation (AUC) can provide information on shape,  
stoichiometry, molecular mass and interactions of macromolecules. Initially, 
macromolecules will be uniformly distributed throughout a solution. Application of 
a centrifugal force to this solution results in sedimentation of the macromolecules. 
Sedimentation is opposed by the frictional force acting upon the sedimenting 
particles, which permits the characterisation of these opposing forces in an AUC 
experiment through the Svedberg equation: 
 
   
 
   
   
       
  
                                          
 
where v is the rate of sedimentation, f is the frictional coefficient, M is the molar 
mass,    is the partial specific volume, ρ is the solvent density, ω is the angular 
velocity, r is the distance from the centre of rotation and N is Avogadro's number. s 
is the Svedberg coefficient where 1 Svedberg is equal to 10-13 seconds. 
 
The sedimentation of the macromolecules is followed by optically monitoring the 
contents of the sample cell. Proteins and nucleic acids have characteristic 
absorbance maxima that can be utilised in an AUC experiment to locate their radial 
position in the sample cell using absorbance optics that scan the cell at set 
wavelengths and record the absorbance relative to a reference cell. If the 
macromolecule being studied does not absorb incident light or if the concentration 
is too low to permit accurate absorbance measurements, then interference optics 
can be used to measure the displacement of the interference pattern caused by the 
change in refractive index between the sample and reference cells as the 
macromolecule sediments. 
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 Measurement of the rate of sedimentation is performed by sedimentation velocity 
experiments and this permits the determination of the sedimentation coefficient 
from which shape and hydration information can be obtained. Sedimentation 
equilibrium is performed at lower rotor speeds, where there is dynamic 
equilibrium between sedimentation and diffusion, which sets up an exponential 
concentration gradient throughout the cell. Analysis of this distribution enables 
determination of the molecular mass, stoichiometry and binding constants of 
macromolecules. 
5.3.1   Determination of the monomer-dimer equilibrium constant 
For accurate calculation of the affinity of C.Esp1396I for its operator sequences 
using an affinity based SPR approach, it is preferable to first obtain the 
monomer-dimer equilibrium constant. Sedimentation equilibrium AUC was carried 
out over a range of concentrations as described in section 2.9. The C.Esp1396I 
Y29W mutant (see section 4.6) was used as it has a higher extinction coefficient at 
280 nm, which enables lower concentrations to be measured at 280 nm in the AUC 
experiment. The protein sample was purified as described in section 2.5 and a final 
dialysis against the AUC buffer (20 mM Tris pH7.5, 150 mM NaCl, 5% w/v glycerol) 
was performed. The sample was filtered and checked for evidence of aggregation 
by DLS, from which the Rh was measured as 2.4 nm with a polydispersity of ~11% 
which is typical for C.Esp1396I (section 4.6.2). Six channel AUC cells were set up as 
three buffer/reference pairs with 90 µL sample and 100 µL buffer. The cells were 
equilibrated at 3,000 rpm and then accelerated to 15,000, 21,000 and 28,000 rpm. 
The distribution of C.Esp1396I was allowed to equilibrate for 21 hrs before the 
absorbance scans were performed. 
 
The absorbance scans of the Y29W mutant of C.Esp1396I in the concentration 
range 1 - 30 µM were analysed using a single species model in SEDPHAT to 
determine the species average molecular weight (figure 5.2). At low 
concentrations the molecular weight was determined to be 8.8 ± 1.2 kDa, which is 
similar to the theoretical molecular weight of a C.Esp1396I monomer (~9.5 kDa). 
At higher concentrations (e.g. 10 µM) the species average molecular weight was 
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Figure 5.2: Weight averaged molecular mass of C.Esp1396I at different concentrations. 
Sedimentation equilibrium AUC data for a Y29W mutant of C.Esp1396I at the indicated 
concentrations was collected using a Beckman XL-A analytical ultracentrifuge with 
absorbance optics. For each concentration, the data were fitted to a single ideal species 
model using SEDPHAT to estimate the species average molecular weight. The data were 
collected at 28,000 rpm and at a wavelength of 280 nm, except for the 1 µM sample which 
was collected at 230 nm. 
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Figure 5.3: Sedimentation equilibrium data fitted to a self-associating model. A global fit of 
data collected at C.Esp1396I concentrations of 1, 5 and 10 µM was performed using the self-
association model in SEDPHAT (Vistica et al., 2004) resulting in a Kdim of 1.6 µM. The raw data 
is shown for three different rotor speeds: 15,000, 21,000 and 28,000 rpm (orange, green and 
blue circles respectively. (Top panel) The absorbance of 5 µM C.Esp1396I at a wavelength of 
225 nm is shown as a function of radial displacement (top) as are the residuals (bottom). 
(Bottom panel) The residuals for the other fits used in the global analysis are shown: (top) 1 
µM C.Esp1396I (λ=225 nm), (middle) 5 µM C.Esp1396I (λ=280 nm) and (bottom) 10 µM 
C.Esp1396I (λ=280 nm). 
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 calculated as 19.4 ± 0.5 kDa, which is the expected weight of a C.Esp1396I dimer. 
This suggests that the KD for the monomer-dimer equilibrium lies between 1 and 
10 µM and that an accurate value for KD can be determined as sample 
concentrations above and below the KD were used. 
 
The equilibrium constant was determined as 1.62 µM (within the range 
0.88 - 2.99 µM) by globally fitting the C.Esp1396I distribution at three different 
concentrations (1, 5 and 10 µM) and three different rotor speeds (15,000, 21,000 
and 28,000 rpm) to a self-associating species model using SEDPHAT (Vistica et al., 
2004). At 1 µM C.Esp1396I concentration only the data collected at a wavelength of 
225 nm could be used as the absorbance at 280 nm was too low. Conversely, at 
10 µM only the 280 nm data was used as the absorbance at 225 nm was too high. 
At 5µM both the 225 nm and 280 nm data were used in the global analysis. The fit 
for the 5 µM sample measured at 225 nm is shown in figure 5.3 along with the 
distribution of the residuals for all of the absorbance scans used in the global 
analysis. The KD can be used to calculate the free energy of binding using the 
equation: 
 
                             (       ) 
 
where    is the Gibb's free energy change, R is the gas constant (8.314 J/mol/K) 
and T is the temperature in kelvin. The free energy of binding in the dimerisation 
of C.Esp1396I at 20°C is -32.5 ± 1.5 kJ/mol.  
 
The KD for the monomer-dimer equilibrium estimated by Bogdanova et al. (2009) 
falls just outside the range determined by the AUC analysis presented in this 
section. They used a range of C.Esp1396I concentrations from 5 - 64 µM and 
estimated that the KD was ~0.6 µM. As the concentration range did not span the KD 
it is likely that the final estimate is slightly less accurate than the value presented 
in this section. The value of monomer-dimer KD that will be used in the analysis of 
protein-DNA interactions is 1.62 µM. 
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5.4 SPR analysis of C.Esp1396I and its operators 
5.4.1   Ligand immobilisation and chip regeneration 
The two single-stranded oligonucleotides for each operator (OM, OL, OR and OL+R) 
were annealed as described in section 2.6. One strand in each duplex contained a 5' 
biotin tag. The SPR sensor chips used throughout the binding assays were 
streptavadin coated (SA chips) and the very strong interaction between 
streptavadin and biotin permitted immobilisation of the duplex DNA on the sensor 
chip surface. The stock duplex DNA was diluted to approximately 20 nM with SPR 
running buffer (10 mM HEPES pH 7.4, 100 mM NaCl, 5 mM MgCl2, 5 mM CaCl2, 
0.05% v/v Tween-20) and immobilised onto the sensor chip to a level of < 200 RU 
in multiple injections (figure 5.4). The reference channel was left blank as 
non-specific binding of C.Esp1396I to a control oligonucleotide appeared to be 
non-existent by SPR (data not shown). 
 
In order to perform a series of measurements, all bound analyte (protein) must be 
dissociated from the ligand (DNA) prior to subsequent injections of analyte. This is 
achieved by injecting a solution which returns the response to the baseline level. 
The regeneration solution used throughout the binding assays was 2 M NaCl. 
5.4.2   Mass transport 
Mass transport affects both the association (ka) and dissociation (kd) rates of the 
interaction. In order to perform kinetic analysis of the interaction of C.Esp1396I 
and its operators, the effects of mass transport must be minimised. The effect of 
mass transport on kd arise through re-association of a dissociated complex. 
Reducing the ligand density has been shown to reduce the mass transport effects 
on kd by reducing the number of available binding sites for the dissociating analyte 
(Wofsy & Goldstein, 2002); however there is always a trade-off between minimising 
mass transport artefacts and maximising signal:noise ratio. The rate at which the 
analyte is passed across the ligand can also alter the extent of the effect of mass 
153
Figure 5.4: Immobilisation of biotinylated DNA containing OL onto a streptavadin coated 
SPR sensor chip. The biotinylated 35 bp duplex at ~20 nM was passed through a single flow 
cell (at 30 µL/min) of the sensor chip until a total immobilisation of ~200 RU was achieved. 
Injections of DNA (ligand) are denoted by the black arrows. The red arrows denote the 
injection of regeneration buffer (2M NaCl) to remove any non-specifically bound DNA. 154
Figure 5.5: Mass transport analysis at different flow rates. A 400 µL sample of C.Esp1396I 
was passed over immobilised DNA containing OL and a reference channel at 5, 15 and 
75 µL/min. The resultant sensorgrams were fitted to a 1:1 kinetic model using the BiaEval 
software (Biacore) and the results are shown in the table. 
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 transport. Higher flow rates have been shown to reduce the effect of mass 
transport (Myszka, 1997; Myszka et al., 1998).  
 
Figure 5.5 shows the sensorgrams generated when a 400 nM sample of C.Esp1396I 
is passed across DNA containing the OL sequence at three different flow rates. At 
low flow rates the dissociation of the analyte is approximately ten-fold slower 
(0.1 s-1) than at higher flow rates (1.1 s-1), which is indicative of a mass transport 
controlled reaction. In order to reduce sample consumption, the binding assays 
were performed at 30 µL/min. The generated response is proportional to the 
change in mass at the sensor surface, which is small for C.Esp1396I as the dimer is 
only ~ 19 kDa. At the low concentrations required to determine the KD the signal is 
relatively low (≤   RU)  Reduction of  the surface density of the ligand to reduce the 
effect of mass transport would reduce the signal:noise ratio and it was deemed 
that an immobilisation level of ~ 200 RU provided a good balance between mass 
transport and the signal:noise ratio. 
 
The reaction appears to be mass transport controlled which prevents accurate 
determination of the kinetic parameters and hence the dissociation constant (KD). 
However, at all flow rates (figure 5.5) the maximum response appears very similar. 
This permits the calculation of KD from the response generated at different analyte 
concentrations using steady-state equilibrium analysis. 
5.4.3   Steady-state equilibrium analysis 
As discussed in section 5.4.2, the resulting sensorgrams from kinetic analysis were 
influenced by mass transport, which prevents a reliable determination of KD. 
Additionally, the on and off rates (ka and kd respectively) for the interaction are 
just outside the range that can be reliably determined using the Biacore T-100 
(103–107 M-1.s-1 for ka and 10-5–0.5 s-1 for kd as described in the BIAcore T-100 
manual). This prevented an accurate kinetic analysis of the interaction between 
C.Esp1396I and its operator sequences. The sensorgrams in figure 5.6 demonstrate 
this fast on/off rate. Although the fitted curve (black line) describes the data 
relatively well, the values of of ka and kd are unreliable as they either approach or 
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Figure 5.6: Global kinetic analysis of the C.Esp1396I-OM interaction. The sensorgrams (red) 
for total C.Esp1396I concentrations of 10, 20, 30, 40 and 50 nM were passed over the 
immobilised DNA at 30 µL/min. The data were fitted to a 1:1 kinetic model (black lines) using 
the BiaEval software (Biacore). Although the model describes the data well, the ka rate was 
outside the range that the Biacore T-100 could reliably measure. 
ka (M
-1.s-1) kd (s
-1) KD (nM) χ
2 
1.61 ± 0.01 x 108 0.1774 ± 0.0003 1.10 ± 0.01 0.079 
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Figure 5.7: On/off rate map for the kinetic analysis of the C.Esp1396I-OM interaction. The 
ka and kd at each concentration were determined using a 1:1 kinetic model and fitting each 
concentration separately. The dashed lines represent the values of KD obtained from the 
calculation of kd/ka. The individual concentrations are shown as red crosses and the global fit 
is shown as a blue circle. 
Total C.Esp1396I 
concentration (nM) 
Ka 
 (M-1.s-1) 
Kd (s
-1) KD (nM) 
10 4.64 x 107 0.2806 6.1 
20 2.08 x 109 0.7826 0.37 
30 3.29 x 109 2.066 0.63 
40 1.24 x 1012 1047 0.84 
50 1.18 x 1012 1105 0.93 
Global 1.61 x 108 0.1774 1.1 
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 exceed the limitations of the instrument. At higher concentrations the rates 
obtained from individual sensorgrams were both outside the limits that the 
instrument could accurately measure (figure 5.7).  
 
After the injection of C.Esp1396I had started, the sensorgrams quickly reached 
their maximum response, which remained constant throughout the injection. At 
this point the rates of binding and dissociation are equal and equilibrium has been 
attained. By measuring the response generated at equilibrium at different 
concentrations, it is possible to obtain KD by plotting the response against protein 
concentration. Steady-state equilibrium analysis requires a broad range of analyte 
concentrations that lie both above and below the KD of the interaction and reach a 
maximum response at higher concentrations, which is determined by the binding 
capacity of the immobilised ligand. 
 
As C.Esp1396I binds as a dimer, the concentration of the dimer must be known; 
alternatively the value of Kdim can also be a parameter in fitting the binding curve. 
Using the dimer dissociation constant determined by AUC (section 5.3.1) and the 
equation derived in section 5.2 it is possible to estimate the dimer concentration 
given the total protein concentration.  
 
All models used to fit data make certain assumptions. In the case of fitting the 
affinity SPR data it is assumed that at the point at which the measurement is taken 
the system has reached a steady-state equilibrium such that the rate at which the 
complexes are formed is equal to the rate at which the complexes dissociate  and 
that the dimer concentration is constant. Also it is assumed that the free dimer 
concentration, [D] is equivalent to the total protein concentration. There are other 
factors that are not taken into account (e.g. the rate of dimer association and 
dissociation) that may affect the validity of these assumptions in addition to the 
fact that the DNA is not free in solution.  
 
Four different duplexes containing either OM, OL, OR or the double site, OL+R were 
immobilised on separate streptavadin chips. For the three duplexes that contained 159
 a single C.Esp1396I binding site, the plot of response against dimer concentration 
was a rectangular hyperbola, which can be described by: 
 
  
        
         
                                         (       ) 
 
where R is the generated response, Rmax is the maximum response possible which 
is determined by the binding capacity of the immobilised ligand, [D] is the dimer 
concentration and KD is the dissociation constant of the interaction. For the duplex 
containing OL+R a 2:1 binding model with cooperativity between the binding events 
was assumed based upon the results presented by Bogdanova et al. (2009). A 
2-site Adair equation was used to fit the data: 
 
  
       
    
   
 
   
   
       
   
   
 
   
   
 
                           
 
where KD1 is the first binding event (C.Esp1396I to OL) and KD2 is the second 
binding event (C.Esp1396I to OR). By determining the affinity of C.Esp1396I for OL 
in isolation, KD1 can be fixed which permits an accurate determination of the 
apparent affinity between C.Esp1396I and OR once OL is occupied. The derivation 
of the equations used to fit the data is shown in appendix 2.  
 
Various concentrations of C.Esp1396I were passed across a sensor chip upon 
which was immobilised DNA containing a C.Esp1396I operator sequence as 
described in section 2.8. The response generated once equilibrium had been 
reached was determined for each protein concentration and the resulting binding 
curve fitted to obtain KD (figures 5.8 - 5.11). The total protein concentration is 
plotted on the x-axis and the dimer concentration was calculated for each point 
during fitting using equation 5.2.7. As expected, C.Esp1396I had the highest affinity 
for OM (KD = 0.61 nM) followed by OL (KD = 5.6 nM) followed by OR (KD = 120 nM). 
Once the OL site has been occupied by a C.Esp1396I dimer the affinity between 160
Figure 5.8: Determination of the KD for the interaction between C.Esp1396I and OM. 
C.Esp1396I was flowed over the immobilised ligand and a reference channel at 30 µL/min 
with an injection length of 45 seconds. The maximum response (Rmax) generated during each 
injection was plotted as a function of total protein concentration. The estimated dimer 
concentration was calculated using equation 5.2.7 and this was used to fit the data to 
equation 5.4.3.1 using GraFit (Erithacus Software) to obtain the KD. The fitted parameters are 
shown in the table along with their associated errors. The Kdim was fixed at 1.6 µM for the 
analysis. 
Parameter Value 
Rmax (RU) 28.0 ± 0.3
 
KD (nM) 0.61 ± 0.02
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Figure 5.9: Determination of the KD for the interaction between C.Esp1396I and OL. 
C.Esp1396I was flowed over the immobilised ligand and a reference channel at 30 µL/min 
with an injection length of 45 seconds. The maximum response (Rmax) generated during each 
injection was plotted as a function of total protein concentration. The estimated dimer 
concentration was calculated using equation 5.2.7 and this was used to fit the data to 
equation 5.4.3.1 using GraFit (Erithacus Software) to obtain the KD. The fitted parameters are 
shown in the table along with their associated errors. The Kdim was fixed at 1.6 µM for the 
analysis. 
Parameter Value 
Rmax (RU) 49.6 ± 0.6
 
KD (nM) 5.6 ± 0.3
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Figure 5.10: Determination of the KD for the interaction between C.Esp1396I and OR. 
C.Esp1396I was flowed over the immobilised ligand and a reference channel at 30 µL/min 
with an injection length of 45 seconds. The maximum response (Rmax) generated during each 
injection was plotted as a function of total protein concentration. The estimated dimer 
concentration was calculated using equation 5.2.7 and this was used to fit the data to 
equation 5.4.3.1 using GraFit (Erithacus Software) to obtain the KD. The fitted parameters are 
shown in the table along with their associated errors. The Kdim was fixed at 1.6 µM for the 
analysis. 
Parameter Value 
Rmax (RU) 68.3 ± 0.4
 
KD (nM) 120.6 ± 4.4
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Figure 5.11: Determination of the apparent KD for the interaction between C.Esp1396I and 
OR in the wildtype C/R promoter. C.Esp1396I was flowed over the immobilised ligand and a 
reference channel at 30 µL/min with an injection length of 45 seconds. The maximum 
response (Rmax) generated during each injection was plotted as a function of total protein 
concentration. The estimated dimer concentration was calculated using equation 5.2.7 and 
this was used to fit the data to equation 5.4.3.2 using GraFit (Erithacus Software) to obtain 
the KD for binding of the second protein dimer. The KD for the interaction with OL was fixed at 
5.6 nM. The fitted parameters are shown in the table along with their associated errors. The 
Kdim was fixed at 1.6 µM for the analysis. 
Parameter Value 
Rmax (RU) 115.5 ± 0.8
 
KD (nM) 0.95 ± 0.05
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Table 5.1: Comparison of the affinity constants obtained by SPR and fluorescence 
anisotropy. The SPR data was fitted to the appropriate model (see text) with the Kdim fixed at 
the value specified in the table. The data presented in Bogdanova et al. (2009) are shown for 
comparison. 
SPR 
(Kdim = 1.6 µM) 
SPR 
(Kdim = 0.6 µM) 
Anisotropy* 
(Kdim = 0.6 µM) 
KD OM (nM) 0.61 1.5 0.3 
KD OL (nM) 5.6 12.5 N/A 
KD OR (nM) 121 191 N/A 
KD OL+R 
(nM) 
OL: 5.6 
OR: 0.95 
OL: 12.5 
OR: 2.1 
OL: 6.9 
OR: 322 
cooperativity: 219 
* Results presented by Bogdanova et al., (2009). 
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 C.Esp1396I and OR increases ~ 128 fold (KD = 0.94 nM) which indicates that there 
is cooperativity between the two operators. Comparison of these results with those 
obtained by Bogdanova et al. (2009) using fluorescence anisotropy cannot be 
performed directly as the dimer dissociation constant is different in both cases. 
Applying a dimer KD of 600 nM to the SPR data, the affinity constants for 
C.Esp1396I and its operators are within a factor of 2-3 of those obtained by 
Bogdanova et al. (2009) and are shown in table 5.1. The KD for OR obtained by 
Bogdanaova et al. (2009) is the intrinsic value which does not take into account the 
cooperativity. Taking their calculated cooperativity factor of 219 into account, the 
value for binding to OR when both OL and OR are present is ~1.5 µM, which is in 
good agreement with the value obtained from SPR analysis. The order of affinity 
between C.Esp1396I and its operators is the same but the KD for OM and OL as 
measured by anisotropy is smaller and the KD for OR is larger.  
5.5 Discussion 
Kdim was determined by sedimentation equilibrium AUC to be 1.6 µM 
(0.88 - 2.99 µM). A Y29W mutant was used as it had a higher molar extinction 
coefficient than the native protein which enabled data to be collected at 280 nm for 
concentrations as low as 5 µM. The 280 nm data was less noisy than the 225 nm 
data which improves the accuracy of the fit and hence the accuracy of Kdim. The 
Kdim estimated by Bogdanova et al. (2009) was 0.6 µM. This value lies just outside 
the error range of the value determined in section 5.3.1. It is likely that the 
disparity between the two values is due to the fact that Bogdanova et al. (2009) 
used only C.Esp1396I concentrations that were above Kdim and that the low 
concentration samples could only be measured at 230 nm. Currently the only other 
C-protein to have both a crystal structure and a value for Kdim is C.AhdI (McGeehan 
et al., 2004; Streeter et al., 2004). The Kdim for C.AhdI is 2.5 µM. This means that the 
interaction between C.Esp1396I monomers is stronger than the interaction 
between C.AhdI monomers and the free energy of binding (ΔG) for C.Esp1396I and 
C.AhdI are -32.5 and -31.4 kJ/mol respectively. This is to be expected as the surface  
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Table 5.2: Comparison of the affinity constants obtained using either kinetic or affinity 
analysis. For the affinity analysis the data were fitted to equation 5.4.3.1 and for the kinetic 
analysis the data were fitted to the 1:1 model using the BiaEval software that came with the 
instrument. In the kinetic analysis only the lowest five concentrations were used in the global 
analysis. 
Complex 
Calculated KD (nM) 
kinetic               affinity 
OM 1.1 0.61 
OL 6.9 5.6 
OR 157 121 
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 area at the dimer interface is larger in C.Esp1396I than C.AhdI (~1900 Å2 vs. 
~1400 Å2). 
 
When the data for OM, OL and OR were fitted using a simple 1:1 kinetic model the 
resultant KD was within a factor of 2 of the values obtained from the affinity model 
(table 5.2). However, the SPR data were fitted using affinity models because the ka 
and kd of individual sensorgrams were outside the limits that could be reliably 
recorded by the Biacore T-100 (e.g. figure 5.7). Using Kdim = 1.6 µM the binding 
affinities that C.Esp1396I has for OM, OL, OR and OR once OL is occupied were 
calculated (table 5.1). The affinity that C.Esp1396I has for its three operator 
sequences is such that OM > OL > OR which is consistent with the data presented by 
Bogdanova et al. (2009). Additionally, if OL is occupied by a C.Esp1396I dimer, the 
apparent KD for OR increases ~130-fold. The data presented in table 5.1 
demonstrates that the two sets of results are within an order of magnitude of each 
other with the largest difference between the OM KD values (5-fold difference). A 
possible reason for these differences is that the buffers in each experiment 
differed. In particular the ionic strength of the solvent was markedly different (130 
mM in the SPR experiments and 50 mM in the fluorescence experiments) which 
could directly affect the KD. Also, the difference in buffer composition could affect 
the Kdim which in turn would affect the calculated KD for the protein-DNA 
interactions.  
 
The fact that the AUC detailed in section 5.3 was performed upon a Y29W mutant 
of C.Esp1396I may have a small effect on the ΔG which would lead to significant 
change in Kdim. When considered in terms of binding energy (equation 5.3.1.1) the 
apparent differences are reduced as there is a logarithmic relationship between ΔG 
and KD and for the OM data the difference in the free energy of binding is ~4 kJ/mol 
which is the equivalent of a single weak hydrogen bond. The Kdim was determined 
by AUC to be 1.62 µM (in the range 0.88 - 2.99 µM). This propagates an error when 
determining the KD for the protein DNA interaction. The KD for the C.Esp1396I-OM 
interaction is in the range: 0.34 - 1.08 nM which includes the value obtained by 
Bogdanova et al. (2009). As the two sets of data lie within the experimental error 168
 inherent in each analysis, the agreement of the binding data determined by 
fluorescence anisotropy and SPR is not unreasonable. The error in Kdim in addition 
to the assumptions made in the data analysis (see section 5.4.3) mean that the 
affinity constants obtained for the protein-DNA interactions are only an 
approximation. Improvement of the accuracy of the Kdim and determination of the 
KD for the protein-DNA interaction using a variety of alternative techniques would 
be necessary to improve the accuracy of the determined affinity constants. 
 
The order in which C.Esp1396I binds to its operator sequences is important in the 
temporal regulation of the RM system. At low levels of cellular C.Esp1396I 
concentration, the M gene (esp1396IM) is expressed constitutively, allowing the 
host DNA to be methylated and protected from the action of the restriction 
enzyme. C.Esp1396I is expressed at a low level from a weak C-independent 
promoter and the concentration gradually increases. As the C.Esp1396I 
concentration increases, dimers are formed which first bind to OM (as this is the 
highest affinity site) which down-regulates the expression of esp1396IM as the 
binding site overlaps the start of transcription (Bogdanova et al., 2009; figure 5.1). 
Subsequently, dimers will then bind to OL which up-regulates the expression of the 
C/R operon (esp1396IC/R) through cooperative recruitment of RNA polymerase. 
As the population of C.Esp1396I dimers increases further, the expression of 
esp1396IC/R is gradually down-regulated as the C-protein competes with the RNA 
polymerase for the OR site. This demonstrates the importance of the C.Esp1396I 
binding sites having different affinities and how this plays a role in the temporal 
regulation of the RM system. 
 
Further characterisation of the protein-DNA interactions would provide further 
insight into the energetics, thermodynamics and kinetics of the association. ITC 
experiments were attempted to provide the thermodynamic information for the 
interactions but usable data proved impossible to obtain. A preliminary HSQC 
nuclear magnetic resonance (NMR) experiment was performed on 15N-labelled 
C.Esp1396I (kindly performed by Dr. Chris Read) to determine if NMR could be 
used to provide a mechanistic explanation for the differences in affinities of 169
 C.Esp1396I for its operator sites. The raw data are shown in appendix 3 and may 
provide a starting point for a detailed NMR analysis of these interactions in the 
future. 
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 Chapter 6: Structural analysis of the 
dimer bound to OL 
6.1 Introduction 
The tetrameric repression complex structure consisting of two C.Esp1396I dimers 
bound to the OL and OR sites of the C/R promoter was crystallised by McGeehan et 
al (2008). This structure identified that the two dimers bound on almost opposite 
faces of the DNA and that the two dimers interacted with one another across the 
major groove between the two operator sites. Some clear protein-DNA interactions 
were also identifiable, in particular the interaction of R35 with the conserved G3 
on both DNA strands. However, the structure was relatively low resolution and 
was symmetry averaged. Due to these limitations, the OL and OR sites could not be 
distinguished from one another, nor could some of the non-symmetry related 
protein-DNA interactions. As the DNA sequence was non-symmetric, base 
positions could not be defined unambiguously which was also true for the protein 
sidechains. This was clearly evident in the interactions at the dimer interface 
where the E25 and R35 side-chains could either interact with the DNA or with the 
adjacent dimer. These side-chains were placed with 50% occupancy with the R35 
from the dimer bound to OL contacting the DNA. The flexible loop regions seen in 
the free protein (see section 4.4.1) were similarly poorly defined. Additionally, at a 
resolution of 2.8 Å, the placement of solvent was ambiguous and only four waters 
could be placed in the structure. 
 
In 2007, Mruk and colleagues performed a logo analysis of the known and putative 
C-protein binding sites. They noted that there was a highly conserved inverted 
repeat with the consensus GACT. It was proposed that these sites were the 
recognition sequence for a C-protein dimer to bind. In addition to the C-boxes, the 
flanking TG and the symmetry related CA were also highly conserved as was the 
central GT and the TAT sequences between the C-boxes. The C-boxes and the other  
conserved elements follow different symmetries (figure 6.1) with the pseudo-dyad 171
Figure 6.1: The conserved DNA sequences obey different symmetries. (a) The C-boxes are 
symmetrical if the pseudo-dyad axis is placed between the central GT. (b) If the pseudo-dyad axis 
is placed at the central T, the C-boxes are no longer symmetrical but the other conserved 
element are. The pseudo dyad axes within operators (blue) and between operators (red) are 
shown as dotted lines. Figure reproduced from McGeehan et al., (2008). 
b 
a 
172
 axis either between the central GT (C-box symmetry) or through the central T 
(McGeehan et al., 2008). As both of these sequence elements are quite well 
conserved and have been shown to be important in C-protein binding (Bogdanova 
et al., 2009) the protein must be able to adapt to both symmetries. As the 
repression complex structure is an average of orientations, the details of how the 
protein is able to recognise both symmetries are unclear. 
 
In order to be able to clearly identify the protein-DNA interactions, the symmetry 
averaging had to be overcome and ideally the resolution had to be improved. To 
resolve these issues, crystallisation of a dimer bound to a single dimer binding site, 
OL, was attempted with an oligonucleotide that should promote pseudo-continuous 
DNA in a single orientation. By identifying the protein-DNA contacts in this 
structure, it was hoped that the mechanism by which C.Esp1396I was able to 
recognise the two different symmetries present in OL could be determined. 
Additionally a structure of the OL complex may give an insight into how the binding 
of a dimer to OL is able to enhance the binding affinity of C.Esp1396I to OR.  
6.2 Data collection and refinement 
6.2.1 Crystallisation 
The DNA containing OL consisted of an 18 bp duplex with either an A or a T as a 5' 
overhanging base on each strand (hereafter referred to as the 19mer DNA) in an 
attempt to promote pseudo-continuous DNA in a single orientation. C.Esp1396I 
was purified as described in section 3.3 and was incubated with the DNA at varying 
ratios (1:1, 1.5:1, 2:1, 2.5:1, 3:1 and 4:1 protein monomer:DNA) prior to crystal 
screening. Initially, sparse matrix screens (e.g. PACT premier from Molecular 
Dimensions) were used and sitting drops were set up using the Honeybee robot 
(Cartesian). Screens were incubated at either 4 °C  or 16 °C and were checked for 
evidence of crystallisation by polarising light microscopy (Leica MZ12-5) at regular 
intervals. Initial hits were screened on an Excalibur Nova (Oxford Diffraction) and 
suggested that two conditions (both with a protein monomer:DNA ratio of 2:1) 
were most promising, PACT-67 (0.2 M sodium acetate, 0.1 M Bis-Tris propane pH 
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 6.5, 20% w/v PEG 3350) and PACT-69 (0.2 M potassium/sodium tartrate , 0.1 M 
Bis-Tris propane pH 6.5, 20% w/v PEG 3350). 
 
The initial conditions were optimised by Dr. Sarah Thresh and Dr. Simon Streeter. 
The optimisation screens involved varying the concentration of PEG 3350 from 5-
35% in one dimension and the pH from 6 - 7.5 in the other dimension. Additional 
screens were set up containing the additives spermine or spermidine. However, 
the initial conditions could not be improved upon and selected crystals were 
formed in the PACT-67 condition in 4 µL hanging drops (2 µL protein/DNA and 2 
µL mother liquor) at 16 °C. The protein:DNA ratio was 2:1 (monomer:DNA) at 
~30 µM final DNA concentration. The crystals were mounted in litholoops 
(Molecular Dimensions), cryoprotected in 30% v/v glycerol and cryo-cooled in 
liquid nitrogen. 
 
Screens were set up by Dr. Sarah Thresh in an attempt to crystallise the 
C.Esp1396I ternary complex with a 25 bp duplex (25mer) containing OL and one 
C-box from OR and the sigma-70 subunit of RNA polymerase from Thermus 
aquaticus. The selected crystals formed in 0.1 M PCB pH 4.0, 20% w/v PEG 1500 
and 10 mM spermidine (final concentration) and were cryo-protected  in 20 % v/v 
PEG 400 prior to being cryo-cooled in liquid nitrogen.  
6.2.2 Structure solution and refinement 
Cryo-cooled crystals of the 19mer and 25mer complexes were exposed to 
synchrotron radiation on ID14-4 at the ESRF (Grenoble). A selection of crystals 
was screened using the automated sample changer and datasets of the most 
promising crystals were collected at 100 K using an ADSC 4Q CCD detector. The 
19mer crystals (figure 6.2) were often split, but by careful beam centring and 
adjustment of the beam size it was possible to collect usable data. The 19mer 
complex crystallised in the space group P22121; reflections extended to ~1.9 Å and 
110 images were collected with an oscillation angle of 1°. The 25mer complex 
crystallised in the space group P32 and 120 images were collected with an oscillation 
angle of 1°. The 25mer data was processed, scaled, phased (by molecular 
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Figure 6.2: The conserved DNA sequences obey different symmetries. (a) The C-boxes are 
symmetrical if the pseudo-dyad axis is placed between the central GT. (b) If the pseudo-dyad 
axis is placed at the central T, the C-boxes are no longer symmetrical but the other conserved 
element are. The pseudo dyad axes within operators (blue) and between operators (red) are 
shown as dotted lines. Figure reproduced from McGeehan et al., (2008). 175
 replacement) and refined by Dr. John McGeehan and the details are not discussed 
in this thesis. The current 25mer model contains two complexes (dimer bound to 
DNA) per asymmetric unit and has been refined to 2.5 Å with a current R/Rfree of 
24.8/27.4%.  
 
The 19mer data were processed and scaled using XDS/XSCALE as this provided 
better integration statistics than processing using MOSFLM. The resolution of the 
scaled data was limited to 2.1 Å as this provided an Rmerge < 40% in the highest 
resolution shell. The overall Rmerge was 11% with an overall completeness of 
90.7%. The lower resolution shells (50 - 15 and 15 – 10 Å) had relatively low 
completeness (~76% and 83% respectively) which resulted in the low overall 
completeness. The collection and refinement statistics are shown in table 6.1. 
 
The scaled data was phased by molecular replacement using Phaser (McCoy et al., 
2005). The phasing model consisted of the C.Esp1396I dimer bound to the left 
operator within the tetrameric complex (chains A and B, residues 5 - 75) and an 8 
base pair fragment from within OL. One complex (C.Esp1396I bound to the 19 bp 
DNA; figure 6.3) was present in the asymmetric unit and the structure refined to 
2.1 Å with a final R/Rfree of 16.8/22.4%. Iterative refinement was carried out using 
Refmac (Murshudov et al., 1997) with TLS restraints enabled (table 6.2). The 
missing DNA bases were manually added into interpretable electron density using 
Coot (Emsley & Cowtan, 2004), as were 11 of the 16 missing terminal amino acid 
residues. Waters were added during refinement either manually or using the "find 
waters" option in Refmac. The final structure contained all 38 bases and amino 
acid residues 2-77 and 3-79 in chains A and B respectively. The final parameters 
used during refinement are shown in table 6.2. 
 
The 19mer DNA sequence was designed to try to promote the formation of 
pseudo-continuous DNA in a single orientation in order to overcome the 
limitations encountered in the repression complex structure. The symmetry 
averaging problem was overcome in the 19mer structure but the DNA was not 
pseudo-continuous. The DNA ends were involved in crystal packing interactions 176
Table 6.1: X-ray crystal data, refinement and model statistics for the 19mer OL complex 
structure. Values in parentheses are for the highest resolution shell.  
 
* Rmerge = ∑hkl∑i|Ii(hkl) - «I(hkl)»|/∑hkl∑iIi(hkl),  where «I(hkl)» is the mean intensity of reflection 
I(hkl) and Ii(hkl) is the intensity of an individual measurement of reflection I(hkl). 
ǂ Rcryst = ∑hkl│|Fobs| - |Fcalc|│/∑hkl|Fobs|, where Fobs is the observed structure- factor amplitude 
and Fcalc is the calculated structure-factor amplitude. Rfree is the same as Rcryst but for the 5% of 
structure- factor amplitudes that were set aside during refinement.  
Data collection 
Space group     P22121    
Unit-cell parameters (Å, o)   a = 44.3, 
          b = 61.6,   
          c = 113.7,   
       α = β = γ = 90,   
Resolution limits (Å)    50 - 2.1 (2.2 - 2.1)   
Rmerge* (%)     11.0 (37.1)    
I/σ(I)      15.3 (4.6)    
Completeness (%)    90.7 (86.9)  
Redundancy     4.6 
Refinement model statistics 
No. of reflections    17096    
Rcryst/Rfree
ǂ (%)     16.8/22.4    
No. of atoms 
Protein      1279 
DNA      773 
Water      314     
B-factors (Å2) 
Protein      31.89 
DNA      35.5    
Water      47.3    
R.M.S deviations from ideal 
Bond lengths (Å)    0.009    
Angles (o)     1.3    
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Figure 6.3: The 19mer OL complex structure present in the asymmetric unit of the crystal. A 
single complex consisting of a C.Esp1396I dimer bound to DNA was present in the asymmetric 
unit. Chains A and B comprise the dimer and chains C and D comprise the DNA duplex. The DNA 
duplex consists of 18 base pairs with a 5' overhang on each strand. 
Chain C: 5’-ATGTGACTTATAGTCCGTG 
Chain D:     ACACTGAATATCAGGCACT-5’ 
5         10       15 
15                        10                           5 
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Table 6.2: Refinement parameters for the 19mer OL complex structure.  
Refinement 
Resolution limits (Å) 50 - 2.1 
B-factors Overall anisotropic 
Weighting Auto 
Scaling Babinet 
TLS 
No. of groups 4 
Description individual chains 
179
Fi
gu
re
 6
.4
: 
Tr
ip
le
 h
el
ic
al
 D
N
A
 i
n
te
ra
ct
io
n
s 
b
et
w
ee
n
 s
ym
m
e
tr
y 
re
la
te
d
 1
9
m
er
 c
o
m
p
le
xe
s.
 (
a)
 T
h
e 
tr
ip
le
 h
el
ic
al
 in
te
ra
ct
io
n
s 
o
cc
u
r 
b
et
w
e
en
 A
1 
an
d
 G
1
9
 
o
f 
ch
ai
n
 C
 (
b
lu
e
 a
n
d
 y
el
lo
w
) 
an
d
 T
1
 a
n
d
 A
1
9
 o
f 
ch
ai
n
 D
 (
p
in
k 
an
d
 g
re
en
).
 (
b
) 
Th
e
 o
ve
rh
an
gi
n
g 
5
' 
b
as
e
 H
o
o
gs
te
in
 p
ai
rs
 w
it
h
 t
h
e 
te
rm
in
al
 b
as
e
 o
f 
a 
sy
m
m
et
ry
 r
el
at
ed
 m
o
le
cu
le
. T
h
es
e
 in
te
ra
ct
io
n
s 
st
ab
ili
se
 t
h
e 
D
N
A
 e
n
d
s 
in
 t
h
e 
co
m
p
le
x 
an
d
 r
ed
u
ce
 t
h
e 
B
--
fa
ct
o
rs
. 
b
 
a 180
Figure 6.5: Comparison of the sidechain position between the 19mer OL complex and the 
25mer OL complex structures. Chains A and B of the 19mer complex (red) and chains A and B of 
the 25mer complex (yellow) were overlaid using the align command in PyMol with 
RMSD =  0.444 Å (across 947 atoms). The majority of the amino acid sidechains are in equivalent 
positions despite the two complexes crystallising in different space groups. 181
 between symmetry related molecules and formed triple helical interactions 
(figure 6.4). The bases paired on both the Hoogstein and Watson-Crick edges to 
form a base “triple” at both ends of the DNA (T-AT and A-GC). These triple helical 
interactions helped to stabilise the DNA ends, which refined with low B-factors 
despite not being involved in protein-DNA interactions. 
 
The amino acid sidechains in the 19mer and 25mer complexes are in very similar 
positions (figure 6.5) despite the complexes crystallising in different space groups 
with different crystal packing interactions. This increases the likelihood that the 
sidechain positions in the crystal structure are representative of the sidechain 
positions in vivo. 
6.3 Comparison of the OL complex with the tetrameric complex 
The OL structure was obtained to resolve the symmetry averaging problems 
inherent in the repression complex structure. The symmetry averaging blurred the 
details as the conformation of the two dimers was averaged as were the dimer 
recognition sites on the DNA. Figure 6.6 shows a superposition of OL and the 
tetrameric complex. Some regions are very similar between the two structures 
such as the backbone and sidechain position in helix 1 (figure 6.6a). There are also 
differences between the two structures that may arise from symmetry averaging, 
such as the flexible loop region in chain B (figure 6.6b). The OL structure 
overcomes the problems encountered with the tetrameric complex structure such 
as low resolution and symmetry averaging. Chains A and B in the OL structures are 
equivalent to their counterparts in the tetrameric complex. Bases 1-19 of chain E in 
the tetrameric complex are equivalent to chain C in the OL structure and bases 
17-35 of chain F in the tetrameric complex are equivalent to chain D in the OL 
structure. 
6.3.1 Overcoming symmetry averaging 
The repression complex was solved to 2.8 Å and was symmetry averaged which 
prevented detailed analysis. The OL structure was solved to 2.1 Å and was not 
symmetry averaged. Figure 6.7 highlights the quality of the electron density map 
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Figure 6.6: Comparison of the 19mer OL complex and the repression complex structures. (top) 
OL chains A and B (red) superimposed on chains A and B of the repression complex (blue) using 
the align function in PyMol. RMSD = 0.477 Å (558 main chain atoms). (a) Side chain position for 
residues in Helix 1 from the A chains are consistent between OL and the repression complex. (b) 
The repression complex has identical loop regions (residues 43--47) in all monomers, but OL has 
both the major (chain A) and minor (chain B) conformation identified in the free protein 
structures. 
a 
b 
a b 
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Figure 6.7: Electron density for the two alternative loops present in the 19mer OL complex 
structure. Residues 43-47 of monomer A (major conformation; top) and monomer B (minor 
conformation; bottom). The electron density was contoured at 2σ. 184
 that higher resolution and lack of symmetry averaging provides. The depicted 
residues form the flexible loop region that was observed in the free protein 
structure (section 4.4.1). In the tetrameric complex structure, the four loop regions 
were constrained to be identical using NCS restraints as the electron density was 
unclear in this region. The same region in OL can be positioned with a greater 
degree of certainty as the electron density is very clear. The increase in resolution 
of OL permits more accurate positioning of amino acid sidechains and allows a 
more detailed analysis of the protein-DNA interactions than was possible from the 
tetrameric complex structure. 
 
Increased resolution also permits the location of more ordered water molecules 
both at the protein-DNA interface and elsewhere within the unit cell. At 2.8 Å, few 
water molecules can be seen in the structure of the tetrameric complex. In this 
structure there are only four waters (figure 6.8a) and these also suffer from the 
problem of  symmetry averaging. In contrast, the OL structure contains 314 waters 
(figure 6.8b), of which some are involved in mediating protein-DNA interactions 
(figure 6.8c). As the OL structure does not suffer from the problem of symmetry 
averaging, it is possible to identify differences in the distribution of water 
molecules between the two half sites such as the interactions depicted in figure 
6.8c. In one half site, the R46 makes direct contact with the DNA bases and in the 
other half site, the R46 makes one direct and one water mediated contact. This is 
discussed further in section 6.4.2. 
 
The alternative loop conformations that are present in the free protein structure 
(section 4.4.1) are not present in the tetrameric complex structure in which all four 
loops appear to exist in the major conformation. Conversely, in the OL structure the 
two loops clearly adopt different conformations. The loop in monomer A adopts 
the major conformation whereas the loop in monomer B adopts the minor 
conformation (figure 6.6b). The lack of symmetry averaging in the OL structure has 
permitted the identification of different loop conformations when C.Esp1396I is 
bound to a non-symmetrical DNA sequence, which may explain the differences in 
affinity between operator sequences.  185
Figure 6.8: Water molecules can be placed in the 19mer OL structure at a resolution of 2.1 Å. 
(a) In the repression complex structure only 4 solvent molecules could be positioned due to 
relatively low resolution (2.8 Å). (b) Over 300 water molecules could be placed in the 19mer OL 
structure including water molecules that are involved in interactions between protein and DNA 
(c).  
b 
a 
c 
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Figure 6.9: Comparison of the electron density for the symmetric and non-symmetric bases in 
the tetrameric complex and 19mer OL structures. (a) The DNA sequence of the OL and OR 
operators. The OR sequence is located on the complementary strand to that depicted in figure 
6.1. Non-symmetric bases are highlighted in yellow. (b & c) Electron density representation of 
the bases highlighted in the box (residues 3-7) where (b) is the repression complex structure and 
(c) is the OL structure. The electron density is contoured at 1.5 σ. 
b 
c 
a 5 
| 
OL: 5’-atgtgacttatagtccgt 
OR: 5’-atgttgactataatcaca 
10 
| 
15 
| 
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Figure 6.10: Position of the R35 in the tetrameric complex and the 19mer OL complex. (a) The 
E25 and R35 from both dimers in the tetrameric complex were positioned and refined with 50% 
occupancy. (b) The R35 in the 19mer OL complex interacts with G17.  
a 
b 
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 In addition to the structure of the protein dimers being averaged in the tetrameric 
complex structure, the non-symmetric DNA bases are also averaged. Figure 6.9a 
shows the sequence of OL and OR with the non-symmetric bases highlighted. 
Comparison of the density of the symmetric and non-symmetric bases in the 
tetrameric complex is shown in figure 6.9b. The density for the symmetrical GT is 
continuous and the difference between purine and pyrimidine is clear. The 
non-symmetrically related GAC does not have continuous density and all 3 bases 
are poorly defined. The density for the same bases in OL (figure 6.9c) shows 
density of similar quality throughout with A being clearly distinguishable from G 
and T being clearly distinguishable from C. As the bases in the OL structure are not 
averaged, the structure can be used to reliably identify sequence specific contacts. 
 
The two dimers in the tetrameric complex structure interact across the major 
groove of the DNA via R35 and E25. However, due to symmetry averaging, the side 
chains of these two residues were set at 50% occupancy as it was impossible to 
distinguish between the residues from the OL bound dimer (chains A and B) and 
the OR bound dimer (chains C and D). Figure 6.10a shows how the R35 in the OR 
bound dimer (chain C) was positioned to interact with E25 from the OL bound 
dimer (chain B) as the R35 cannot make a bidentate interaction with the bases in 
chain F since the major groove only contains one electronegative donor atom in an 
appropriate position. The R35 in the OL bound dimer (chain B) was positioned to 
interact with G17 of chain E. The OL complex structure is consistent with the 
hypothesis that R35 binds to G17 (figure 6.10b) and implies that the salt bridge 
formed between the dimers in the tetrameric complex is formed between E25 of 
chain B and R35 of chain C. However, as there is no adjacent dimer bound to OR in 
the OL complex structure there is no opportunity for the R35 to bind to E25. The 
conformation adopted in the OL complex structure may therefore represent the 
lowest energy conformation as the charge of the R35 head group is 
counter-charged by the electronegative atoms on the base. 
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 The OL structure overcomes the symmetry averaging problems inherent in the 
tetrameric complex structure and thus permits a more detailed analysis of the 
protein-DNA interactions. 
6.4 Detailed analysis of protein-DNA interactions 
6.4.1 The recognition helix 
The recognition helix (helix 3, residues 35-43) is inserted into the major groove of 
the DNA in the manner of a typical helix-turn-helix protein. Two residues in this 
helix are involved in direct readout of the DNA sequence while other residues are 
involved in non-specific interactions with the phosphate backbone (figures 6.11 & 
6.12 and tables 6.3 & 6.4). The residues involved directly in sequence recognition 
are R35 and T36. In both monomers the γ-hydroxyl of T36 interacts with the N4 
group of cytosine. T36 in chain A recognises C16 of chain D and the T36 in chain B 
recognises C15 of chain C.  
 
The amino groups of R35 interact with the N7 and O6 of a guanine residue. R35 in 
chain A recognises G3 of chain C and R35 in chain B recognises the non-symmetry 
related G17 of chain C. In addition to hydrogen bonding with G3, R35 in chain A is 
involved in indirect readout by stacking the planar guanidinium group with the 
exposed face of T2 (figure 6.13b) as described by McGeehan et al. (2008). The R35 
in chain B cannot make the symmetrical interaction as a cytosine is in the 
equivalent position in chain D (figure 6.13a). Instead, the R35 interacts with the N7 
and O6 of the highly conserved G17 in chain C (figure 6.13c) as it has a long, flexible 
sidechain that is capable of breaking the symmetry of the interactions. 
 
Helix 3 of C.Esp1396I recognises bases within the 5'-AGTC sequence, rather than 
the 5'-GACT on the complementary strand. The recognition helix only makes two 
sequence specific interactions, one to the highly conserved G3/G17 and another to 
the cytosine in the AGTC sequence. In addition, however, the G and T bases in this 
sequence are recognised by R46 that is within the flexible loop region (see section 
6.4.2). The two C.Esp1396I monomers are able to make non-symmetrical 
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Figure 6.11: Interactions between the recognition helix of chain A and the DNA in the 19mer 
OL complex. (top) The interactions are shown as black dashes and the region of the DNA 
depicted is highlighted in the overall sequence. (bottom) A schematic representation of the 
interactions. A red line indicates a hydrogen bond and a blue line indicates a water mediated 
contact. The atoms involved and the bond distances are given in table 6.3. 
Chain C: 5’-ATGTGACTTATAGTCCGTG 
Chain D:     ACACTGAATATCAGGCACT-5’ 
C:5’-p-A-p-T-p-G-p-T 
R43 
R35 R35 
E42 
S39 
S39 
Y37 
D:3’-C-p-T-p-G-p-A-p 
T36 
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Table 6.3: Interactions between the recognition helix of chain A and the DNA in the 19mer OL 
complex. The bond distances for the interactions depicted in figure 6.11. (W) denotes that the 
interaction between the protein and DNA is water mediated. Distances for water-mediated 
contacts (which occur between electronegative atoms) are given as (x/y) where x is the distance 
between the protein and the water and y is the distance between the DNA and the water. 
Distances < 3.2 Å represent potential hydrogen bonds. 
Protein DNA Bond 
Residue Atom Chain Residue Atom Length (Å) 
Arg35 
NH1 C 
G3 N7 3.24 
T2 (W) OP2 2.91/2.88 
NH2 C G3 O6 2.65 
Thr36 OG1 D C16 N4 2.88 
Tyr37 OH D A13 
OP1 3.33 
OP2 2.76 
Ser39 OG C 
G3 OP2 2.92 
T4 (W) OP2 3.21/2.85 
Glu42 OE1 C G3 (W) 
OP1 2.96/3.04 
OP2 2.96/3.11 
Arg43 
NE C T4 OP2 3.35 
NH1 C T4 OP1 3.56 
NH2 C G3 OP1 3.44 
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Figure 6.12: Interactions between the recognition helix of chain B and the DNA in the 19mer 
OL complex. The interactions are shown as black dashes and the region of the DNA depicted is 
highlighted in the overall sequence. (bottom) A schematic representation of the interactions. A 
red line indicates a hydrogen bond and a blue line indicates a water mediated contact. The 
atoms involved and the bond distances are given in table 6.4.  
Chain C: 5’-ATGTGACTTATAGTCCGTG 
Chain D:     ACACTGAATATCAGGCACT-5’ 
D:3’-G-p-C-p-A-p 
R43 
E42 
S39 
T36 
C:5’-p-A-p-G-p-T-p-C-p-C-p-G 
Y37 R35 
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Table 6.4: Interactions between the recognition helix of chain A and the DNA in the 19mer OL 
complex. The bond distances for the interactions depicted in figure 6.12. (W) denotes that the 
interaction between the protein and DNA is water mediated. Distances for water-mediated 
contacts (which occur between electronegative atoms) are given as (x/y) where x is the distance 
between the protein and the water and y is the distance between the DNA and the water. 
Distances < 3.2 Å represent potential hydrogen bonds. 
Protein DNA Bond 
Residue Atom Chain Residue Atom Length (Å) 
Arg35 
NH1 C G17 N7 3.29 
NH2 C G17 O6 2.82 
Thr36 OG1 C C15 N4 3.11 
Tyr37 OH 
C G13 OP2 2.62 
C A12 (W) OP2 2.85/3.21 
Ser39 OG D A3 OP2 2.66 
Glu42 OE1 D A3 (W) OP1 2.62/2.68 
Arg43 NH1 
D C4 OP2 3.11 
D G5 (W) OP2 2.90/2.97 
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Figure 6.13: Direct and indirect readout of DNA by R35. (a) The R35 recognises the G3 and G17 in 
the DNA sequence and the highlighted bases are shown in b and c. (b) The R35 from chain A 
recognises the conserved TG by interacting with the O6 and N7 of the guanine base. The planar 
guanidinium group of R35 also stacks with the thymine base. (c) The symmetry related 
interaction cannot be made by chain B as the base in that position is a cytosine. Instead the R35 
from chain B recognises the G17 via the O6 and N7. All hydrogen bond distances are less than 
3.2 Å. 
 
A-T-G-T-G-A-C-T-T-A-T-A-G-T-C-C-G-T-G 
  A-C-A-C-T-G-A-A-T-A-T-C-A-G-G-C-A-C-T 
1   2   3  4   5   6   7   8  9  10  11  12  13 14  15  16  17  18  19 
19  18 17  16  15  14  13  12  11 10   9   8  7   6   5   4   3   2  1 
a 
c 
b 
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 interactions with the DNA due to the flexible nature of the R35 sidechain. Amino 
acid side-chains in the recognition helix also make phosphate backbone contacts, 
which will be discussed in section 6.4.3. 
6.4.2 The alternative loop conformations 
In the free protein structure, two alternative conformations of the loop region 
(residues 43-46) between helices 3 and 4 were observed (section 4.4.1). 
Comparing the two conformations, residues 44 and 45 (asparagine and serine 
respectively) were flipped almost 180° about the peptide backbone. In the minor 
conformation it was postulated that the polar head groups of the N44 sidechain 
would be in close proximity to the DNA and may be involved in protein-DNA 
interactions. The crystal structure of the complex clearly shows that two 
conformations are indeed present in the OL structure, with monomer A containing 
a loop in the major conformation and monomer B containing a loop in the minor 
conformation. 
 
Figure 6.14 shows both loop conformations with respect to the DNA and the atoms 
involved and the bond distances are shown in table 6.5. The sidechain of N44 in the 
major loop (figure 6.14a) points toward the core of the protein and the terminal 
polar groups, the δ-carbonyl and δ-amino groups, are stabilised directly through 
interactions with the backbone amino of S7 and the γ-hydroxyl of S10. The 
δ-amino of N44 and the backbone carbonyl of S7 also coordinate a water. These 
interactions provide stability for the major loop conformation. In the minor loop 
conformation (figure 6.14b) the N44 has rotated about the backbone 
approximately 180° and the sidechain points toward the DNA backbone. The 
δ-amino of N44, the η-amino of R43 and the phosphate oxygen of G5 coordinate a 
water that stabilises the N44 sidechain. The δ-carbonyl of N44 may coordinate a 
water but this appears unclear in the structure as the distance and orientation are 
unfavourable.  
 
Although the sidechain of S45 is rotated approximately 180° between the two loop 
conformations, in both instances the γ-hydroxyl is stabilised by interactions with 
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Figure 6.14: Comparison of the interactions made by the flexible loop region in chains A and B 
of the 19mer OL complex structure. The interactions made by the flexible loop regions in chains 
A and B (a and b respectively) are shown as black dashes. The region of the DNA depicted is 
highlighted in the overall sequence where the bases highlighted in red are shown in (a) and the 
bases highlighted in blue are shown in (b). The atoms involved and the bond distances are given 
in table 6.5. 
Chain C: 5’-ATGTGACTTATAGTCCGTG 
Chain D:     ACACTGAATATCAGGCACT-5’ 
a b 
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Table 6.5: Comparison of the interactions made by the flexible loop region in chains A and B of 
the 19mer OL complex structure. The bond distances for the interactions depicted in figure 6.14. 
(W) denotes that the interaction between the protein and DNA is water mediated. Distances for 
water-mediated contacts (which occur between electronegative atoms) are given as (x/y) where 
x is the distance between the protein and the water and y is the distance between the DNA and 
the water. 
Monomer A (major conformation) Monomer B (minor conformation) 
Residue Atom Chain Residue Atom Distance (Å) Chain Residue Atom Distance (Å) 
Arg43 
NE C T4 OP2 3.35 B Ser39 OG 2.77 
NH1 C T4 OP1 3.56 
D C4 OP2 3.11 
D G5(W) OP2 2.90/2.97 
NH2 C G3 OP1 3.44 S 120 O 2.91 
Asn44 
OD1 A Ser7 N 3.41 
ND2 
A Ser7(W) O 2.71/2.53 
D G5(W) OP2 3.16/2.97 
A Ser10 OG 2.78 
Ser45 OG A Gly40 O 2.99 
B Ser10 OG 3.07 
S 193 O 2.58 
Arg46 
NH1 D G14 N7 3.28 C T14 O4 2.77/2.87 
NH2 
D G14 O6 3.06 
C G13 N7 3.27 
D T15 O4 3.18 
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 the protein. In the major loop conformation the γ-hydroxyl interacts with the 
backbone carbonyl of Gly-40 while in the minor loop conformation the γ-hydroxyl 
interacts with the γ-hydroxyl of S10 and also coordinates a water. The R43 
interacts with the phosphate backbone in both loop conformations and the polar 
groups of N44 and S45 are also stabilised in both conformations, albeit by different 
groups. Although both loop regions have B-factors which are slightly higher than 
the average for each monomer, the loop in the major conformation has a lower 
B-factor (34.5 Å2) than the loop in the minor conformation (35.8 Å2). This suggests 
that the stabilisation of the major loop conformation in chain A may be more 
effective than the stabilisation for the minor loop conformation in chain B. 
 
Both conformations of the loop region are involved in interacting with the DNA 
bases via arginine 46. In the major loop conformation (monomer A) R46 
recognises the N7 and O6 of G14 from chain D as well as recognising the O4 of T15 
(figure 6.15a). Only guanine and thymine have electron donors in the correct 
position to interact with the amino groups of the arginine; thus the recognition of 
these two bases is specific. In the minor loop conformation (monomer B) R46 is 
involved in interactions between the GT of chain C (figure 6.15b). However, the 
head group of the arginine is positioned in such a way as to only directly interact 
with the N7 of G15. This interaction is sufficient to distinguish between purine and 
pyrimidine but is unable to distinguish between adenine and guanine. The η-amino 
group of R46 also makes a water mediated contact with the O4 of T14. As water can 
act as either a donor or an acceptor in hydrogen bonding, this interaction cannot 
distinguish thymine from cytosine. This water forms part of the network of highly 
organised waters found in the major groove of the DNA.  
 
Figure 6.16 shows a superposition of monomers A and B. The overall backbone 
structure of the two monomers is very similar with the only notable difference 
occurring in the flexible loop region. The GTC sequence recognised by T36 and R46 
appears to shift by approximately half a base pair relative to the protein. This shift 
may be due to the fact that the R35 in the two monomers recognise guanines that 
are on the same DNA strand (when ideally they should be on symmetry related 199
Figure 6.15: Sequence recognition by R46 in the two alternative loop conformations. (a) The 
position of R46 in chain A (major conformation) permits direct readout of the GT bases in the C-
box. (b) In the minor conformation (chain B) the R46 cannot perform direct readout of the C-box 
but can distinguish between purine and pyrimadine at base 13. The hydrogen bond distances are 
all less than 3.3 Å. 
90o 90o 
a b 
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Figure 6.16: Comparison between the two half-sites in the 19mer OL complex structure. 
Monomers A and B (red and pink  respectively) were superimposed with RMSD = 0.34 Å (222 
main chain atoms). The DNA bases are offset by approximately half a base pair.  Bases involved 
in direct readout are shown as thick lines. The half base pair shift is compensated for through 
the flexibility of the loop region, permitting recognition of the GTC bases.  201
Figure 6.17: Comparison of the monomer position relative to the GTC recognition sequence. 
Residues  13-15 of chain C (light red) were superimposed upon residues 14-16 of chain D (pink) 
using the pair fit command in PyMol (RMSD = 0.54 Å over 61 backbone atoms).  
90o 
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 strands), which causes a conformational change in the DNA (section 6.4.3). The 
flexible loop is able accommodate this half base pair shift, permitting recognition 
of the GTC by monomer B. Alternatively, if the GTC bases recognised by the two 
monomers are superimposed (figure 6.17), the protein appears to be rotated by 
about 30° relative to the DNA which may be due to the pseudo-dyad axis being 
offset by approximately half a base pair (i.e. the monomers are offset by a base pair 
relative to the C-boxes). The protein dimer sits on one face of the DNA and in order 
to recognise the GTC the flexible loop region has to compensate. In the OM operator 
the spacing between the GTC bases is such that the monomers are positioned 
identically relative to the DNA (section 7.3). The fact that the flexible loop has to 
make this adjustment in the OL complex structure may explain why the protein has 
a lower affinity for OL than it does for OM.  
6.4.3 Backbone interactions 
Analysis of the OL DNA structure in the complex was performed using CURVES 
(Lavery et al., 2009). The minor groove at the TATA site is compressed (from ~7 Å 
to ~2 Å) which leads to the DNA being significantly bent about this sequence as 
shown in figure 6.18. The overall bend of the DNA duplex is approximately 41°. The 
bend measured in the tetrameric complex was ~51°. The discrepancy between the 
two angles may be due to the fact that the angle was measured across fewer base 
pairs in the OL structure due to the overhanging bases at the DNA ends. The fact 
that the DNA can be significantly bent around the TATA site permits a form of 
indirect readout that relies on the overall structure of the DNA. Only DNA that can 
be bent in such a way will permit binding of a C.Esp1396I dimer to both half sites 
in OL. The bend in the DNA at the TATA site is accompanied by distortion in the 
base pair and step parameters (figure 6.19). TATA sequences have well conserved 
bending properties that differ from standard B-form DNA (compare the last two 
columns in figure 6.19). The parameters for the OL sequence show values that are 
typical of TATA sequences (Olson et al., 2001) except for the roll parameter which 
is more similar to standard B-form DNA.  
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Figure 6.18: The minor groove is compressed at the TATA sequence resulting in an increased 
DNA bend angle. The overall DNA bend is ~41o (top) and the bend angle between adjacent base 
pairs (calculated as the angle formed between the normals of adjacent base pairs) is greatest at 
the TATA sequence (bottom). The graph demonstrates that as the minor groove width (black 
line) decreases the bend angle increases (blue line). The minor groove width for the sequence in 
the standard B-form DNA is also shown (dashed line). The values were calculated using CURVES.  204
Figure 6.19: Step and base pair parameters of the TATA sequence.  (top) The twelve step and 
base pair parameters (picture reproduced from Rice & Correll, p.70). (bottom) The values of 
these 12 parameters for the TATA sequence were calculated using CURVES and the typical 
values are from Olson et al. (2001). 
 
A-T-G-T-G-A-C-T-T-A-T-A-G-T-C-C-G-T-G 
  A-C-A-C-T-G-A-A-T-A-T-C-A-G-G-C-A-C-T 
1   2   3   4  5   6   7   8  9  10  11  12 13  14  15  16  17  18  19 
19  18  17  16  15 14  13  12  11  10  9   8   7  6   5   4   3  2   1 
T A T A 
Typical  
TATA 
Typical 
B-form 
Tilt (o) 2.9 0.2 -2.8 -1.6 0.9 (2.4)  0.6 (5.2) 
Roll (o) -3.3 -5.1 -9.3 5.9  16.6 (15.9)  0.6 (5.2) 
Twist (o) 43.3 27.5 48.5 32  25.0 (10.3)  36.0 (6.8) 
Shift (Å) 0.67 0.03 -0.47 0.39 -0.04 (0.78) -0.02 (0.45) 
Slide (Å) 0.18 -0.56 0.77 -0.33  0.37 (1.04)  0.23 (0.81) 
Rise (Å) 3.55 3.05 3.74 3.3  3.6 (0.53)  3.32 (0.19) 
Buckle (o) 5.6 -6.1 6.8 -7.9  -0.93 (17.8)  0.5 (6.7) 
Propeller (o) -10.2 -5.2 -3.3 -16.2 -5.9 (7.9) -11.4 (5.3) 
Opening (o) 3.3 5 8.9 7.3  2.7 (4.1)  0.6 (3.1) 
Shear (Å) -0.09 0.01 -0.03 0.09  0.07 (0.20)  0.00 (0.21) 
Stretch (Å) -0.09 -0.07 -0.04 -0.09 -0.09 (0.13) -0.15 (0.12) 
Stagger (Å) 0.01 -0.07 -0.05 0.24  -0.03 (0.29)  0.09 (0.19) 
205
Figure 6.20: Amino acid sidechains are responsible for the compression of the minor groove at 
the TATA sequence. (a) The DNA is significantly bent about the TATA sequence as the minor 
groove is compressed. (b) The compression of the minor groove is achieved through interactions 
between the protein and the DNA backbone. Y37, N47 and S52 from both monomers are 
involved in these interactions. The hydrogen bond distances are all between 2.7 and 3.0 Å 
except for the Y37/O2P interaction (chain A) which is 3.3 Å. (c) The location of the TATA 
sequence is highlighted in yellow and the bases represented in a and b are coloured brown. The 
atoms involved in the interactions and the bond distances are given in table 6.6. 
 
A-T-G-T-G-A-C-T-T-A-T-A-G-T-C-C-G-T-G 
  A-C-A-C-T-G-A-A-T-A-T-C-A-G-G-C-A-C-T 
1   2   3   4  5   6   7  8   9  10  11  12 13  14  15  16  17  18  19 
19  18  17  16  15 14  13  12  11  10  9   8   7  6   5   4   3   2  1 
a 
c 
b 
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Table 6.6: The Interactions involved in the compression of the minor groove at the TATA sites. 
The atoms involved in protein-DNA interactions and the bond distances are shown for residues 
in chains A and B. Residues in chain A interact with the phosphate backbone in chain D and 
residues in chain B interact with the phosphate backbone of chain C. Residue marked with an 
asterisk (*) have a dual conformation in the structure, and each conformation is set to 50% 
occupancy. 
DNA Chain A (interactions with chain D) Chain B (interactions with chain C) 
Residue Atom Residue Atom Distance Residue Atom Distance 
12 OP1 N47 ND2 2.84 N47 ND2 3.04 
13 
OP1 
Y37 OH 3.33 
S52* OG 2.70 
S52 OG 2.67 
OP2 Y37 OH 2.76 
Y37 OH 2.62 
S52* OG 2.90 
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 Using CURVES to analyse the two half-sites in the OL DNA structure (bases 2-10 
and 11-19), it can be seen that the bend generated in each half-site is 
approximately 16° (data not shown). Overall, there is relatively little difference 
between the two half-sites (see appendix 5 for CURVES output), which suggests 
that it is the protein structure and not the DNA structure that compensates for the 
lack of symmetry between the half sites. 
 
The tetrameric complex structure highlighted the role of Y37 and S52 of each 
subunit in the dimer in compressing the minor groove at the TATA sequences by 
binding to the phosphate backbone of the DNA on either side. Where the 
phosphate groups are identified as belonging to a specific residue, the phosphate is 
on the 5' side of the base. These interactions are also seen in the OL complex 
structure with additional backbone contacts being made by N47 (figure 6.20 and 
table 6.6). The Y37 and S52 from the same monomer interact with the same 
phosphate group in the backbone (residue 13 in both DNA strands) and N47 
interacts with the phosphate from residue 12. The serine in chain B has a dual 
conformation (with both conformations set at 50% occupancy) in the structure, 
but both conformations interact with the same phosphate group. These 
interactions cause the minor groove to be compressed and consequently the DNA 
is bent. There are many other interactions between the protein and the DNA 
backbone (sections 6.4.1 and 6.4.2 and appendix 4) that increase the binding 
affinity. However, these do not play such an important role as the interactions 
surrounding the TATA sequence in determining the DNA structure.  
 
The OL structure gives further insight into the distortion of the DNA within the 
operator and how this contributes to indirect readout. However,  this structure is 
unable to shed light on whether C.Esp1396I binding to OL causes an expansion of 
the major groove between OL and OR prior to the cooperative recruitment of a 
second dimer at the OR site. 
208
Fi
gu
re
 6
.2
1
: 
A
 C
.E
sp
1
3
9
6
I 
d
im
e
r 
b
o
u
n
d
 t
o
 O
L 
is
 s
u
ff
ic
ie
n
t 
to
 w
id
e
n
 t
h
e
 m
aj
o
r 
gr
o
o
ve
 b
e
tw
ee
n
 O
L 
an
d
 O
R
. 
C
h
ai
n
s 
A
 a
n
d
 B
 o
f 
th
e 
25
m
er
 s
tr
u
ct
u
re
 
(y
el
lo
w
) 
an
d
 c
h
ai
n
s 
A
 a
n
d
 B
 o
f 
th
e 
re
p
re
ss
io
n
 c
o
m
p
le
x 
st
ru
ct
u
re
 (
b
lu
e)
 w
er
e
 o
ve
rl
ai
d
 u
si
n
g 
th
e 
al
ig
n
 c
o
m
m
an
d
 i
n
 P
yM
o
l 
w
it
h
 a
n
d
 R
M
SD
 =
 1
.1
0
9
 Å
 
(a
cr
o
ss
 1
2
4
8
 a
to
m
s)
. 
209
Figure 6.22: The B-factors at the unbound end of the 25mer DNA are much higher than the 
rest of the structure. The 25mer is coloured by temperature factor (B-factor) where red 
represents high B-factors and blue represents low B-factors. The scale bar represents B-factor 
ranges from 30-100 Å2. The terminal bases have a much higher B-factor than the rest of the 
structure. 210
 6.5 The 25mer DNA structure 
C.Esp1396I was incubated with a 25 base pair DNA (containing an intact OL and 
one half-site of OR) and the sigma-70 subunit of RNA polymerase from Thermus 
aquaticus in an attempt to crystallise the ternary complex. However, the crystal 
structure did not contain the sigma-70 subunit, but did contain a dimer of 
C.Esp1396I bound to DNA. This structure, nevertheless, provides insight into the 
mechanism underlying the cooperativity between the dimers in the tetrameric 
complex.  
 
McGeehan et al (2008) postulated that the cooperativity exhibited by a dimer of 
C.Esp1396I binding to OR may be due to the major groove being opened up by the 
dimer bound to OL. This pre-bending would lower the free energy of binding to OR 
and permit interactions between the two dimers across the expanded major 
groove. This conformational selectivity may play a role in the apparent increase in 
affinity for OR when a dimer is bound to OL as shown previously for the Esp1396I 
system (McGeehan et al., 2008; Bogdanova et al., 2009) and confirmed by SPR 
(section 5.4.2). Although the structure is not fully refined, the model satisfies the 
majority of the electron density. The current model is shown in figure 6.21 where 
the C.Esp1396I dimer has been superimposed upon the dimer bound to OL in the 
tetrameric complex structure. The DNA structure in the two complexes is very 
similar and strengthens the hypothesis that binding to OL is sufficient to expand 
the major groove between the OL and OR operators and thus facilitate the binding 
of a second dimer. The terminal bases in the 25mer structure have very high B-
factors (figure 6.22) as they are not involved in crystal packing interactions. This 
results in poor electron density for these bases and has hindered full refinement of 
the model.  
6.6 Discussion 
The tetrameric complex structure presented by McGeehan et al. (2008) did not 
permit detailed examination of the protein-DNA interactions due to being 
symmetry averaged and relatively low resolution. A DNA duplex containing the OL 
recognition site was crystallised with C.Esp1396I and the structure was solved to 211
Figure 6.23: Schematic representation of interactions involved in direct readout. The residues 
Arg35, Thr36 and Arg46 are involved in direct readout. T36 and R46 recognise the first three 
bases in the C--box. In monomer A (red), R35 recognises the conserved G3. The R35 in monomer 
B (brown) contacts the conserved G17 on the same DNA strand as the C--box is recognised as 
there is no G in an equivalent position on the opposite strand.  
Protein DNA Bond 
Chain Residue Atom Chain Residue Atom Length (Å) 
A 
Arg35 
NH1 C G3 N7 3.24 
NH2 C G3 O6 2.65 
Thr36 OG1 D C16 N4 2.88 
Arg46 
NH1 D G14 N7 3.28 
NH2 
D G14 O6 3.06 
D T15 O4 3.18 
B 
Arg35 
NH1 C G17 N7 3.29 
NH2 C G17 O6 2.82 
Thr36 OG1 C C15 N4 3.11 
Arg46 
NH2 C G13 N7 3.27 
NH1 C T14(W) O4 2.77/2.87 
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 2.1 Å. The 19mer OL structure overcame both of the limitations inherent in the 
tetrameric complex structure and highlights the differences between the 
recognition of the two half sites of OL. 
 
The protein is able to recognise DNA sequences that obey different symmetries. 
The flexible loop that was observed in the free protein plays a fundamental role in 
breaking the symmetry of the protein dimer and permits base-specific interactions 
with a variety of related DNA sequence motifs. The GTC bases in the C-box are 
recognised by T36 and R46 and the conserved T2/G3 and G17 are recognised by the 
R35, albeit to different extents (figure 6.23). In order for the R46 in chain B to 
interact with the DNA bases in the second half-site, the flexible loop adopts the 
minor conformation as the protein is oriented differently with respect to the 
C-boxes. The R46 in the minor loop conformation cannot perform direct readout of 
the DNA as one DNA contact is water mediated. However, the C15 is still recognised 
by T36 and R46 can distinguish between purine and pyrimidine at the G13 position. 
 
The DNA is bent by ~41° via a compression of the minor groove at the conserved 
TATA sequence. This deformation of the DNA is likely to play a role in indirect 
readout by the protein. The 25mer DNA structure shows that binding of a dimer to 
OL is sufficient to cause an expansion of the major groove between OL and OR. This 
enlarged major groove permits interactions between dimers via E25 and R35 as 
seen in the repression complex. This induced DNA structure extending into the OR 
site may play an important role in the cooperative recruitment of a C.Esp1396I 
dimer to OR to form the tetrameric repression complex. 
 
Many other known and putative C-protein recognition sites are similar to that 
found in the Esp1396I restriction-modification system (Sorokin et al., 2009). This 
suggests that a similar mechanism of recognition may be present (i.e. the 
recognition of the two different DNA symmetries through a flexible loop region).  
The C-boxes and the other conserved elements (e.g. TG, TATA) are equally 
important for sequence recognition, as was seen by the mutational analysis of the 
promoter sites performed by Bogdanova et al. (2009). However, C.Esp1396I also 213
 has a recognition site upstream of the methyltransferase gene that has a higher 
binding affinity than OL. The differences between the affinity of C.Esp1396I and its 
three recognition sites are discussed in chapter 5. 
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 Chapter 7: Structural analysis of the 
dimer bound to OM 
7.1 Introduction 
C.Esp1396I is capable of binding to three distinct operator sequences, but with 
different affinities. Binding of a dimer to OM down-regulates transcription of the 
methyltransferase gene and binding of a dimer to OL up-regulates transcription of 
the C/R operon (Bogdanova et al., 2009). Once a dimer is bound to OL a second 
dimer can bind cooperatively to OR which down-regulates transcription of the C/R 
operon. SPR analysis of the binding affinities (chapter 5) are in close agreement 
with fluorescence anisotropy measurements performed by Bogdanova et al. 
(2009) in which C.Esp1396I binds with highest affinity to the OM sequence and 
with lowest affinity to the OR sequence.  
 
The two conserved elements present in C/R promoter (the C-boxes and TG - TATA) 
obey different symmetries, with the pseudo dyad axis shifted by half a base pair. 
The OM sequence also contains these elements but they are arranged 
symmetrically with the pseudo dyad axis lying between the central AT. A 
comparison of the three operators (OM, OL and OR; figure 7.1) demonstrates that 
both OL and OR lack the TG - CA inverse repeat. In OL the C-boxes are arranged 
non-symmetrically with respect to the TATA and in OR one C-box is mutated from 
GACT to GATT.  
 
Despite the differences between the operator sequences, C.Esp1396I is able to 
recognise these three sequences, albeit with varying affinity. The OL complex 
structure presented in chapter 6 identified amino acid residues that perform both 
direct and indirect readout of the sequence and that the DNA is significantly bent 
at the TATA site. In order to determine the mechanism by which the OM sequence 
is recognised by C.Esp1396I, the crystallisation of a dimer of C.Esp1396I bound OM 
was attempted using an oligonucleotide that should promote crystallisation of the  215
Figure 7.1: The DNA sequences of the three operators to which C.Esp1396I binds. 
The C-boxes are highlighted in red and the other conserved elements are underlined. 
OM: 5’-TGTAGACTATAGTCGACA 
OL: 5’-TGTGACTTATAGTCCGTG 
OR: 5’-GTGTGATTATAGTCAACA 
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 complex in a single orientation. In addition, this complex structure could provide 
insight into why the affinity between C.Esp1396I and OM is significantly stronger 
than between C.Esp1396I and the OL sequence. 
7.2 Data collection and refinement 
7.2.1 Crystallisation 
The DNA containing OM was designed to promote the crystallisation of the complex 
in a single orientation in a similar manner to the OL complex. The DNA consisted of 
an 18 bp duplex with 5' overhangs of A on one strand and T on the other. 
C.Esp1396I was purified as described in section 3.3 and was incubated with the 
DNA at varying ratios (1:1, 1.5:1, 2:1, 2.5:1, 3:1 and 4:1 protein monomer:DNA) 
prior to crystal screening. The protein-DNA complex was subjected to sparse 
matrix screening using the Honeybee robot (Cartesian) to set up sitting drops. 
These screens were incubated at either 4°C or 16°C and were checked for evidence 
of crystallisation by polarising light microscopy (Leica MZ12-5) at regular 
intervals. The complex demonstrated a propensity to precipitate and formed very 
small crystals which could not be checked for diffraction quality on the home 
source (Excalibur Nova, Oxford Diffraction). These initial micro crystals were 
crushed and used to seed further drops in an effort to promote the formation of 
larger crystals by supplying a nucleation point. These seeding attempts were 
similarly unsuccessful and micro crystals formed in the majority of the drops.  
 
Further screens were set up containing the complex and the additive spermidine at 
a final concentration of 10 µM. This reduced the number of conditions in which 
crystals formed (permitting optimisation of the initial conditions) and larger 
crystals formed in some drops (e.g. PACT 5: 0.1 M SPG buffer (succinic acid, 
phosphate, glycine) pH 8, 25% w/v PEG 1500). Larger hanging drops (2 µL 
complex, 2 µL mother liquor) were set up and incubated at 16°C. The diffraction 
quality was assessed and it was noted that the quality was highly variable even 
between crystals from the same drop. Often the crystals formed in clusters and had 
to be manually separated before being mounted in a loop or the crystals were 
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 hollow rods. The crystals that formed in the PACT 5 condition provided the most 
consistent diffraction quality and usually formed as single crystals, so this 
condition was optimised. 
 
The optimisation screens of PACT 5 were carried out using protein-DNA complex 
at a ratio of 2:1 (protein:DNA) in which the final DNA concentration was ~ 20 µM. 
The complex was incubated in the presence of 20 µM spermidine prior to 
crystallisation. Sitting drops were set up using 2 µL complex and 2 µL mother 
liquor. The initial condition (0.1 M SPG buffer pH 8, 25% w/v PEG 1500) was 
optimised by varying the pH from 7 to 8.5 (in 0.5 unit increments) whilst 
simultaneously varying the PEG 1500 concentration from 5-30 % w/v (in 5% 
increments). The screens were incubated at 16°C and checked at regular intervals 
using polarising light microscopy. The resulting crystals still had varying 
diffraction quality and many duplicate screens were set up to provide an increased 
probability of obtaining good crystals. This variability in the diffraction quality 
prevented the optimisation of the cryoprotectant and the crystals were 
cryoprotected in 30 % v/v glycerol. The crystals were cryocooled in liquid nitrogen 
and stored prior to exposure to synchrotron radiation. The crystal that gave rise to 
the final OM structure formed in 0.1 M SPG buffer pH 8, 25% w/v PEG 1500 with 
spermidine at a final concentration of 10 µM in the drop. 
7.2.2 Structure solution and refinement 
Cryocooled crystals of the OM complex were exposed to synchrotron radiation on 
ID14-4 at the ESRF (Grenoble). A selection of crystals was screened using the 
automated sample changer and datasets of the most promising crystals were 
collected at 100 K using an ADSC 4Q CCD detector. Often the crystals were split or 
hollow and diffraction data quality was poor which prevented indexing. Over 100 
crystals were screened, most of which were low resolution and/or twinned. Data 
was collected from a single needle-shaped crystal and reflections extended to 
~ 2.7 Å. The crystal did not appear to be twinned but the data were very 
anisotropic in one orientation. The OM complex crystallised in space group P21 and 
180 images were collected with an oscillation angle of 1°.  
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 The data was processed and scaled using MOSFLM/scala as this provided better 
integration statistics than processing the data using XDS/XSCALE. The overall 
completeness of the data was 98.9% (99.7% in highest resolution shell) with an 
overall Rmerge of 6.6% (20.1% in highest resolution shell). The collection and 
refinement statistics are shown in table 7.1. 
 
The scaled data was phased by molecular replacement using Phaser (McCoy et al., 
2005). Chains A and B of the OL structure along with 10 base pairs from the OL 
structure (chains C and D) were used as separate ensembles to search for a 
replacement solution. The OM structure contained two complexes (i.e 2 dimers 
bound to DNA) in the asymmetric unit (figure 7.2). The structure was refined to 
2.8Å using iterative cycles of Refmac (Murshudov et al., 1997) and real-space 
refinement in Coot (Emsley & Cowtan, 2004). NCS and TLS restraints were used in 
Refmac and the missing bases were manually added into interpretable electron 
density using Coot. The restraints used in refinement are shown in table 7.2. 
Waters were added manually in Coot as the electron density maps were fairly 
noisy and automatic water finding over-interpreted the density. The final structure 
refined with R/Rfree = 19.6/23.7% and contained all 76 DNA bases (38 per duplex) 
and the following amino acid residues: 2-77 (chain A), 2-78 (chain B), 1-77 (chain 
E) and 4-78 (chain D). Chains A-D comprise one complex and chains E-H comprise 
the second complex found in the asymmetric unit. Chains A and E are equivalent as 
they bind to the DNA in the same position (determined by the non-symmetric base; 
figure 7.2b) and chains B and F are also equivalent. The non-symmetric bases were 
identifiable during the building of the DNA duplex, in particular the thymine, which 
could be identified through the C5 methyl group. 
 
The OM DNA was designed as an 18 bp duplex with an overhanging base at the 5' 
end of each strand. In chains C/G the overhanging base was an adenine and in 
chains D/H it was a thymine. The design of the oligonucleotide was based upon the  
design of the oligonucleotide used to form the OL complex as this had overcome 
symmetry averaging problems and promoted a single orientation of the complex 
through triple helical interactions at the DNA ends (see section 6.2.2). However, 219
Data collection 
Space group     P21    
Unit-cell parameters (Å, o)   a = 47.5, 
          b = 147.1,   
          c = 47.8,   
        α = γ = 90,  
          β = 93.7  
Resolution limits (Å)    45.4 – 2.7 (2.85 – 2.7) 
Rmerge* (%)     6.6 (20.1)    
I/σ(I)      7.4 (3.8)    
Completeness (%)    98.9 (99.7)  
Redundancy     3.5 
Refinement model statistics 
No. of unique reflections   17783   
Rcryst/Rfree
ǂ (%)     19.6/23.7    
No. of atoms 
Protein      2496 
DNA      1546 
Water      8     
B-factors (Å2) 
Protein      31.8 
DNA      35.6    
Water      34.8    
R.M.S deviations from ideal 
Bond lengths (Å)    0.015    
Angles (o)     2.1    
Table 7.1: X-ray crystal data, refinement and model statistics for the OM complex 
structure. Values in parentheses are for the highest resolution shell.  
 
* Rmerge = ∑hkl∑i|Ii(hkl) - «I(hkl)»|/∑hkl∑iIi(hkl),  where «I(hkl)» is the mean intensity of 
reflection I(hkl) and Ii(hkl) is the intensity of an individual measurement of reflection 
I(hkl).  
ǂ Rcryst = ∑hkl│|Fobs| - |Fcalc|│/∑hkl|Fobs|, where Fobs is the observed structure-factor 
amplitude and Fcalc is the calculated structure-factor amplitude. Rfree is the same as Rcryst 
but for 5% of structure-factor amplitudes which were set aside during refinement.  220
Figure 7.2: The OM complex structure. (a) The OM complex crystallised with two 
complexes in the asymmetric unit (light and dark green). The eleven water molecules 
present in the structure are shown as blue spheres and the chloride ion is shown as a 
yellow sphere. The DNA consisted of an 18 bp duplex with 5' overhanging bases which 
promoted a single orientation of the complex in the crystal. (b) The binding sites of the 
C.Esp1396I chains are shown with the C-boxes highlighted in red. The pseudo dyad 
symmetry axis is shown as a blue line between the central AT and the non-symmetric 
bases are shown in yellow boxes. 
OM: 5’-TGTAGACTATAGTCGACA 
Chain A/E Chain B/F 
b 
Chain C/G: ATGTAGACTATAGTCGACA 
Chain D/H:  ACATCTGATATCAGCTGTT 
1  5  1 0  1 5  1 9  
1  5  1 0  1 5  1 9  
a 
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Refinement 
Resolution limits (Å) 50 - 2.8 
B-factors Isotropic 
Weighting 0.04 
Scaling Babinet 
NCS 
No. of groups 1 
Chains in group All protein chains 
Residue range (restraint 
level) 
5-75 (tight) 
TLS 
No. of groups 10 
Description Individual chains (A,C,D,F,G,H) 
Residues 1-41,48-79 (B,E) 
Residues 42-47 (B,E) 
Table 7.2: Refinement parameters for the 19mer OM complex structure. 222
 this did not occur with the OM complex. Instead, the packing interactions in the OM 
complex promoted the formation of pseudo-continuous DNA via Watson-Crick 
base pairing of the 5' - A and 5' - T overhangs (figure 7.3). 
 
During the initial stages of refinement, no NCS restraints were placed upon the 
flexible loop regions (residues 43-46). It was noted that in two of the four protein 
chains in the asymmetric unit, there was poorly defined density in this region. 
Figure 7.4 shows a comparison of the density for the loop regions in chains A and 
B. In chain B the sidechain of R43 and the whole of the S45 are omitted as the loop 
was in the process of being manually rebuilt. The density suggests that the loop 
most likely followed the minor conformation seen in chain A (overlaid as thin 
lines). This poor density was also present in chain E and upon closer inspection, it 
appeared that the R43 and K17 sidechains from chains B and E were involved in 
packing interactions, probably mediated by solvent. Figure 7.5 shows the packing 
interactions of chains B and E with a chloride ion placed in the solvent density. The 
bond distances are too large for the coordinated atom to be a water. Also, the 
coordinating residues all have a positive charge which would suggest that the 
coordinated ion would have a negative charge. As sodium chloride was present in 
the protein purification buffer, it is likely that the coordinated ion is a chloride. 
 
Chains A and F do not suffer from poorly defined density in the loop regions. As 
these chains bind to different halves of the operator sequence (and are therefore 
non-equivalent) it appears that both chains in a single complex exhibit the minor 
loop conformation. Additionally, both monomers in a single complex are 
orientated identically with respect to the DNA sequence (section 7.3). Due to the 
packing forces between chains B and E, the fact that the non-equivalent chains (A 
and F) had clearly defined loops in the minor conformation and that each 
monomer is orientated the same with respect to the DNA, subsequent rounds of 
refinement was carried out with tight NCS restraints applied to all loop regions 
based on the conformation of chain A (table 7.2). The NCS restraints for the entire 
protein (residues 5-75) including the loop regions were tightened from the default 
values (NCS position: 0.05, NCS B-factor: 0.5) to constrain the dimers to be 223
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Figure 7.4: The density surrounding the flexible loops in the OM complex 
structure. The grey mesh represents the |FO|map, the blue mesh represents positive 
difference density and the red mesh represents negative difference density from a 
|FO|-|FC| map. The  |FO| map is contoured at 2σ and the |FO|-|FC| map is contoured at 3σ. 
(top panel) The map and model are taken from an early stage during the refinement 
process in which no NCS restraints were placed upon the loop region. (a) The loop 
region from chain A. (b) The loop region from chain B. The R43 sidechain is missing and 
the entire S45 residue is also missing in this model. The thin lines represent an overlay 
of chain A onto chain B and show the direction that the loop region may take in chain B. 
(c) The final model. This is the same overlay as in (b) with tight NCS restraints 
employed (using chain A as the master chain) and the loop fully built. 
a b 
c 
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Figure 7.5: The loop regions may be involved in crystal packing interactions. The 
grey mesh represents |FO| map, the blue mesh represents positive difference density 
and the red mesh represents negative difference density from a |FO|-|FC| map. The 
|FO|map is contoured at 1.5 σ and the |FO|-|FC| map is contoured at 2.7 σ. The R43 from 
chains B and E (light and dark green respectively) may be involved in crystal packing 
through solvent molecules (here represented by a chloride ion; yellow sphere). The 
black dashed lines represent hydrogen bonds with the distances given in Å. 226
 identical using final parameters of 0.01 and 0.1 (NCS position and NCS B-factor 
respectively). This also necessitated adjusting the overall refinement weighting in 
order to constrain the bond angles and bond lengths of the model. 
7.3 Comparison of the OM and OL complexes 
The OM complex was crystallised in order to determine the structural basis for the 
increased affinity between the C.Esp1396I dimer and the DNA when compared 
with the OL DNA sequence. Figure 7.6 shows the superposition of the OM and OL 
complexes. The global structures of the two complexes appear very similar and the 
backbone and sidechain positions are almost identical in some regions (figure 
7.6a). As discussed in chapter 6, there are alternative loop conformations (residues 
43-46) in OL that are also seen in the free protein structure. In the OM structure 
there is a single loop conformation present: the minor conformation (figure 7.6b). 
R46 in this loop involved in DNA sequence recognition in the OL complex and plays 
the same role in the OM complex (see section 7.4.2). In the OL complex the 
C.Esp1396I monomers were oriented differently with respect to the C-box (see 
section 6.4.2). Despite the two different loop conformations in the OL complex the 
same three bases (GTC) are able to be recognised. In the OM complex the two 
chains in the C.Esp1396I dimer are positioned in the same orientation with respect 
to the GTC bases that are recognised (figure 7.7). This orientation lies between the 
two orientations seen in the OL complex and the minor loop conformation is 
adopted in order to facilitate recognition of the OM promoter sequence.  
 
The high resolution (2.1 Å) of the OL complex permitted placement of solvent 
atoms in the structure and detailed analysis of the protein-DNA interaction 
identified many water-mediated interactions. The OM complex structure was 
refined to 2.8 Å and consequently there are fewer waters that can be located. A 
water that is notably absent in the OM complex structure is the water that mediated 
contact between R46 and the thymine in the C-box. The lower resolution also 
reduces the certainty with which atoms can be positioned. The density 
surrounding the DNA bases is such that it there is  a degree of inaccuracy in the 
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Figure 7.6: Comparison of the OM and OL complex structures. (top) The C.Esp1396I 
dimer bound to OM was superimposed upon the dimer bound to OL (RMSD = 0.359 Å 
across 447 main chain atoms). The OM complex structure is coloured green and the OL 
complex structure is coloured red. (a) The side chains in helix 1 are similarly positioned 
in both complexes. (b) The flexible loop region (residues 43-47) shows evidence of 
alternative conformations in the two complexes.  
a 
b 
a b 
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Figure 7.7: The orientation of the monomer with respect to the GTC recognition 
sequence. (left) The orientation of the C.Esp1396I monomers with respect to the GTC 
in the OM complex structure are almost identical. Chains A and D are light green and 
chains B and C are dark green. The GTC bases of chains C and D were superimposed 
across 61 atoms with an RMSD of 0.268 Å. (right) The orientation of the monomer with 
respect to the GTC in the OM complex lies between the orientations of the two monomers 
found in the OL complex. The two GTC sequences in OL (pink: chains B and C, red: chains 
A and D) were superimposed upon the GTC sequence in OM (chain D) with an RMSD of 
~3.2 Å (across 61 atoms). 229
 roll, twist, tilt etc. parameters. As the DNA is bent, the relative positions of the DNA 
bases with respect to one another cannot be reliably constrained.  
 
The OL complex permitted detailed analysis of the protein-DNA interactions due to 
the high resolution and lack of symmetry averaging. Symmetry averaging is not a 
problem in the OM complex either, but the relatively low resolution limits the 
analysis of the finer details of the protein-DNA interactions. 
7.4 Recognition of OM by C.Esp1396I 
7.4.1 DNA structure 
The OM DNA structure was analysed using the online CURVES server (Lavery et al., 
2009). At 2.8 Å resolution the density for the bases is relatively diffuse and does 
not provide adequate restraints to position the DNA bases (i.e. the bases can be 
rotated and translated within the density and still refine correctly). As the DNA is 
distorted it is not possible to restrain the base pair or step parameters as these 
parameters may vary considerably from standard B-form DNA (as demonstrated in 
the OL DNA analysis, section 6.4.3). The local DNA bend angle (calculated as the 
angle formed between the normals of adjacent base pairs) and the compression of 
the minor groove in the two complexes in the asymmetric unit (complex 1: chains 
A-D, complex 2: chains E-H) is shown in figure 7.8. Both complexes exhibit an 
overall bend angle of 56°. Additionally, both complexes show a similar degree of 
bending and minor groove compression at equivalent base pairs despite the fact 
that no NCS restraints were applied to the DNA during refinement. The minor 
groove width varies from ~ 10Å to ~ 2Å, being most severely compressed at the 
TATA sequence. The compression of the minor groove is accompanied by an 
increased bend angle per base pair and at the TATA sequence the local bend angle 
of the DNA increases.  This TATA site is present between each half-site in the three 
operators that bind C.Esp1396I. It is likely that these sites enable direct readout of 
the DNA sequence and this can only be accomplished if the DNA is sufficiently bent. 
 
230
Figure 7.8: The minor groove is compressed at the TATA sequence resulting in an 
increased DNA bend angle. The minor groove width (solid line) of the two complexes 
found in the asymmetric unit (complex 1: chains A-D, black and complex 2: chains E-H, 
green) decreases to approximately 2Å at the TATA sequence. This minor groove 
compression results in increased bending of the DNA (dashed lines). The blue dashed 
line represents the mean minor groove width for standard B-form DNA. 231
Table 7.3: Interactions between the protein and the phosphate backbone of the 
DNA in the OM complex. The values are for chain A which is representative of the four 
protein chains in the asymmetric unit due to the use of tight NCS constraints. 
Protein DNA Bond 
length 
(Å) Residue Atom Chain Residue Atom 
Arg-17 NH1 C T2 O1P 3.08 
Gln-24 
N C T2 O1P 2.74 
NE2 C G3 02P 2.51 
Asp-34 N D T14 O2P 3.11 
Tyr-37 OH D G13 O2P 2.50 
Ser-39 OG C G3 O2P 2.80 
Arg-43 NE C G3 O1P 3.21 
Asn-44 OD1 C T4 O2P 2.76 
Asn-47 ND2 D A12 O1P 3.34 
Ser-52 OG D G13 O2P 3.02 
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 The DNA in the OM complex has a higher overall bend angle (56°) than the DNA in 
the OL complex (41°). The fact that the bend angle is greater in the OM complex may 
be due to spacing of the conserved elements in the sequence. In the OL complex, the 
C-boxes are separated by 3 base pairs and are positioned non-symmetrically 
relative to the TATA sequence (figure 7.1). In the OM complex, the C-boxes are 
separated by 2 base pairs which are positioned symmetrically relative to the TATA 
sequence. The bend angle between the guanines (the G5 in figure 7.1 and the 
equivalent guanine on the complementary strand) in the two C-boxes is achieved 
using fewer base pairs in the OM complex, hence the increased bend per base pair. 
The overall axial bend angle is calculated through the summation of the local bend 
angles (which can occur in three dimensions). As the exact position of the base 
pairs is less well defined in the OM structure (due to lower resolution) the 
calculated axial bend is less accurate which may contribute to an erroneous 
estimation of the overall bend angle, although the angle appears to be ~ 50° when 
visually estimating the bend based on the angle made by the external base pairs. 
 
The compression of the minor groove is achieved through interactions between 
the phosphate backbone of the DNA and residues of C.Esp1396I. Residues Y37, S52 
and N47 play a critical role in the compression of the TATA as seen in the OL 
complex structure and the tetrameric repression complex structure, although the 
protein-phosphate backbone contacts are not limited to these residues (table 7.3). 
The Y37, S52 and N47 residues from two monomers interact with the backbone of 
both DNA strands either side of the TATA site and the distances between these 
residues in the two monomers define the angle by which the DNA is bent. 
7.4.2 Sequence readout 
Direct readout of the OM DNA sequence is accomplished by the sidechains of the 
amino acid residues Arg-35, Thr-36 and Arg-46 (figure 7.9). The two terminal 
amino groups of R35 recognise G3 through interaction with the N7 and O6. These 
interactions are present in both monomers in the complex (figure 7.10). Due to the 
application of NCS restraints, the position of the four R35 side chains in the 
asymmetric unit are identical with the guanidinium head group making a bidentate 
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Figure 7.9: Overview of the direct readout of the OM sequence by C.Esp1396I. The 
residues Arg35, Thr36 and Arg46 are involved in direct readout. T36 and R46 recognise 
the first three bases in the C--box. In one of the four chains (chain  F) the R46 also makes 
a water mediated contact with T14-. This interaction may be present in the other chains 
but the density is too unclear to be certain. The values in the table are for chain A which 
is representative of the four protein chains in the asymmetric unit due to the use of tight 
NCS constraints.  
Protein DNA Bond 
length 
(Å) Residue Atom Chain Residue Atom 
Arg35 
NH1 C G3 O6 3.20 
NH2 C G3 N7 3.12 
Thr36 OG1 D C15 N4 3.03 
Arg46 NH2 D G13 N7 3.02 
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Figure 7.10: The R35-G3 interaction. The four protein chains were overlaid with an 
RMSD of 0.07 Å (across 582 mainchain atoms). The density is shown for chain A and the 
hydrogen bond distances are given in Å. The grey mesh represents |FO| map, the blue 
mesh represents positive difference density and the red mesh represents negative 
difference density from a |FO|-|FC| map. The |FO| map is contoured at 2σ and the 
|FO|-|FC| map is contoured at 3σ. 235
Figure 7.11: The T36-C15 interaction. The interaction between chains A and D are 
shown. The hydrogen bond distances are given in Å. The grey mesh represents |FO| map, 
the blue mesh represents positive difference density and the red mesh represents 
negative difference density from a |FO|-|FC| map. The |FO| map is contoured at 2σ and 
the |FO|-|FC| map is contoured at 3σ. 
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Figure 7.12: The R46-G13 interaction. The interaction between chains A and D are 
shown. The hydrogen bond distances are given in Å. The grey mesh represents |FO| map, 
the blue mesh represents positive difference density and the red mesh represents 
negative difference density from a |FO|-|FC| map. The |FO| map is contoured at 2σ and 
the |FO|-|FC| map is contoured at 3σ. 
90o 
237
Figure 7.13: Comparison of the R46 interactions present in the OM and OL 
complexes. (top) The R46 interactions in chain B from both the OM (green) and OL (red) 
complexes are compared by superimposing the two chains (RMSD = 0.36 Å across 447 
main chain atoms). The black dashed lines represent hydrogen bonds with the distance 
given in Å. In both complexes the R46 interacts with the N7 of G13. In the OL complex the 
R46 makes a water mediated interaction with the O4 of T14. (bottom) The density in this 
region in the OM complex suggests that this water mediated contact could be achieved by 
placing a water in the difference density (arrow). When placed in this density the water 
molecule refined with a B-factor < 2 Å2 and was omitted from the final stages of 
refinement. In chain F in the OM structure there is sufficiently clear density to place a 
water molecule (B-factor: 29.6 Å2) to achieve the interaction seen in the OL structure. 
The grey mesh represents |FO| map, the blue mesh represents positive difference 
density and the red mesh represents negative difference density from a |FO|-|FC| map. 
The |FO| map is contoured at 2σ and the |FO|-|FC| map is contoured at 2.8 σ. 
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Figure 7.14: Indirect readout of the OM sequence by R35. (top) The conserved T2/G3 
steps are present in both halves of the operator (boxed). The R35 hydrogen bonds with 
the N7 and O6 of the G3 and the guanidinium head group π-stacks with the planar face of 
T2. (bottom) The R35 residue in chain A is shown. The black dashed lines represent 
hydrogen bonds between atoms with  distances < 3.3 Å. 239
 interaction with the guanine. The γ-hydroxyl of T36 recognises the amino group at 
position 4 of cytosine 15 (figure 7.11). This base forms part of the C-box and lies on 
the opposite DNA strand to the G3. The R46 recognises the N7 of G14 that also 
forms part of the C-box (figure 7.12). However, one of the terminal amino groups 
does not appear to make contact with DNA, protein or solvent. It is unlikely that a 
group with a partial positive charge and hydrogen bonding potential would not be 
counter charged. There appears to be density in two of the four monomers (chains 
B and F) to place a water which would permit R46 to make a water-mediated 
interaction with the carbonyl group at position 4 in T14. Refinement was carried 
out with water molecules located in the appropriate positions in the two 
monomers. The water in chain B refined with a B-factor of ~ 2 Å2 and was removed 
from subsequent rounds of refinement. The water interacting with monomer F was 
retained. This water-mediated interaction exists in the OL complex structure  in 
chain B which also contains the minor loop conformation (figure 7.13) but the 
density is insufficiently clear (due to NCS averaging) to determine if this 
interaction exists in all four of the monomers in the OM structure.  
 
As in both the OL complex and the tetrameric repression complex structures, the 
R35 is involved in both direct and indirect readout of the DNA sequence. The 
planar guanidinium head group of the arginine hydrogen bonds with the N7 and 
O6 of G3 but it is also involved in a π-stacking interaction with the planar T2 (figure 
7.14). The direct and indirect readout of the OM DNA sequence by C.Esp1396I is 
very similar to the readout of the OL DNA sequence. Due to the relatively low 
resolution at which the OM complex was solved, more subtle differences between 
the recognition of the two operators cannot be identified. 
7.5 Discussion 
The purpose of solving the OM complex structure was to determine the mechanism 
by which C.Esp1396I recognises the DNA sequence and to provide insights into 
why the affinity of the protein for OM is significantly greater than for OL. The OM 
complex structure was solved to 2.8 Å and the complexes crystallised in a single 
orientation. The OM sequence is recognised with the same residues that recognise 240
Table 7.4: Summary of the loop conformations present in C.Esp1396I in the three 
nucleoprotein complexes. The interactions made by the residues in the loop region are 
shown. Where the loop makes a base contact, the numbering of the base involved is 
shown in the schematic below the table. This schematic is a representation of the C-box 
sequence. Water mediated contacts are denoted with a (W). 
Structure 
loop conformation 
(chains) 
Typical residue contacts 
Arg-43 Asn-44 Ser-45 Arg-46 
OM complex Minor (A,B,E,F) Phosphate Phosphate Ser-10 G2 
OL complex 
Minor (B) 
Phosphate, 
Ser-39 
Solvent Ser-10 G2, T3(W) 
Major (A) Phosphate Ser-7 Gly-40 G2/T3 
Tetrameric repression 
complex 
Major (A-D) Phosphate Ser-7 Gly-40 G2 
5’- G-A-C-T 
3’- C-T-G-A 
4         3          2         1  
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 the OL sequence (R35, T36 and R46). In the case of the OL complex structure, the 
flexible loop regions (residues 43-46) are in two different conformations. In the OM 
complex structure, both loop regions adopt the minor conformation and the DNA 
recognition is symmetrical in each half of the operator. The R35 is capable of 
recognising the G3 through hydrogen bonding interactions and the R35 also 
participates in indirect readout of the conserved T2 through π-stacking. T36 
directly interacts with C15 and R46 is capable of distinguishing between purine and 
pyrimidine by binding to N7 of G13. As in chain B of the OL structure, R46 may also 
interact with O4 of T14 but the density is insufficiently clear to be able to place a 
water in the correct position to mediate this interaction in three of the four 
monomers. 
 
Due to the relatively low resolution and unclear density in two of the loop regions 
caused by packing interactions, further details of the protein-DNA interactions 
could not be readily determined. The DNA is significantly distorted and bent 
(particularly around the TATA site) but due to the low resolution the base pair and 
step parameters could not be reliably determined. However, it appears that the 
overall bend in OM (56°) is greater than that in OL (41°). This deformation of the 
DNA may play a role in the indirect readout of both sequences. 
 
These studies begin to provide an explanation for why OM has higher affinity for 
C.Esp1396I than does OL. To elucidate more subtle details of the molecular 
recognition mechanism, higher resolution structure would need to be determined,  
preferably without the packing forces found in two of the four loop regions. The 
presence of the flexible loop region in C.Esp1396I appears to be critical in 
permitting the recognition of the different operators (table 7.4) but the details will 
remain unclear until a higher resolution structure is solved. 
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 Chapter 8: Final Discussion 
8.1 Conclusions 
The aim of this project was to attempt to obtain structural information in order to 
determine which DNA symmetry the protein followed (either the C-box symmetry 
or the TATA symmetry) or indeed whether both symmetries could be 
accommodated. Additionally, detailed structural data would permit the 
identification of key residues involved in DNA binding and sequence recognition 
and would help in understanding how C.Esp1396I is able to recognise different 
operator sites with different affinities. To determine the affinity of C.Esp1396I for 
its operator sites, DNA binding studies were carried out, as was AUC to obtain the 
monomer-dimer equilibrium constant. During the course of this project, 
Bogdanova et al. (2009) published affinity constants for C.Esp1396I binding to OM, 
OL and OR that were obtained by fluorescence anisotropy measurements. The 
binding data generated from this project provided a cross-check on these values 
using an alternative method, surface plasmon resonance (SPR). Bogdanova et al. 
(2009) also defined the sequence of the C/R and M promoters, which permitted 
structural and biophysical studies to be carried out. 
 
During routine purification of C.Esp1396I it was noted that a crystalline precipitate 
formed upon removal of imidazole by dialysis. In order to improve the yield of 
purified C.Esp1396I for use in biophysical and structural studies the purification 
procedure was optimised. The final yield was improved from ~1.5 mg/L culture to 
~4 mg/L culture whilst maintaining a high purity. The final purification strategy 
involved nickel affinity chromatography after which the His-tag was removed by 
thrombin cleavage, followed by size exclusion chromatography. To obtain the 
higher concentrations required for structural studies, a final step of heparin 
affinity chromatography was used to concentrate the purified protein. The over 
expression of the Y29 mutant proteins was optimised and the final yields of the 
mutant proteins were equivalent to the yield of the native protein. The Y29S 
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 mutant of C.Esp1396I was more soluble than the native protein and remained 
soluble at concentrations of ~5 mg/mL.  
 
The structures of the native C.Esp1396I protein and an R35A mutant were solved 
by X-ray crystallography. The overall structure of the two proteins were found to 
be identical except for the mutated residue. The fact that the R35A mutant retained 
its tertiary structure meant that its greatly reduced affinity for DNA (shown by 
McGeehan et al., 2008) must be directly due to the loss of the arginine side chain. 
The structure of C.Esp1396I is similar to other C-protein structures (C.AhdI -
 McGeehan et al., 2005; C.BclI - Sawaya  et al., 2005) in that it consists of five 
α-helices joined by loop regions and contains an HTH motif (formed by helices 2 
and 3). The loop region between helices 3 and 4 (residues 43-46 inclusive) can 
adopt one of two distinct conformations, as seen in both free protein structures. 
The  minor conformation (seen in 2 of the 14 monomers present in the asymmetric 
unit of the native protein structure) is characterised by the side chain of N44 
pointing away from the core of the protein and the major conformation is 
characterised by the side chain of N44 pointing toward the core of the protein. 
These alternative loop structures were also seen in the nucleoprotein complexes 
and play a role in sequence recognition. The free protein structures were 
elucidated from crystals that formed by precipitation during routine purification. 
The Y29 residue was identified as being involved in packing interactions between 
dimers. This residue was then mutated to either a serine (Y29S) or a tryptophan 
(Y29W) by site-directed mutagenesis. The Y29W mutant of C.Esp1396I was 
designed to increase the extinction coefficient for use in AUC. Both Y29 mutants 
retained their affinity for DNA, confirming that the Y29 is not involved in DNA 
binding. 
 
The structure of the tetrameric complex solved by McGeehan et al. (2008) was 
relatively low resolution and was symmetry-averaged in this crystal form. Due to 
these limitations, relatively few interactions between the protein and DNA could 
be identified. The OL complex structure was solved at 2.1 Å resolution and the 
crystals did not show any non-crystallographic pseudo-symmetry-averaging. From 244
 the structure, three key residues involved in DNA sequence recognition were 
identified: R35, T36 and R46. It could be seen that T36 and R46 recognise the GTC 
within the C-box and R35 recognises a guanine in the other conserved symmetry 
element. Mutation of the R35 results in a protein with a drastically reduced affinity 
for its recognition sites (McGeehan et al., 2008). In the absence of a dimer bound to 
OR, the R35 in monomer B (the monomer bound to the proximal half of the 
operator) binds to the central conserved G. The dimer is able to  "hinge" about 
helix 5 and the distance between the recognition helices in the two monomers in 
the bound complex is ~1.4 Å greater than that seen in the free protein structures. 
 
The conserved TATA sequence permits bending of the DNA, which may play a role 
in indirect readout. The minor groove is compressed at the TATA sequence and 
Y37, N47 and S52 side chains are involved in stabilising the bend through 
interactions with the phosphate backbone. The loop region between helices 3 and 
4 exhibits different conformations in the two monomers. The monomer bound to 
the most distal half of the operator (monomer A) has a loop that is in the major 
conformation and the other monomer has a loop that is in the minor conformation. 
These flexible loops enable the protein to recognise both the C-boxes and the 
flanking TG, which follows a different symmetry. The binding of C.Esp1396I to the 
OL sequence is sufficient to cause an expansion of the major groove, as seen in the 
25mer structure, which may play a role in the cooperative binding of a second 
dimer to the OR site. 
 
The OM sequence is almost entirely symmetrical and there are no alternative 
symmetry elements present in the DNA. Additionally, the two C-boxes are 
separated by 2 bp as opposed to being separated by 3 bp in OL. In the OM complex 
structure R35, T36 and R46 are involved in direct readout of the DNA, as was the 
case in the OL complex structure. The residues responsible for stabilising the DNA 
bend are also the same in both nucleoprotein complexes. In the OM complex, the 
loop regions between helices 3 and 4 both adopt the minor conformation, in 
accordance  with the almost perfect dyad symmetry of the DNA sequence in this 
complex. 245
  
During the course of this investigation, Bogdanova et al. (2009) reported that the 
affinity with which C.Esp1396I binds to its operators is of the order OM > OL > OR. 
Their paper also provided an estimate for the monomer-dimer equilibrium 
constant (600 nM). Using a Y29W mutant of C.Esp1396I, the monomer-dimer 
equilibrium constant (Kdim) was determined as 1.62 µM (in the range 
0.88 - 2.99 µM) using AUC. This value for Kdim was used in the analysis of SPR data 
to determine the affinity of C.Esp1396I for its three operator sites. From this 
analysis, C.Esp1396I binds to OM, OL and OR with affinity constants (KD) of 0.61, 5.6 
and 121 nM respectively. Additionally, the binding of a dimer to OR once OL is 
occupied has a KD of 0.95 nM, indicating a cooperativity parameter of around 130. 
These values are of a similar magnitude to the values published by Bogdanova et 
al. (2009). A structural explanation for the differences in affinities between OL and 
OM could not be determined from the crystal structures as the OM complex 
structure is relatively low resolution, thus requiring the imposition of tight NCS 
restraints that could average subtle structural differences between subunits. In 
addition,  packing forces could well influence the flexible loop conformations in the 
crystal. Overall, however, the higher affinity for OM is likely to be related to the 
greater symmetry of this DNA sequence, and may be linked to the associated 
symmetry in the protein structure, in particular in the region of the flexible loop. 
8.2 Future work 
Currently for C.Esp1396I, the free protein structure, three nucleoprotein 
structures and binding data for the interactions have been obtained (McGeehan et 
al., 2008; Ball et al., 2009; Bogdanova et al., 2009). Bogdanova et al. (2009) also 
characterised the promoter regions and performed mutational analysis of the DNA 
sequence to determine the critical bases involved in recognition. However, there 
are a number of areas that require further investigation. A preliminary NMR study 
was performed on 15N-labelled C.Esp1396I and the data suggest that C.Esp1396I 
would be a suitable candidate for further study by NMR. In the free protein 
structure, the flexible loop between helices 3 and 4 is able to adopt two 
conformations. In the crystal structure these loops are static and it is impossible to 246
 determine whether these loops are freely flexible in solution and adopt a particular 
conformation upon DNA binding. NMR studies on free C.Esp1396I and on the 
protein in complex with its three operator sequences may be able to determine the 
behaviour of this loop region.  
 
The affinity of C.Esp1396I for OM is approximately 10-fold greater than for OL and 
approximately 200-fold greater than for OR. It was not possible to identify a 
detailed structural explanation for this difference in affinity between OM and OL 
through comparison of the nucleoprotein structures. The OL complex structure was 
sufficiently clear to identify residues involved in binding, whereas the OM complex 
structure was limited by resolution and unclear density in the flexible loop region. 
In order to determine the structural basis for the increased affinity of C.Esp1396I 
for OM, it is necessary to improve the resolution. Although many different 
conditions were screened to obtain the OM complex structure, there are alternative 
strategies that may be employed (e.g. varying the length of the DNA and/or varying 
the size and nature of the overhangs to permit crystallisation in other space groups 
or with different packing interactions). To be able to understand the structural 
basis of the much reduced affinity of C.Esp1396I for OR, the OR complex structure 
needs to be determined. Preliminary sparse matrix screens were set up on 
complexes with the OR operator during the course of this project and were 
unsuccessful, but the crystal trials were far from exhaustive.  
 
The functional role of the "key" residues that were identified from the OL complex 
structure should be tested experimentally. By mutating these residues and 
performing binding analysis, the importance of each residue for DNA binding can 
be determined. The contribution of residues E25 and R35 has already been 
determined (McGeehan et al., 2008) and some of the other residues are currently 
being analysed by the Biomolecular structure group at the University of 
Portsmouth.  
 
These investigations will improve the understanding of how the Esp1396I RM 
system is regulated and may be applicable to other similar RM systems. Through 247
 studying other C-proteins and their binding mechanisms, a wider picture of the 
general mechanism of regulation of RM systems can be obtained. In the longer 
term, this may lead to the potential for developing anti-bacterial agents that could 
disrupt the control of the RM system, leaving the bacteria vulnerable to invasion by 
bacteriophage although this is currently a distant prospect. 
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Y29S 
Forward Primer 
5' GGAATGACTCAAGAAGATTTAGCATCTAAATCAAACTTGGATAGAAC 3‘ 
 
Sequencing 
Appendices 
Appendix 1: Y29 mutagenesis 
The  plasmids resulting from mutagenesis were sequenced by GATC Biotech. The 
data below shows the primers used for mutagenesis (with the Y29 codon 
underlined and the mismatched base highlighted in green) and the raw 
sequencing data with the mutated codon boxed. 
Y29W 
Forward Primer 
5' GGAATGACTCAAGAAGATTTAGCATGGAAATCAAACTTGGATAGAAC 3‘ 
 
Sequencing 
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Appendix 2: SPR data analysis 
Derivation for one-site model 
 
         
  
       
 
where D is a C.Esp1396I dimer, DNAf is free (unbound) DNA and D:DNA is a 
complex between the dimer and the DNA. At equilibrium the dissociation constant 
(KD) is given by: 
 
                                     
         
       
 
 
and the fractional saturation of the binding sites is given by the number of 
occupied sites divided by the total number of sites: 
 
                                
 
    
 
       
              
 
 
Rearranging equation 1 to make [D:DNA] the subject and substituting into equation 
2 yields: 
 
                              
 
    
 
   
  
       
        
 
  
    
 
 
Cancelling the [DNAf] terms and solving for R: 
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Derivation for two-site model 
 
     
  
        
  
          
 
where D2:DNA represents two dimers bound to the DNA (one to OL and one to OR). 
The above schematic for the formation of a tetrameric complex can be split into 
two half reactions, each with its own dissociation constant: 
 
                                      
  
                             
          
       
 
 
                                     
  
                          
           
        
 
 
where KL is the dissociation constant associated with OL and KR is the dissociation 
constant associated with OR. The fractional saturation of the binding sites is given 
by the number of occupied sites divided by the total number of binding sites: 
 
                          
 
    
  
                
                            
 
 
Using equations 5 and 6, [D:DNA] and [D2:DNA] can be given in terms of [D] and 
[DNAf]: 
 
                                   
          
  
 
 
                                     
           
  
  
           
     
 
 
Substituting equations 8 and 9 into equation 7 yields: 
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Cancelling the [DNAf] terms and solving for R: 
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Appendix 3: NMR raw data 
An HSQC spectrum was collected for 15N labelled native C.Esp1396I-GSH. 
The 2D spectrum shows the shift for 15N on the F2 axis and the 1H shift on 
the F1 axis. 
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Appendix 4: NUCPLOT for the OL complex 
The NUCPLOT was generated by uploading the OL structure file to the 
PDBSum web server: http://www.ebi.ac.uk/pdbsum/. The plot shows the 
interaction between the DNA and either solvent or amino acid residues 
that lie within 3.35 Å. 
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Appendix 5: CURVES analysis of the OL DNA structure. 
The OL duplex (bases 2-19) was analysed using the online CURVES+ web server 
(http://gbio-pbil.ibcp.fr/cgi/Curves_plus) using the default settings. 
 
 
 
     **************************************               ************** 
     **** CURVES+ Version 1.2 12/2010  ****               *   5 Apr 11 * 
     **************************************               ************** 
 
 
  FILE : 19OL_DNA.pdb                      ftop :                                  
  LIS  : 19OL_DNA                          LIB  : standard                         
 
  WBACK :  2.90  WBASE :  3.50 
 
  ISYM  :     1  itst  :     0  itnd  :     0  itdel :     1 
 
  CIRC  :     F  LINE  :     F  ZAXE  :     F  FIT   :     T  TEST  :     F 
  ions  :     F  REFO  :     F 
 
 
  LS fitting of standard bases ...RMS max =  0.030 
 
  Strands =    2 Atoms =   773 Units =    38 
 
  Combined strands have   18 levels ... 
 
  Strand  1 has  18 bases (5'-3'): TGTGACTTATAGTCCGTG 
  Strand  2 has  18 bases (3'-5'): ACACTGAATATCAGGCAC 
 
  (A) BP-Axis        Xdisp   Ydisp   Inclin    Tip  Ax-bend 
 
    1) T   2-A  19   -1.23    1.11     4.1     0.9     --- 
    2) G   3-C  18   -0.54    0.11     1.0     2.2     0.9 
    3) T   4-A  17   -1.08   -0.49     3.6     3.4     1.0 
    4) G   5-C  16   -1.14    1.09     6.7    -1.0     1.2 
    5) A   6-T  15   -0.36    0.96     5.5    -2.1     1.8 
    6) C   7-G  14    0.27   -0.23     2.7    -5.5     2.7 
    7) T   8-A  13   -0.35   -0.46     1.9     0.7     3.8 
    8) T   9-A  12   -0.62   -0.36    -2.5    -4.1     4.3 
    9) A  10-T  11    0.03    0.15    -5.0    -1.4     4.3 
   10) T  11-A  10    0.09   -0.51    -5.3     0.1     4.1 
   11) A  12-T   9   -0.57    0.35    -6.7    -0.8     3.6 
   12) G  13-C   8   -0.18    0.05    -3.1     9.6     3.1 
   13) T  14-A   7   -1.09   -0.60     3.1     4.4     2.8 
   14) C  15-G   6   -2.28   -0.24     7.9     0.5     2.9 
   15) C  16-G   5   -1.94    0.87     6.5    -3.7     2.3 
   16) G  17-C   4   -1.11   -0.08    14.1     2.5     2.3 
   17) T  18-A   3   -1.98   -0.57    12.0    -3.2     2.6 
   18) G  19-C   2   -2.11    1.38    14.2    -8.0     2.6 
 
       Average:      -0.90    0.14     3.4    -0.3  Total bend =    41.3 
 
  
 
 
 
 
 
 
 (B) Intra-BP parameters 
 
  Strands 1-2       Shear  Stretch Stagger  Buckle  Propel Opening 
 
    1) T   2-A  19   -0.02   -0.14    0.09     4.7    -3.5     6.6 
    2) G   3-C  18   -0.40   -0.12    0.24     0.8    -6.9     2.9 268
  
    3) T   4-A  17   -0.06   -0.16    0.23    -2.7    -6.1     4.3 
    4) G   5-C  16   -0.02   -0.16    0.06     4.7    -4.4     0.6 
    5) A   6-T  15    0.11   -0.22    0.13    11.6    -9.2     3.4 
    6) C   7-G  14   -0.08   -0.05    0.20     8.4   -19.1     2.5 
    7) T   8-A  13    0.01   -0.06    0.24     4.7   -16.8     9.6 
    8) T   9-A  12   -0.09   -0.09    0.01     5.6   -10.2     3.3 
    9) A  10-T  11    0.01   -0.07   -0.07    -6.1    -5.2     5.0 
   10) T  11-A  10   -0.03   -0.04   -0.05     6.8    -3.3     8.9 
   11) A  12-T   9    0.09   -0.09    0.24    -7.9   -16.2     7.3 
   12) G  13-C   8   -0.16   -0.08    0.17    -8.0   -17.8     1.6 
   13) T  14-A   7   -0.01   -0.18    0.36   -13.8    -8.3     5.2 
   14) C  15-G   6    0.25   -0.27    0.15    -5.8    -9.5     1.3 
   15) C  16-G   5    0.09   -0.08    0.42   -15.7    -4.3     2.5 
   16) G  17-C   4   -0.14    0.01   -0.03   -15.9   -15.5     2.9 
   17) T  18-A   3    0.04   -0.09    0.55   -12.6    -8.2     9.4 
   18) G  19-C   2   -0.37   -0.04   -0.24    -3.3    -8.9     3.3 
 
       Average:      -0.04   -0.11    0.15    -2.5    -9.6     4.5 
 
  (C) Inter-BP       Shift   Slide    Rise    Tilt    Roll   Twist   H-Ris   H-Twi 
 
    1) T   2/G   3   -0.10   -1.13    3.34    -3.1     2.6    35.6    3.29    35.7 
    2) G   3/T   4   -0.61   -0.68    3.43     1.0     1.3    26.9    3.44    26.9 
    3) T   4/G   5   -0.37    0.94    3.22     0.8    -0.6    41.4    3.31    41.4 
    4) G   5/A   6    0.16   -0.28    3.14    -1.6     3.4    29.7    3.11    30.0 
    5) A   6/C   7    0.48   -0.93    3.37    -1.6     1.2    26.8    3.32    26.9 
    6) C   7/T   8   -0.38   -0.06    3.36     2.8    10.7    36.0    3.35    36.3 
    7) T   8/T   9   -0.01   -0.19    3.21     1.3    -4.1    39.3    3.23    39.4 
    8) T   9/A  10    0.67    0.18    3.55     2.9    -3.3    43.3    3.58    43.6 
    9) A  10/T  11    0.03   -0.56    3.05     0.2    -5.1    27.5    3.08    27.9 
   10) T  11/A  12   -0.47    0.77    3.74    -2.8    -9.3    48.5    3.65    49.1 
   11) A  12/G  13    0.39   -0.33    3.30    -1.6     5.9    32.0    3.30    32.0 
   12) G  13/T  14   -0.52   -0.80    3.44    -1.3    -5.4    36.2    3.46    36.4 
   13) T  14/C  15   -0.28   -0.58    3.05     0.5    -0.1    30.8    2.94    30.9 
   14) C  15/C  16    0.57   -0.41    3.53    -2.1     2.3    38.7    3.41    38.8 
   15) C  16/G  17    0.80   -1.40    3.13     6.4    12.4    23.9    2.80    25.2 
   16) G  17/T  18   -0.40   -0.94    3.22    -2.1     4.1    30.6    2.84    31.4 
   17) T  18/G  19   -0.13    0.59    3.17     7.5     6.4    38.2    3.10    39.6 
 
       Average:      -0.01   -0.34    3.31     0.4     1.3    34.4    3.25    34.8 
 
  (D) Backbone Parameters 
 
   Strand 1     Alpha  Beta   Gamma  Delta  Epsil  Zeta   Chi    Phase  Ampli  Puckr   
 
    1) T   2     ---- -174.8   64.0  135.7 -176.4  -92.2 -126.3  159.0   30.8  C2'en 
    2) G   3    -57.9 -170.3   34.0  132.2 -165.9 -102.2 -116.8  149.0   31.7  C2'en 
    3) T   4    -57.2  172.1   40.6  129.4 -147.7 -147.2 -113.6  136.2   39.7  C1'ex 
    4) G   5    -41.9  155.4   39.6  139.7 -174.3  -98.4  -99.6  176.2   32.0  C2'en 
    5) A   6    -56.4  174.2   37.6  128.3 -159.3  -72.6 -101.6  136.7   41.1  C1'ex 
    6) C   7   -113.4   93.2  147.5   84.7 -137.9  -83.7 -168.7   50.7   34.8  C4'ex 
    7) T   8    -63.3  173.9   59.4  134.6  178.4  -94.2 -115.2  159.6   28.2  C2'en 
    8) T   9    -63.3 -179.8   52.2  132.4 -178.9 -107.0 -104.4  152.4   36.3  C2'en 
    9) A  10    -58.2  173.7   52.4  133.4 -178.5 -101.1 -111.4  156.0   34.0  C2'en 
   10) T  11    -63.8  177.0   52.1  144.3 -107.5  173.3 -104.3  147.5   49.6  C2'en 
   11) A  12    -69.7  145.8   51.7  144.1 -166.7  -83.8 -118.5  165.7   36.9  C2'en 
   12) G  13    -79.3  170.2   50.5  112.9  152.0  -94.3 -114.3  119.8   46.7  C1'ex 
   13) T  14    -54.2 -160.3   52.7  139.3 -172.3  -93.4 -114.6  164.1   33.6  C2'en 
   14) C  15    -65.4  176.7   40.9  123.5 -173.7 -113.2 -113.4  128.1   40.8  C1'ex 
   15) C  16    -59.6  163.9   43.7   89.3 -173.7  -82.8 -147.0   45.9   36.3  C4'ex 
   16) G  17    139.6 -152.0 -170.5   79.9 -153.7  -77.3 -171.9   22.6   43.6  C3'en 
   17) T  18    -59.2  178.8   56.2  108.0 -166.2  -87.8 -147.0   53.0   16.0  C4'ex 
   18) G  19    -60.0 -177.2   56.0  147.4   ----   ---- -103.0  174.8   34.6  C2'en 
 
   Strand 2     Alpha  Beta   Gamma  Delta  Epsil  Zeta   Chi    Phase  Ampli  Puckr   
 
    1) A  19    -81.2 -176.8   30.4  120.2   ----   ---- -111.4  124.9   38.7  C1'ex 
    2) C  18   -107.4   71.9  175.3  126.9 -151.6  -67.5 -164.6  138.8   37.0  C1'ex 
    3) A  17    -25.3  143.7   28.7  145.3 -160.3  -65.1  -96.0  164.6   39.4  C2'en 
    4) C  16    -48.8  174.5   38.9  137.4 -148.2 -153.7 -107.3  148.3   41.8  C2'en 
    5) T  15    -61.3 -169.8   39.6  115.5 -173.9  -96.3 -119.3  118.0   33.9  C1'ex 
    6) G  14    -69.1  172.6   47.5  115.7  174.8  -89.3 -113.7  124.4   40.7  C1'ex 
    7) A  13    -65.3 -166.4   54.2  140.4 -171.5  -88.2 -106.5  162.8   36.2  C2'en 
    8) A  12    -59.9  154.4   49.5  144.8  175.5  -98.7 -122.5  165.3   37.1  C2'en 
    9) T  11    -66.4  177.8   56.0  138.6 -143.1 -165.4 -105.6  142.7   49.7  C1'ex 269
  
   10) A  10    -52.4 -178.6   44.5  139.2  169.4  -91.4 -102.8  174.8   30.5  C2'en 
   11) T   9    -55.1 -177.7   55.2  143.4 -177.3 -112.1 -106.7  166.8   36.6  C2'en 
   12) C   8    -56.4  142.3   55.6   82.4 -177.8  -84.3 -144.5   63.8   44.4  C4'ex 
   13) A   7    -69.2  178.4   45.6  129.0 -153.8 -125.3 -103.0  139.0   42.0  C1'ex 
   14) G   6    -54.7  177.8   51.3  142.2 -171.8  -88.4 -111.6  168.0   36.7  C2'en 
   15) G   5    -40.2  171.2   31.2  129.6 -170.5 -118.6 -117.0  147.4   35.8  C2'en 
   16) C   4    -60.5  162.7   44.0   91.4 -174.3  -94.9 -125.6   86.2   46.3  O1'en 
   17) A   3    -41.5  163.0   39.5  139.9 -170.7  -87.9 -105.9  169.9   28.7  C2'en 
   18) C   2     ----  165.0   41.7  121.1 -163.1 -138.9 -102.9  129.2   40.9  C1'ex 
 
  (E) Groove parameters 
 
   Level           W12     D12     W21     D21 
 
    1.5                                        
    2.0  G   3                                 
    2.5                                        
    3.0  T   4                                 
    3.5            6.2     5.3                 
    4.0  G   5     6.8     5.2                 
    4.5            7.4     4.6                 
    5.0  A   6     7.8     4.1    11.5     6.4 
    5.5            7.5     4.6    10.4     5.6 
    6.0  C   7     6.7     5.1     9.6     5.4 
    6.5            5.9     5.0    10.6     6.1 
    7.0  T   8     4.9     4.7    11.8     5.5 
    7.5            3.5     5.3    11.8     0.6 
    8.0  T   9     2.4     5.6    12.0     4.2 
    8.5            2.4     5.8    11.7     3.9 
    9.0  A  10     2.5     6.1    11.6     3.8 
    9.5            1.5     6.2    12.3     3.6 
   10.0  T  11     1.7     6.0    12.4     2.8 
   10.5            2.9     5.5    12.7     2.4 
   11.0  A  12     4.0     4.9                 
   11.5            3.6     5.5    13.0     5.5 
   12.0  G  13     3.6     5.8    11.5     5.0 
   12.5            4.8     5.1    10.7     5.2 
   13.0  T  14     6.1     4.4    10.9     6.1 
   13.5            6.9     4.2    12.5     7.4 
   14.0  C  15     7.4     4.0    12.9     8.2 
   14.5            7.8     4.0                 
   15.0  C  16     8.4     3.3                 
   15.5            8.8     3.4                 
   16.0  G  17     8.9     3.4                 
   16.5                                        
   17.0  T  18                                 
   17.5                                        
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ABSTRACT
Controller (C) proteins regulate the timing of the
expression of restriction and modification (R–M)
genes through a combination of positive and nega-
tive feedback circuits. A single dimer bound to the
operator switches on transcription of the C-gene
and the endonuclease gene; at higher concentra-
tions, a second dimer bound adjacently switches
off these genes. Here we report the first structure
of a C protein–DNA operator complex, consisting of
two C protein dimers bound to the native 35bp
operator sequence of the R–M system Esp1396I.
The structure reveals a role for both direct and indir-
ect DNA sequence recognition. The structure of the
DNA in the complex is highly distorted, with severe
compression of the minor groove resulting in a 508
bend within each operator site, together with a large
expansion of the major groove in the centre of
the DNA sequence. Cooperative binding between
dimers governs the concentration-dependent acti-
vation–repression switch and arises, in part, from
the interaction of Glu25 and Arg35 side chains at
the dimer–dimer interface. Competition between
Arg35 and an equivalent residue of the p70 subunit
of RNA polymerase for the Glu25 site underpins the
switch from activation to repression of the endonu-
clease gene.
INTRODUCTION
Restriction–modiﬁcation (R–M) systems play a pivotal
role in modulating the horizontal transfer of genes in
bacterial populations - a major factor in the transmission
of antibiotic resistance between bacterial species (1).
The emergence of multi-drug-resistant strains through
horizontal transfer of antibiotic resistance genes repre-
sents an increasing threat to world health. An
understanding of R–M systems, and of their regulation,
is thus of signiﬁcant microbiological and biomedical
interest.
R–M systems encode a restriction endonuclease and
a DNA methyltransferase. The action of the DNA
sequence-speciﬁc methytransferase (M) protects the host
DNA from cleavage by an associated restriction enzyme
(R), and the speciﬁc methylation pattern of the host R–M
system allows the discrimination of ‘self’ from ‘non-self’
DNA (2). This ancient form of innate immunity provides
a basis for the selective destruction of foreign DNA.
Clearly, expression of the endonuclease prior to protection
of the host DNA by the methyltransferase would be lethal.
Thus there are a variety of control mechanisms that ensure
the correct temporal expression of R–M genes. One
common mechanism employs a ‘controller’ (C) protein
encoded by a gene downstream of its own promoter,
which is co-transcribed with the endonuclease gene from
a common promoter (3–7). The C-protein binds to the
C/R promoter to regulate transcription of its own gene
and the associated endonuclease (R) gene (8).
Biochemical and biophysical analysis in recent years has
revealed the general features of this genetic switch (9,10).
X-ray crystallographic analysis of the controller protein
C.AhdI showed it to be a dimer consisting of two 74 aa
subunits, each containing a helix-turn-helix (HTH) motif,
and a weak dimer interface consistent with a relatively
high Kd (2.5 mM) for dimerization (11). Low-level expres-
sion of the C-protein from a weak promoter leads to a
delay in transcription until suﬃcient protein accumulates
to form a functional dimer. The C-protein dimer activates
transcription of the C/R operon, forming a positive feed-
back loop, leading to an exponential increase in C-protein
expression; at higher concentrations, a second dimer is
recruited to the promoter, displacing RNA polymerase
and thereby repressing transcription of its own gene
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(and hence expression of the R gene) in a negative feed-
back loop (Figure 1).
This simple but elegant control circuit has been con-
ﬁrmed by in vitro transcription assays and has been suc-
cessfully modelled mathematically (12). A similar control
circuit is likely to apply to other C-protein-regulated sys-
tems, PvuII being the best studied of these (13). The time
delay in expression of the C and R genes, relative to the
M gene, when establishing a new R–M system has recently
been experimentally veriﬁed in vivo (14).
Bioinformatic analysis of known and potential
C-protein binding sites has identiﬁed a repeating sym-
metrical consensus sequence consisting of four symmet-
rical ‘C-boxes’ GACTnnnAGTCnnnnGACTnnnAGTC
upstream of the C/R genes (6,8). However, the degree of
sequence homology between species is moderate and the
internal symmetry between ‘C-boxes’ is far from perfect
(Figure 2A). The operator sequence includes binding sites
(denoted OL and OR) for two C-protein dimers (9). The
left-hand operator sequence, OL, is distal to the gene and
is believed to activate transcription through favourable
interactions with the s70 subunit of RNA polymerase,
bound at the -35 site that overlaps with OR. The right-
hand operator sequence, OR, is proximal to the gene and
binding of a second dimer to OR blocks s
70 binding to the
-35 site, thus switching oﬀ the C/R genes (9–11).
It is notable that the GT in the centre of the proposed
consensus sequence is more highly conserved than the
proposed tetranucleotide recognition sequences (13), but
clearly lacks dyad symmetry. The proposed 3 bp ‘spacers’
within the left and right operator sequences are equally
well conserved, the consensus being TAT. Within the sym-
metrical framework discussed above (Figure 2A), the two
TAT ‘spacer’ sequences are not related by dyad symmetry,
and nor do they have internal symmetry. If the protein
dimer were centred on this sequence, the dyad axis of
the dimer would pass through the central A.
However, we note that if the pseudo-dyad axis relating
the two operators is shifted by half a base (i.e. centred on
T rather than GT), then although the pseudo-dyad
between AGTC/GACT sequences is lost, instead there
would be perfectly symmetrical TATA sequences at the
centre of each operator (Figure 2B). In this case, the
dyad axis of each dimer would be located between
the central A and T bases of the TATA ‘spacer’.
Without structural analysis, it is not possible to predict
which of these symmetries is adopted by the nucleoprotein
complex.
Since these ‘spacer’ sequences are so strongly conserved,
they are likely to play an important structural role.
Figure 2. Pseudo-symmetry of the C.Esp1396I DNA binding site. (A) the original C-box symmetry with a pseudo-dyad centred on GT; (B) an
alternative symmetry centred on the central T, which is deduced from the structure of the nucleoprotein complex; (C) sequence of the DNA duplex
used to form nucleoprotein complexes for crystallography. In (A) and (B), the location of pseudo-dyad axes within operators (blue) and between
operators (red) are shown as dotted lines. In (C), nucleotides involved in DNA–protein interactions in the crystal structure of the complex are
indicated in blue. When discussed in the text, nucleotides on the lower strand are indicated with a prime ( 0 ).
O
R
O
L C-gene
−10
−35
on
σ
off
σ
Figure 1. The genetic switch regulating the timing and expression of
R–M genes. The -35 (green) and -10 (red) transcriptional signals are
indicated upstream of the C-gene (blue) and the R-gene (not shown).
C-protein dimers are shown in pink and the sigma subunit of RNA
polymerase in yellow. Low-level C-protein expression occurs from a
weak C-independent promoter (not shown). Occupation of the high
aﬃnity OL site by C-protein dimers stimulates transcription of the C-
gene via recruitment of RNA polymerase sigma subunit to the -35 site;
at higher concentrations of C-protein, occupation of the OR site dis-
places the subunit and down-regulates the C- and R-genes.
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Circular dichroism indicates that a large structural defor-
mation is induced in the DNA when each C.AhdI dimer
binds to the operator (15). Circular permutation gel assays
show that binding of a C.AhdI dimer results in a sub-
stantial (508) bend in the DNA. It was proposed that
these structural distortions could arise from the TAT
(or TATA) ‘spacers’ since these sequences are frequently
found in bent DNA structures (15). However, in the
absence of detailed structural data, the precise nature of
the conformational changes in the DNA that are induced
by C-protein binding remain unknown.
To investigate the structure and symmetry of C-protein/
DNA complexes and provide insight into the structural
deformation of the DNA and relevant intermolecular con-
tacts, we are carrying out a systematic study of C-protein
complexes with a variety of DNA sequences. Here, we
investigate the DNA-binding properties of the controller
protein of the Esp1396I R–M system, and report the ﬁrst
crystal structure of any C-protein–DNA complex. In addi-
tion, we have used site-directed mutagenesis to elucidate
the role of key amino acid residues implicated in coopera-
tive binding between adjacent protein dimers on the DNA.
Our results reveal the mechanism whereby cooperative
binding of dimers to the DNA operator governs the
switch from activation to repression of the C and R genes.
MATERIALS AND METHODS
Protein and DNA purification
Large-scale cultures of Escherichia coli BL21 (DE3) cells
bearing the plasmid pET-28b/esp1396IC were grown, har-
vested and disrupted by sonication. Cell lysates were pur-
iﬁed by chromatography on a His-Trap HP column, the
His-tag removed by thrombin digestion, dialysed and the
protein re-applied to the His-Trap column. The ﬁnal pro-
tein sequence following thrombin cleavage includes an
N-terminal tripeptide Glycine-Serine-Histidine in addition
to the native sequence. Site-directed mutagenesis was per-
formed as previously described (11) and mutant proteins
puriﬁed as above. DNA duplexes were prepared by
annealing equimolar quantities of each oligonucleotide
strand, and slowly cooling to room temperature; correct
formation of double-stranded DNA was conﬁrmed by
native polyacrylamide gel electrophoresis.
Electrophoretic mobility shift assays (EMSAs)
Electrophoretic mobility shift assays were performed
using non-denaturing electrophoresis on 8% polyacryla-
mide gels as previously described (10). C.Esp1396I
was incubated at various concentrations with 240 nM
g-33P-labelled DNA duplex at 48C for a period of
30min. Gels were run at 100V for 90min, dried and ana-
lysed on a phosphorimager. The 35 bpWT sequence cor-
responds to that in Figure 2C. Additional 35 bp
oligonucleotide duplexes in which the right or left opera-
tor sequences have been mutated to a random sequence
(indicated in bold) were also used for EMSAs. The
sequences of these were as follows:
OL (OR mutated):
ATGTGACTTATAGTCCGTCTAGCCTAGCCTAGCCT
TACACTGAATATCAGGCAGATCGGATCGGATCGGA
OR (OL mutated):
CTAGCCTAGCCTAGCCGTGTGATTATAGTCAACAT
GATCGGATCGGATCGGCACACTAATATCAGTTGTA
DNA bending assays
DNA bending assays were performed as described else-
where (15) using the native 35 bp promoter (OL + OR)
and an equivalent 35 bp sequence with the intact OL and a
randomized OR (as deﬁned above). Relative mobilities
(y = Rbound/Rfree) were plotted as a function of the posi-
tion of the binding site (x) and ﬁtted to the quadratic
function y= ax2  bx + c, where a=b= 2c(1 cos a),
from which the bend angle a could be determined (16).
Crystallization and data collection
Crystallization was carried out at the High Throughput
Crystallization Laboratory of the EMBL Grenoble
Outstation employing vapour diﬀusion sitting drops of
100 nl nucleoprotein solution and 100 nl mother liquor.
Pure C.Esp1396I protein (0.7mg/ml) was mixed with pur-
iﬁed double-stranded 35-mer DNA at a 4 : 1 molar ratio.
Crystals of dimensions 30  30  10 mm grew within
1 month at 208C in 50mM MES, pH 7.5, 25% MPD,
40mM MgCl2. The crystals were vitriﬁed directly in
a cold N2 gas stream at 100K from an Oxford
Cryosystems 700 series Cryostream (Oxford Cryosystems
Ltd., Oxford, UK). Data were collected at beamline
ID29 at the ESRF, Grenoble, France, employing a
custom-designed pinhole (R. Ravelli & F. Felisaz,
EMBL Grenoble) producing a 25 mm spherical low diver-
gence beam suitable for small crystals. A total of 100
18 oscillation images were collected at 0.9787 A˚ wave-
length on an ADSC Q315R mosaic CCD detector.
Structure determination and refinement
Data were integrated and scaled using XDS and XSCALE
(17). Molecular replacement was performed with the pro-
gram Phaser (18) using a single chain from the C.BclI
dimer (PDB entry 2B5A). Four monomers were placed
consecutively and, following solvent ﬂattening and density
averaging using DM (19), the DNA chains were built
manually using COOT (20). Simulated annealing was
performed using PHENIX (21) and iterative reﬁnement
using REFMAC5 (22) employing non-crystallographic
restraints and TLS parameterization. The ﬁnal model
was reﬁned to 2.8 A˚ and contains four protein chains
with residues 2–77 (chains A and D) and residues 2–78
(chains B and C) together with the complete 35-mer
DNA duplex. There is a single tetramer–DNA complex
in the asymmetric unit with a solvent content of 69%.
There are no residues in disallowed regions of the
Ramachandran plot. DNA parameters were calcu-
lated using CURVES (23,24), contact analysis with
NUCPLOT (25) and all structure ﬁgures were produced
using PyMol (26).
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RESULTS
Binding of C.Esp1396I to DNA operator sites
Previous studies on C.AhdI have shown the existence of
two operator sequences upstream of the C.AhdI gene
(OL and OR). Occupation of the high-aﬃnity distal site
(OL) leads to activation of transcription, and binding of
a second dimer to the weaker proximal site (OR) represses
the gene (9,10). C.AhdI was the ﬁrst C-protein structure to
be determined, but we have been unable to produce sui-
table crystals of DNA–protein complexes with C.AhdI to
date. We therefore turned to a study of the closely related
C-protein, C.Esp1396I.
We ﬁrst investigated by EMSA the interaction of
C.Esp1396I with 35 bp DNA sequences corresponding to
the operator region upstream of the C/R gene. Titrating in
C.Esp1396I to the native operator DNA (Figure 3) shows
that tetrameric complexes predominate, as was the case
with the related protein C.AhdI (10). Mutation of the
OR operator results in the loss of tetrameric complexes
so that only dimeric complexes can form; mutation of
the OL operator, however, results in complete loss of
DNA binding as the protein cannot bind to OR alone.
The binding of a second dimer to form tetrameric com-
plexes on the native operator DNA is highly cooperative,
since binding to the intrinsically low-aﬃnity OR site
cannot occur unless a dimer is already bound to OL.
DNA bending assays were used to see whether binding
of dimers and tetramers induced bending in the DNA. By
introducing the 35 bp operator sequence into a plasmid
with a series of paired restrictions sites, the position of
the DNA binding site across a 1 kb fragment can be
varied (15,27). Bending of the DNA results in decreased
mobility of complexes when the protein is bound in
the centre of the sequence, relative to the mobility when
bound at the end of the fragment. From an analysis of the
relative mobilities, the bend angle can be estimated (16).
Figure 4 shows the results of the bending assay for
dimeric and tetrameric complexes (the former using just
the OL sequence and the latter using the intact operator,
OL + OR). Clear diﬀerential mobilities are observed in
both cases, but are more pronounced with binding of
the dimer. Fitting the data to the equation derived by
Ferrari et al. (16) leads to an estimate of a bend angle of
518 for the dimeric complex and 438 for the tetrameric
complex. As was the case for C.AhdI, binding of two
dimers results in an overall bend angle less than that
for binding of a single dimer (15), implying that the
two dimers do not bind to the same face of the DNA
(as indeed is expected, since the centres of the two binding
sites are separated by 15 bp). However, they cannot be on
exactly opposite sides of the DNA since the net bend angle
should then be close to zero. Indeed, this interpretation is
conﬁrmed by the crystal structure (see below).
Crystal structure of the tetramer complex
In order to elucidate the structure of the tetrameric
(repression) complex, we crystallized a complex with the
native 35 bp operator sequence (Figure 2C) using a 4 : 1
protein:DNA ratio. The best crystals diﬀracted to a reso-
lution of 2.8 A˚. Using molecular replacement, based on
the structure of the C.BclI dimer (28), we solved the struc-
ture of the protein–DNA complex (Table 1). All the amino
acid residues in the protein can be seen in the electron
density map, with the exception of 1–2 residues at the
N- and C-termini, and all 35 bp of DNA could be located.
T
D
F
WT OL OR
Figure 3. Analysis of binding to left and right operators by EMSA. The 35 bp oligonucleotide duplexes (240 nM) containing the native operator
(WT), the left-hand operator only (OL) or the right-hand operator only (OR) were incubated with C.Esp1396I at 0, 1, 2, 3, 4, 5, 6, 7 and 8 : 1
protein:DNA ratios. F= free DNA; D=dimer–DNA complex; T= tetramer–DNA complex. The sequences of the mutated operator duplexes are
given in Materials and methods section.
OL
OL + OR 
R
b
 / 
R
f
Flexure displacement
Figure 4. DNA bending assay. For complexes with both the native
operator (OR + OL) and the distal operator OL, relative mobilities
(y=Rb/Rf), were plotted against ﬂexure displacement (x) and ﬁtted
to the equation (18): y=ax2 bx+c, where a=b=2c(1 cosa).
For the former a=0.445, b=0.444, c=0.821 and for the latter,
a=0.732, b=0.660, c=0.910, giving bend angles of 518 and 438,
respectively.
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The tetramer complex was found to exist in two evenly
distributed orientations, related by the central pseudo-
dyad (Fig. 2B). The structure therefore represents an
average of two orientations. This crystallographic phe-
nomenon is well documented in pseudo-symmetric nucleo-
protein complexes (29) and is generally only apparent at
high resolution. Given the 2.8 resolution limit of our data,
the electron density is of high quality (Supplementary
Figure 1) and permits clear interpretation of the general
structural features of this complex. In addition, for the
20 bp of the DNA that are related by dyad symmetry,
clear details of the protein–DNA interactions can be seen.
The protein structure is similar to that of C.AhdI, con-
sisting of 5 a-helices, but with an extension of helix 5
resulting from the additional 10 residues at the C-terminus
(Supplementary Figure 2). The dimer interface includes a
network of inter-subunit hydrogen bonds involving the
side chain of Asn47, together with a number of main
chain interactions (Figure 5A), similar to those seen in
the free C.AhdI dimer. However, the more extended
helix 5 allows more extensive contacts to be made at the
dimer interface (buried surface area, 1900 A˚2 c.f. 1400 A˚2
for C.AhdI), consistent with the lower Kd (i.e. tighter
binding) of C.Esp1396I [Kd  0.6 mM, c.f. 2.5mM for
C.AhdI (9)].
The overall structure of the complex (Figure 5) com-
prises two dimers bound to the DNA, each centred on
the pseudo-dyad at the TATA sequence that is found at
the centre of each operator site. The two dimers are bound
to approximately opposite faces of the DNA, as antici-
pated from the DNA bending assays. The two dimers
are related by a 1508 rotation and a 53 A˚ translation
along the DNA helix, the latter being close to the expected
value for a separation of 15 bp between centres (Figure 6).
However, the 1508 rotation, rather than 1808, implies a 308
unwinding of the DNA between the two dimer binding
sites. The overall organization of the DNA–protein com-
plex is quite diﬀerent to that of the tetrameric  CII com-
plex (30), where the protein dimers are on the same face of
the DNA helix, resulting in a large interaction interface
between dimers in the tetrameric complex.
Each subunit interacts with the DNA by inserting helix
3 of the classical HTH motif into the major groove of
DNA, either side of the central TATA within each opera-
tor. The two protein dimers are related by a dyad axis that
coincides with the pseudo-dyad axis lying within the cen-
tral T:A base pair of the 35 bp duplex.
As discussed earlier, previous predictions had placed the
pseudo-dyad at the centre of the conserved GT dinucleo-
tide step (G17-T18), since this conforms to the symmetry
of the idealized GACT—AGTC—GACT—AGTC repeat-
ing C-box sequence (6). However, this is clearly not the
case in the crystal structure of the C.Esp1396I–DNA com-
plex. Instead, the central pseudo-dyad at the T18/A18’
base pair relates the two TATA sequences by a two-fold
rotation (as in Figure 2B). It had previously been noted
(13) that the TAT element of this sequence was at least as
highly conserved between C-proteins as the GACT/AGTC
repeat (6,8). The structural basis for this conservation is
now clear. Moreover, the TG sequence (T2–G3) on the 50
side of the operator sequence and the CA on the 30 side
(C33–A34) are also highly conserved between C-proteins,
although on the original scheme, they were not symmetri-
cally related (Figure 2A). With T18 as the centre of sym-
metry, as observed in the crystal structure of the complex,
these four base pairs are now related by the pseudo-dyad
axis (Figure 2B).
Structural distortion of DNA occurs at TATA sites
The DNA in the complex displays a major kink at the
centre of each of the operator sequences (Figure 5), in
accordance with the results of the circular permutation
assays. From the crystal structure, the overall bend at
each operator is estimated as 508, which is close to
that observed in the gel assay (518). Figure 7 plots the
major and minor groove width across the DNA sequence.
The minor groove width is remarkably narrow (2 A˚) at
each TATA site, compared to typical values of around 7 A˚
elsewhere. In addition, there is a smaller local narrowing
of the minor groove in the centre of the 35 bp sequence
(GTG), where the groove width changes locally
from 8.5 A˚ to 6 A˚. In contrast, the major groove
width is only slightly increased (to 13 A˚) around the
TATA sequences, but increases quite drastically to 16 A˚
at the centre of the DNA binding site.
The severe compression of the minor groove at the
TATA sites is stabilized by interactions of the phospho-
diester backbone (at the 30 end of each strand in both
TATA sequences) with the side chains of Ser52 and
Tyr37 from each of the four subunits (Figure 5C). There
may be additional interactions with the DNA backbone in
this region involving amino acid residues at the dimer
Table 1. Data collection and reﬁnement statistics
Tetramer–DNA
complex (Native)
Data collection
Space group P65
Cell dimensions
a, b, c (A˚) 104.48, 104.48, 139.29
a, b, g (8) 90, 90, 120
Resolution (A˚) 20.0–2.8 (2.9–2.8)
Rmeas 4.6 (41.8)
I / sI 33.7 (4.8)
Completeness (%) 98.5 (98.5)
Redundancy 6.3 (6.2)
Reﬁnement
Resolution (A˚) 19.1–2.80
No. of reﬂections 21,157
Rwork/Rfree 0.207/0.239
No. atoms
Protein 2496
Ligand/ion 1431
Water 4
B-factors
Protein 94
Ligand/ion 96
Water 31
RMSDs
Bond lengths (A˚) 0.007
Bond angles (8) 1.328
4782 Nucleic Acids Research, 2008, Vol. 36, No. 14
276
N47
L48
T49
I50
K51
Helix4 
N47
L48
T49
I50
K51
Helix4 
R35
G17
E25
R35
Y37P28 P13
S52
S52
R35
G3Y37
A B
C D
Figure 5. Structure of the C.Esp1396I–DNA complex. Protein subunits are shown in yellow (subunit A), green (subunit B), pink (subunit C) and
blue (subunit D). Details are shown of (A) hydrogen bonding at the dimer interface; (B) two alternative R35 contacts from the central subunits B and
C, involving both protein–protein and protein–DNA interactions; (C) protein–DNA interactions stabilizing the compressed minor groove around
TATA; (D) R35 contacts to the conserved guanine, G3 (outer subunits, A and D).
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interface (Asn47 and Thr49) but the details are indistinct
at this resolution. In addition, the bent conformation of
the DNA is stabilized by interactions from Gln24 and
Arg43 (and possibly Ser39) of each of the four subunits
with the phosphodiester backbone at the extremities of
each operator site (nucleotides 1, 2 and 17, 18 on each
strand).
The role of Glu25 and Arg35 in stabilizing the
tetrameric complex
The relative orientation of the two protein dimers in the
complex is such that Arg35 and Glu25 of neighbouring
subunits (Subunits B and C) can make contacts between
positively and negatively charged side chains to stabilize
the tetrameric complex (Figure 5B). To test whether these
interactions were indeed stabilizing the tetrameric complex
and contributing to the cooperativity of binding, we sepa-
rately mutated Arg35 and Glu25 and checked the DNA
binding activity of the mutant proteins by EMSA
(Figure 8). In order to conﬁrm their structural integrity
prior to binding studies, C.Esp1396I wild-type, E25A and
R35A proteins were puriﬁed and crystallized individually
in the absence of DNA. Preliminary diﬀraction studies
indicate that all three crystallize with identical unit cell
dimensions in the same space group.
As anticipated, the E25A mutant shows greatly reduced
cooperativity, and thus destabilizes tetramer formation on
the intact operator DNA. More surprisingly, for R35A,
DNA binding was completely abolished. The reason for
the inability of the R35A mutant to bind to the operator
DNA becomes apparent from the structure of the com-
plex; the R35 side chains of the outer subunits (A and D)
are in contact with the conserved G3 base on each strand,
through paired hydrogen-bond interactions between
the guanidinium group of Arg35 and the O6 and
N7H-bond acceptors of guanine G3 in the major groove
(Figure 5D). The loss of two strong H-bonds at each site
will severely weaken the interaction with the operator.
The E25 mutation, however, does not completely abol-
ish cooperativity (Figure 8), and a further contribution
almost certainly arises from distortion of the DNA. The
major groove is signiﬁcantly widened where the HTH
motif inserts into the major groove of the DNA and this
is most noticeable at the centre of the sequence (Figure 7),
where two adjacent HTH motifs are located in the tetra-
meric complex (Figure 5). This is consistent with the
unwinding of the DNA helix between the two operator
sites, as deduced from the DNA bending assays. Binding
of subunit B of the ﬁrst dimer would assist the second
dimer to bind DNA by opening up the major groove to
more easily accommodate the HTH motif from subunit C.
This distortion of the major groove between the two
operators therefore represents an additional contribution
to cooperativity.
DISCUSSION
Our understanding of the recognition of DNA sequences
by proteins is far from complete and it is becoming clear
that there is no simple ‘read-out’ code involving passive
DNA and protein structures (31,32). Frequently both
‘direct’ and ‘indirect’ read-out mechanisms are employed
to achieve speciﬁcity e.g. as seen in the bacterial transcrip-
tional activator catabolite activator protein (AP) (33). In
eukaryotic transcription factors, a combination of read-
out mechanisms can also be found; for example, Hox pro-
teins detect DNA shape in the minor groove, in addition
to base pair recognition in the major groove (31,34).
Figure 6. Topology of the tetramer–DNA complex. The relative posi-
tion of the two dimers (shown in green and blue) is illustrated with
respect to the approximate DNA axis. The overall bend angle of 438
results from the two individual bends imposed by each dimer, which are
related by a 1508 rotation about the helix axis (rather than 1808 that
would cancel the overall bend).
Major
Minor
TATA TATA
Figure 7. DNA distortion in the complex. Variation in major (red) and
minor (blue) groove widths in the crystal structure of the C.Esp1396I
DNA–protein complex are plotted across the 35 bp DNA sequence.
Groove parameters were obtained using the program CURVES.
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We propose that a similar dual read-out mechanism
applies to C-protein recognition of the operator sequences
preceding the C/R genes, but with some unusual features.
Indirect read-out
Indirect readout by C.Esp1396I is based on a number of
structural features in the DNA backbone that must be
recognized (or induced) by the protein: severe compres-
sion of the minor groove at TATA sequences where
there is a major kink at the centre of each operator, and
expansion of the major groove around the central GTG
between operator sites. In total, we can identify 36 inter-
actions to the DNA backbone (8–10 from each subunit),
including a number from positively charged arginine side
chains.
These interactions are concentrated into two areas: (i) at
the extremities of each operator and (ii) either side of the
TATA sequences at the centre of each operator. The com-
pression around TATA is accomplished by phosphodie-
ster backbone interactions with Ser52 and Tyr37
(Figure 5C). The side chains of Arg17, Gln24, Ser39 and
Arg43 of subunits B and C around the central GTG sta-
bilize the conformation of the phosphodiester backbone
deﬁning the wide major groove. Some, but not all, of the
equivalent side chains from subunits A and D also make
symmetry-equivalent interactions to the phosphodiester
backbone near the 50 end of each DNA strand. All of
the above amino acid residues are very highly conserved
between C-proteins, with the exception of Ser39 and
Ser52, which are frequently replaced by Gly or Asn,
respectively (11).
There is evidence from circular permutation gel assays
that the DNA is not intrinsically bent, as diﬀerential mobi-
lity is not seen in the free DNA; moreover, the pronounced
structural deformation of the DNA observed by circular
dichroism is clearly induced by C-protein binding (15).
Thus the interactions of the C-protein with the DNA back-
bone are responsible for deforming its structure; the
sequence of the DNA is also crucial, as it must be capable
of assuming this bent conformation without too big an
energy penalty. TATA sequences are known to be easily
deformable and are frequently found in bent DNA struc-
tures in DNA–protein complexes (35). It is notable that the
compression of the minor groove that we see at the TATA
sites is in stark contrast to the expansion of the minor
groove in TATA box recognition by TATA-box binding
protein (TBP) (36). In the latter case, the expansion is
caused by insertion of aromatic side chains of the protein
into the DNA minor groove; for C.Esp1396I, the minor
groove of the DNA contracts due to the interactions of
amino acid residues of the protein with the phosphodiester
backbone of the DNA, which pulls the two strands
together across the minor groove.
Direct read-out
Direct readout is provided by the insertion of helix 3 of
C.Esp1396I into the major groove of DNA. However,
there is likely to be some plasticity in these interactions
to accommodate the lack of true symmetry between adja-
cent operators. Indeed, across species there is also sub-
stantial variation in C-box sequences, even when the
recognition helices of the C-proteins are identical. The
clearest interactions to the DNA that are visible at this
resolution are from the side chains of Arg35, and interac-
tions from Arg46 and Thr36 are also likely. Again, it is
notable that all three residues are highly conserved in this
family of C-proteins, although occasionally conservative
changes (Lys and Ser, respectively) are found at the latter
two sites (11).
The Arg35 guanidinium group (subunits A and D)
interacts with G3 of each DNA strand, each forming
two H bonds to the base (Figure 5D). These guanines
are strongly conserved across a wide variety of C-protein
binding sites (6,8), as is Arg35 in the recognition helix of
the C-protein (11). The adjacent base T2 is also highly
conserved, perhaps because of the very limited intra-
stand base stacking (but signiﬁcant inter-strand stacking
of the purines) that is typical of TpG (= CpA) steps (37).
This allows the planar guanidinium group of Arg35 to
stack with the exposed face of the thymine base whilst
forming hydrogen bonds to the edge of G3 (Figure 9).
The symmetrically equivalent interactions from the
Arg35 side chains of subunits B and C, however, cannot
occur with this DNA sequence (or indeed any other) as a
guanine would be required at position 18 on both strands
(i.e. a GG base pair at the centre of the 35 bp sequence). In
fact, a T:A base pair is located at this site; moreover, this
T, together with the G on its 50 side, is very highly con-
served, suggesting that the GT might be essential for the
function of the genetic switch (13). We note that the side
chain of arginine is long and suﬃciently ﬂexible to make
alternative contacts in the major groove of the DNA, pos-
sibly to the O6 and N7 of G17 (Figure 5B). Indeed, a small
displacement and a rotation of the guanidinium group of
T 
F 
T
D
F F 
WT E25A R35A
Figure 8. Analysis of E25 and R35 mutants. Wild-type C.Esp1396I, and mutant proteins E25A and R35A were analysed by EMSA. Proteins were
incubated with a 35 bp dsDNA fragment (240 nM) corresponding to the native operator sequence at protein:DNA ratios of 0, 1, 2, 3, 4, 5, 6, 7 and
8:1. Free DNA (F), dimer–DNA complex (D) and tetramer–DNA (T) complex are indicated. The E25 mutation causes the formation of dimers
rather than tetramers. The R35 mutation abolishes all speciﬁc nucleoprotein complexes.
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Arg35 of subunit B would allow it to hydrogen bond
simultaneously with both the O4 of T18 and the O6 of
G17. Although the electron density map in this region is
not of suﬃcient clarity to be unambiguous, such an inter-
action could provide a plausible explanation for the high
conservation of the central GT. The equivalent interaction
from subunit C, however, cannot occur since the major
groove on the opposite strand is populated by amino
groups, rather than carbonyl groups. Instead, we propose
that the Arg35 side chain from subunit C contacts Glu25
of subunit B (Figure 5B), to bridge the two dimers and
stabilize the tetramer, rather than interacting with DNA
(as discussed below).
Stabilization of the repression complex
Repression of transcription requires the occupation of OR
by a C-protein dimer. Since the intrinsic binding of
C.Esp1396I to this site is weak, the ‘oﬀ switch’ is depen-
dent (at least in part) upon stabilizing the tetrameric com-
plex through energetically favourable interactions at the
dimer–dimer interface, resulting in binding of the second
dimer. However, there is very little contact between the
two dimers when bound to DNA, and there is no buried
surface area at the ‘interface’. In the crystal structure of
the complex, the only contact between dimers is between
Glu25 (subunit B) and Arg35 (subunit C). This electro-
static interaction between positive and negative amino
acid side chains of the ion pair contributes signiﬁcantly
to the strength of the dimer–dimer interaction and,
together with conformational changes in the DNA
induced by binding of the ﬁrst dimer to OL, is a major
contribution to the observed cooperativity.
We have shown that Glu25 is important for coopera-
tivity in binding two consecutive C.Esp1396I dimers. The
equivalent acidic amino acid, Glu34, in  repressor is
essential for transcription activation through its interac-
tion with s70 (Arg588) and the equivalent residue has been
suggested to play this role in activation of the C/R pro-
moter (11). We envisage that competition between the
Arg35 side chain of subunit C of C.Esp1396I and
Arg588 (or its equivalent) in the s70 subunit of RNA
polymerase for the negatively charged side chain of
Glu25 leads to competition for the -35 promoter site. It
is this competition that is primarily responsible for switch-
ing oﬀ transcription of the C/R genes at high concentra-
tions of C-protein.
Given the high level of sequence conservation between
the majority of C-proteins so far studied (8,11), we antici-
pate that our ﬁndings will be generally applicable to this
family of proteins (although there may be some subtle
variations in sequence recognition). The ‘spacer’ sequences
originally identiﬁed within C-protein binding sites (6,8)
are almost invariably Py-Pu-Py (usually TAT or CAT).
Moreover, these trinucleotide sequences are generally fol-
lowed by another purine, and all such tetranucleotide sites
(Py-Pu-Py-Pu) would be predicted to be bending sites (15),
even if they lacked the perfect symmetry of the TATA
sequences in the Esp1396I operators. Likewise, the GT
between operator sites is highly conserved, and is likely
to play a similar role in cooperative binding to that
we propose for C.Esp1396I, in which Arg35 plays a
crucial role.
Further understanding of the detailed molecular inter-
actions responsible for the speciﬁcity (and promiscuity) of
sequence recognition by C-proteins will require higher
resolution crystallographic studies of a variety of DNA
sequences, including smaller dimeric complexes, and
these are currently in progress. The current structure high-
lights for the ﬁrst time the principal structural features
that underpin the genetic switch that regulates gene
expression in R–M systems, and provides a paradigm
for a new class of protein–DNA complexes.
Accession code
Atomic coordinates and structure factor ﬁles have been
deposited in the Protein Data Bank with the accession
code 3CLC.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
T2 A34
C33
G3
R35
T2
A34
C33
G3
R35
90°
A
B
Figure 9. Interaction of Arg35 of subunits A and D with conserved TG
(=CA) sequences. Inter-strand stacking of purines A34 and G3, allows
T2 to stack with the planar guanidinium group of Arg35, which also
hydrogen-bonds to G3 in the major groove.
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The controller protein of theEsp1396I restriction–modification
(R–M) system binds differentially to three distinct operator
sequences upstream of the methyltransferase (M) and endo-
nuclease (R) genes to regulate the timing of gene expression.
The crystal structure of a complex of the protein with two
adjacent operator DNA sequences has been reported;
however, the structure of the free protein has not yet been
determined. Here, the crystal structure of the free protein is
reported, with seven dimers in the asymmetric unit. Two of the
14 monomers show an alternative conformation to the major
conformer in which the side chains of residues 43–46 in the
loop region flanking the DNA-recognition helix are displaced
by up to 10 A˚. It is proposed that the adoption of these two
conformational states may play a role in DNA-sequence
promiscuity. The two alternative conformations are also found
in the R35A mutant structure, which is otherwise identical to
the native protein. Comparison of the free and bound protein
structures shows a 1.4 A˚ displacement of the recognition
helices when the dimer is bound to its DNA target.
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PDB References: C.Esp1396I,
3g5g, r3g5gsf; R35A mutant,
3fya, r3fyasf.
1. Introduction
Bacterial restriction–modification (R–M) systems act as a
primitive ‘immune system’ that serves to protect the cell from
invasion by foreign DNA. R–M systems encode a restriction
endonuclease and a DNA methyltransferase. The DNA-
sequence-specific methyltransferase (M) protects the host
DNA from cleavage by the associated restriction enzyme (R);
the specific methylation pattern of the host R–M system allows
the discrimination of ‘self’ from ‘nonself’ DNA (Wilson &
Murray, 1991). The expression of M and R genes must be
subject to temporal control such that restriction activity is
delayed with respect to methylation, so that the bacterial
genome can be methylated and thus protected from the
possibility of subsequent endonuclease activity. This delay is
often accomplished by means of a regulator (or controller)
protein, the C protein, which is required for effective
transcription of its own gene and for transcription of the
endonuclease (R) gene found on the same operon (Tao et al.,
1991; Ives et al., 1992; Rimseliene et al., 1995; Vijesurier et al.,
2000; Cesnaviciene et al., 2003; Knowle et al., 2005).
Measurements of C-dependent transcriptional activity in
vitro have shown the time-dependence of the activity of this
switch (Bogdanova et al., 2008) and in vivo experiments have
directly demonstrated a time lag in the expression of the
endonuclease with respect to the methyltransferase (Mruk &
Blumenthal, 2008). Previous biochemical and biophysical
studies have revealed the general features of this genetic
switch in the AhdI R–M system (Streeter et al., 2004;
McGeehan et al., 2006; Papapanagiotou et al., 2007). In the
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R–M system Esp1396I, it has recently been shown that the C
protein has an additional function of binding to a high-affinity
site upstream of the M gene to repress expression of the
methyltransferase, thus forming part of an intricate control
network in the regulation of R–M activity (Bogdanova et al.,
2009).
The first controller-protein structure to be reported was that
of C.AhdI (McGeehan et al., 2004, 2005), which revealed a
dimeric -helical protein with a helix–turn–helix motif. A
similar structure was subsequently reported for C.BclI
(Sawaya et al., 2005). More recently, we reported the first
structure of a controller protein (C.Esp1396I) bound to its
DNA operator site (McGeehan et al., 2008), in which two
dimers were bound adjacently on the DNA to form a tetra-
meric complex. To enable comparison of the free and bound
forms of the protein and to identify possible conformational
changes when bound to DNA, we have crystallized and solved
the structure of the native C.Esp1396I protein dimer. The
results show that there is conformational heterogeneity of a
small loop region adjacent to the DNA-sequence recognition
helix. In addition, we report that the structure of a mutant of
C.Esp1396I in which a key residue (Arg35) has been mutated
shows a similar heterogeneity.
2. Materials and methods
2.1. Crystallization
The expression and purification of native C.Esp1396I was
performed as described previously (McGeehan et al., 2008),
with the exception that the six-histidine tag was retained.
Briefly, the protein was overexpressed from plasmid pET-28b/
esp1396IC in Escherichia coli BL21 (DE3). The cells were
then harvested and disrupted by sonication. Cell lysates were
applied onto a His-Trap HP column in high-salt buffer
[500 mM NaCl, 20 mM imidazole, 40 mM Tris–HCl pH 8,
5%(w/v) glycerol] and eluted by increasing the imidazole
concentration to 500 mM in a step gradient. Fractions were
pooled and placed in Spectrapor dialysis membrane (3000 Da
cutoff) and dialysed against 5 l low-salt buffer [150 mM NaCl,
20 mM imidazole, 40 mM Tris–HCl pH 8.0, 5%(w/v) glycerol,
2.5 mM CaCl2] at 277 K. A precipitate formed within the first
2 h of dialysis and was stored in a minimal amount of dialysate
at 277 K prior to cryocooling. Site-directed mutagenesis was
performed as described previously (McGeehan et al., 2005)
and the R35A mutant protein was expressed, purified and
crystallized identically.
2.2. X-ray diffraction data collection and structure
determination
The crystals obtained following dialysis were collected and
transferred to cryoprotectant solution (30% glycerol) prior to
cryocooling in liquid nitrogen. For the native protein crystal,
180 images with an oscillation width of 1.0 were collected at a
wavelength of 0.933 A˚, while 90 1.0 images were collected for
the mutant protein crystal owing to high anisotropy. Data
extending to 2.8 A˚ were collected at 100 K on beamline ID14-2
(ESRF, Grenoble) using an ADSC Q4 CCD detector and
processing was performed with either XDS and XSCALE
(Kabsch, 1993) or MOSFLM (Leslie, 1992) and SCALA
(Collaborative Computational Project, Number 4, 1994).
Molecular replacement was carried out using Phaser (McCoy
et al., 2005) and the structures were refined with reiterative
rounds of model building using Coot (Emsley & Cowtan,
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Figure 1
Light-microscope image showing typical precipitate crystals formed
during dialysis. Single crystals with an approximate largest dimension of
100 mm can be seen among many small and fragmented crystals.
Table 1
X-ray crystal data, refinement and model statistics.
Values in parentheses are for the highest resolution shells.
Native R35A
Data collection
Space group P65 P65
Unit-cell parameters (A˚, ) a = b = 128.72,
c = 137.51,
 =  = 90,
 = 120
a = b = 48.44,
c = 135.78,
 =  = 90,
 = 120
Resolution limits (A˚) 50–2.8 (2.9–2.8) 50–3.0 (3.1–3.0)
Rmerge† (%) 13.8 (39.0) 27.7 (45.5)
I/(I) 16.8 (7.7) 1.4 (1.9)
Completeness (%) 96.3 (93.7) 100 (100)
Refinement model statistics
No. of reflections 30225 3617
Rcryst/Rfree‡ (%) 23.7/26.9 24.9/26.7
No. of atoms
Protein 8696 1197
Water 4 0
B factors (A˚2)
Protein 33.09 56.74
Water 13.58 n/a
R.m.s. deviations from ideal
Bond lengths (A˚) 0.015 0.014
Angles () 1.579 1.690
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where hI(hkl)i is the mean
intensity of reflection I(hkl) and Ii(hkl) is the intensity of an individual measurement of
reflection I(hkl). ‡ Rcryst =
P
hkl

jFobsj  jFcalcj

=
P
hkl jFobsj, where Fobs is the observed
structure-factor amplitude and Fcalc is the calculated structure-factor amplitude. Rfree is
the same as Rcryst but for 5% of structure-factor amplitudes which were set aside during
refinement.
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2004) and TLS-based refinement using REFMAC5 (Mur-
shudov et al., 1997). NCS restraints were used throughout,
except in the loop region consisting of residues 43–46.
Analysis of the structural data was performed with SFCHECK
and PROCHECK (Collaborative Computational Project,
Number 4, 1994) and the figures were produced with PyMOL
(DeLano, 2002).
The native and mutant protein structures were deposited in
the PDB with codes 3g5g and 3fya, respectively.
3. Results and discussion
3.1. Crystallization and data collection
Traditional sitting-drop and hanging-drop vapour-diffusion
methods of crystallizing C.Esp1396I resulted in poorly
diffracting and often split crystals. Through serendipity, whilst
purifying the protein it was noticed that a precipitate formed
during routine dialysis of the His-tagged protein and this was
identified as crystalline in nature by polarizing light micro-
scopy (Leica MZ12-5). Single crystals were observed with
largest dimensions of approximately 200  75  75 mm.
Harvesting of these crystals (Fig. 1) followed by X-ray
screening in-house (Xcalibur Nova, Oxford Diffraction)
provided diffraction data that were sufficient for indexing.
Both the native and R35A mutant proteins crystallized in
space group P65, although their crystals had different unit-cell
parameters (Table 1). There was a strong tendency for splitting
of these crystals and, in addition to the presence of secondary
lattices, reflections were often smeared, resulting in poor data
quality. Following extensive screening using the ESRF/EMBL
SC3 sample changer, complete data were collected from both
native and mutant C.Esp1396I crystals, one from each of
the representative unit cells. The native data suffered from
poor spot profiles and proved difficult to process with
MOSFLM. XDS produced much improved integration
statistics, although despite strong intensities [overall I/(I) of
17] Rmerge remained high at 14%. The mutant data were much
weaker and also suffered from poor spot profiles. Processing
with XDS resulted in rejection of a high number of reflections,
compromising the overall completeness. MOSFLM was able
to process these mutant data with high completeness; how-
ever, this resulted in high Rmerge values. Following multiple
processing runs for both the native and the mutant data sets,
the best compromise between data quality and completeness
was achieved using XDS/XSCALE for the native data and
MOSFLM/SCALA for the mutant data. The data-collection
and processing statistics for both proteins are shown in Table 1.
3.2. Structure of native C.Esp1396I protein
The native structure was solved by molecular replacement
using a single monomer (chain A) from the previously solved
nucleoprotein structure (PDB code 3clc; McGeehan et al.,
2008) and yielded seven independent dimers in the asym-
metric unit. Despite the difficulties in processing these data,
the electron-density maps were of good quality (Fig. 2) and
refinement proceeded smoothly. Over 99% of the residues lie
in the preferred regions of the Ramachandran plot, with no
outliers, and the Rcryst/Rfree values and bond geometries are
reasonable for the resolution cutoff of 2.8 A˚ (Table 1).
As expected, the overall structure resembles that of the
protein in complex with DNA: a compact fold comprising five
-helices per monomer, each with a characteristic helix–turn–
helix motif. Resolution limitations prevent a comprehensive
comparison of side-chain conformations between the free and
bound proteins. However, the large-scale rearrangements of
the structure are clear. Superposition of the A chains of the
bound and the free proteins reveals a global movement of the
recognition helix 3 of approximately 1.4 A˚ (Fig. 3). This hinge
action is centred on the dimer interface mediated by helix 5
and is consistent with an opening of the dimer upon DNA
binding. The distance between the recognition helices of the
dimer is increased by approximately 1–1.5 A˚ when bound to
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Figure 2
Representative density of the two alternate loop regions in native C.Esp1396I. Residues 42–48 are shown for (a) chain A and (b) chain N. The 2Fo  Fc
electron-density maps are contoured at 1.5.
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DNA, which may contribute to the significant 54 bend of the
operator DNA (McGeehan et al., 2008).
3.3. Flexibility within the loop region may contribute to
DNA-sequence recognition
Within the 14 copies of the monomer found in the asym-
metric unit of the native protein, there are two that exhibit
variation in a loop structure close to the DNA-binding inter-
face (residues 43–46; Fig. 4a). Release of NCS restraints in this
region allowed the building and refinement of an alternative
loop conformation into clearly interpretable electron density
(Fig. 2b). Compared with the other 12 monomers, which all
show remarkably consistent density in this region, the minor
conformation present in chains L and N adopts a markedly
different backbone path. Residues from each of the two
conformations occupy favoured regions of the Ramachandran
plot and a schematic analysis of temperature factors (Fig. 5)
demonstrates B-factor values that are similar to those of other
loop regions in the structure. In fact, although the major loop
conformation has B factors that are around 14% higher
(38 A˚2) than the average for the whole structure (33 A˚2), the B
factors for residues 43–46 in chains L and N are 2–3% lower,
suggesting increased rigidity afforded by packing interactions.
Although higher resolution data are required to gain an
accurate refinement of the temperature factors, it appears
from these data that there is clear static disorder between two
alternative loop conformations in these crystals.
In the alternative loop conformation, individual C atoms
are displaced by up to 5 A˚ with significant side-chain re-
arrangement (Fig. 4b). This is evident for the side chain of
Arg46, where the NH2 group is displaced by 2.7 A˚ between
the two conformations, and more dramatically for residue
Asn44, where a rotation of approximately 180 about the C
atom results in a maximum displacement of the terminal O
atoms of around 10 A˚. This alternative conformation appears
only twice in 14 chains in the native protein and on both of
these occasions residue Arg43 is involved in intermolecular
hydrogen bonding to an adjacent monomer (residue Asp64).
Presumably, the free-energy difference between the two
conformations is small and reflects the local environment
afforded by specific packing interactions. It is possible that this
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Figure 4
The native protein has two distinct loop conformations. (a) All 14 monomers from the asymmetric unit have been overlaid (r.m.s.d. < 1 A˚ for 180 main-
chain atoms excluding residues proximal to the loop). (b) Chain A and chain N superimposed, highlighting the degree of side-chain movement between
the alternative loop regions (r.m.s.d. = 0.095 A˚ for 180 main-chain atoms excluding residues proximal to the loop). Chain A is shown in light colours and
chain N in dark colours; the side chains of Arg46, Ser45, Asn44 and Arg43 are shown in yellow, blue, red and green, respectively.
Figure 3
Comparison of free and bound C.Esp1396I structures. Chains A and B of
the free protein (red) and chains A and B of the DNA-bound protein
(green; PDB code 3clc) were overlaid, giving an r.m.s.d. of 0.39 A˚ (201
main-chain atoms). The recognition helix moves 1.4 A˚ upon DNA
binding as calculated by taking the average distances between
corresponding C atoms within the recognition helix.
285
region contributes to DNA binding and sequence-specificity:
this loop is located immediately adjacent to the recognition
helix 3, which inserts into the major groove of DNA. It is likely
that a direct readout mechanism operates to discriminate
between subtly different operator sequences. A degree of
flexibility in an extended recognition motif could help to
explain some of the features of this control system at the
biological level. C.Esp1396I has three cognate operator sites,
binding each site with a high degree of specificity and a range
of affinities over several orders of magnitude (Bogdanova et
al., 2009). In order to achieve this biologically important
discrimination, it is likely that the DNA-binding interface
incorporates a degree of structural flexibility. Whether this
loop region imparts the necessary degree of plasticity to
explain the binding mechanism of multiple recognition sites
will hopefully be revealed by high-resolution nucleoprotein
studies.
3.4. Solution and comparison of R35A mutant structure
Previous EMSA studies on this C protein indicated that the
single amino-acid change R35A completely abolished binding
to a cognate 35 base-pair operator site (McGeehan et al.,
2008). The C.Esp1396I protein–DNA structure revealed that
Arg35 is a strong hydrogen-bonding partner to a conserved
guanine located in the DNA-recognition sequence and also
stacks with the adjacent thymine base. However, full inter-
pretation of the EMSA binding data hinges on the structural
consequences of this mutation, since it could simply destabi-
lize the structure of the protein. The structural integrity of this
mutant protein was therefore explored by crystallography.
The R35A mutant protein crystals contained only one
dimer in the asymmetric unit. However, analysis of symmetry-
related chains revealed a packing arrangement resembling
that of the native protein: a small rotation and translation of
adjacent dimers relative to the native crystal packing resulted
in a significantly smaller unit cell. It is possible that a degree of
heterogeneity between these two crystal forms compounded
our search for a single discrete lattice in earlier experiments.
Extensive screening of these crystals was productive for the
collection of complete data, although the overall intensities
were weak [I/(I) of 1.4; Table 1]. Despite this, following
molecular replacement using the C.Esp1396I monomer as a
search model clear alternative backbone paths for the loop
region (residues 43–46) from each monomer were observed in
2Fo  Fc and Fo  Fc electron-density maps. In addition,
following refinement clear negative density surrounding
Arg35 from the model confirmed the presence of the R35A
mutation. Although these data were not sufficient to uniquely
define the side-chain conformations, they confirmed that the
structure of the R35A mutant was essentially the same as that
of the wild-type protein. We conclude from these data that the
significantly reduced binding affinity of the R35A mutant is a
direct consequence of the absence of the Arg35 side chain and
does not arise from a conformational change in the protein.
This validates our previous hypothesis that the side chain of
Arg35, which contacts a conserved TG dinucleotide lying
outside the classic inverted-repeat recognition sequence, is
central to the overall binding affinity (McGeehan et al., 2008).
Interestingly, the flexible loop region identified in the native
structure is also apparent in the mutant structure. Despite only
possessing one dimer in the asymmetric unit, each monomer
presents an alternative conformation, each corresponding to
one of the two states seen in the native protein. Fig. 6 shows
the refined structures of the mutant and native proteins
superimposed and highlights the position of the Arg35 resi-
research papers
904 Ball et al.  C.Esp1396i Acta Cryst. (2009). D65, 900–905
Figure 6
C.Esp1396I R35A mutant overlaid with chains M and N of the native
protein. The main-chain atoms of the R35A protein (blue) were overlaid
with the native protein (red), giving an r.m.s.d. of 0.48 A˚ for 408 atoms.
The position of the Arg35 side chain in the native protein is shown.
Figure 5
Temperature-factor analysis of a native dimer. Chains K and L of the
native free protein are shown as cartoons, where blue represents low and
orange high B factors (C atoms). A colour scale bar illustrates the
B-factor range from 27 to 41 A˚2. The C-terminal residues have the highest
B factors (around 20% higher than the mean) in addition to the
N-terminal regions of the recognition helices. The core of the protein
dimer, including the N-terminal half of helix 4 (shown in dark blue), has
lower than average B factors as expected. This dimer has both alternative
loop conformations, which are highlighted with arrows. The major
conformation (A) has slightly higher B factors compared with the minor
conformation (B), although both are close to the average for all residues.
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dues that flank the DNA-binding interface. As expected, the
overall structure of the two proteins is very similar, with the
greatest degree of variation again arising from the flexible
loop region (residues 43–46) between helix 3 and helix 4. Clear
electron density for each of the conformational states gives
further weight to the interpretation that two local energy
minima exist in the free protein rather than a highly mobile
loop.
High-resolution structures would assist greatly in deter-
mining the role of the conformational changes exhibited by
C.Esp1396I upon DNA binding. To this end, further X-ray
crystallography data sets of bound protein have been obtained
with various lengths and sequences of DNA and structural
analysis is in progress. Understanding the mechanisms that
underlie the ability of C.Esp1396I to bind multiple DNA-
recognition sequences and thus finely tune the expression of
the restriction–modification system are fundamental to a
complete understanding of this intricate control system.
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